Oncological Surgery — MCQs

Q: Which of the following requires the maximum margin of excision?

Dermatofibrosarcoma protuberans. **Explanation:** The correct answer is **Dermatofibrosarcoma Protuberans (DFSP)**. The primary factor determining excision margins is the biological behavior and local invasiveness of the tumor. DFSP is a low-to-intermediate grade cutaneous sarcoma characterized by extensive, subclinical **tentacle-like lateral extensions** (microscopic projections) into the surrounding dermis and subcutaneous fat. Because these extensions often go beyond the clinically visible tumor, standard narrow margins lead to extremely high recurrence rates. Current guidelines recommend a wide local excision with a margin of **2 to 4 cm**, or ideally, Mohs Micrographic Surgery (MMS). **Analysis of Incorrect Options:** * **Malignant Melanoma:** Margins are determined by the **Breslow thickness**. Even for the thickest tumors (>2 mm), the maximum recommended margin is **2 cm**. * **Squamous Cell Carcinoma (SCC):** Standard margins for high-risk SCC are typically **6 mm to 10 mm**. * **Basal Cell Carcinoma (BCC):** This is the least aggressive of the group. Standard excision margins are usually **4 mm to 5 mm** for low-risk lesions. **High-Yield Clinical Pearls for NEET-PG:** * **DFSP Pathognomonic Feature:** Histology shows a characteristic **"storiform" (cartwheel) pattern** of spindle cells and a **"honeycomb" appearance** when invading subcutaneous fat. * **Cytogenetics:** Associated with a translocation **t(17;22)**, leading to overexpression of PDGFB. * **Treatment of Choice:** Mohs Micrographic Surgery (MMS) is preferred over wide local excision to minimize tissue loss while ensuring clear margins. * **Medical Management:** **Imatinib** (a tyrosine kinase inhibitor) is used for metastatic or unresectable DFSP.

Q: The staging system for thymoma was developed by whom?

Masaoka. The correct answer is **A. Masaoka**. ### Explanation The staging of thymic epithelial tumors (thymomas) is primarily based on the **Masaoka Staging System** (later modified as the Masaoka-Koga system). This system is unique because it is based on the degree of **capsular invasion** and the involvement of adjacent structures rather than just tumor size. * **Stage I:** Macroscopically and microscopically completely encapsulated. * **Stage II:** Microscopic transcapsular invasion (IIa) or macroscopic invasion into surrounding fatty tissue (IIb). * **Stage III:** Macroscopic invasion into neighboring organs (pericardium, great vessels, or lungs). * **Stage IV:** Pleural/pericardial dissemination (IVa) or lymphogenous/hematogenous metastasis (IVb). ### Why the other options are incorrect: * **B. Yokohama:** This is not a recognized surgical staging system. It is likely a distractor. * **C. Todani:** This classification is used for **Choledochal cysts** (Types I-V), a high-yield topic in pediatric and hepatobiliary surgery. * **D. Klatskin (often confused with Kluive):** While "Kluive" is a distractor, **Klatskin tumors** refer to hilar cholangiocarcinoma. If the option meant **Bismuth-Corlette**, that is the staging used for those tumors. ### High-Yield Clinical Pearls for NEET-PG: 1. **Most common association:** 30–45% of patients with thymoma have **Myasthenia Gravis**. Conversely, only 10–15% of patients with Myasthenia Gravis have a thymoma. 2. **Treatment of Choice:** Complete surgical resection (**En-bloc Thymectomy**) is the gold standard for resectable tumors. 3. **WHO Classification:** While Masaoka stages the *extent*, the WHO classification (Types A, AB, B1, B2, B3, and C) categorizes thymomas based on *histology* and cytological atypia. 4. **TNM Staging:** Recently, the AJCC/UICC 8th edition introduced a TNM staging system for thymic tumors, but Masaoka-Koga remains the most widely used in clinical practice.

Q: What is the recommended treatment for papillary carcinoma of the thyroid with bony metastasis?

Near total thyroidectomy with radioiodine and radiotherapy. ### Explanation The management of differentiated thyroid cancers (DTC), specifically **Papillary Carcinoma Thyroid (PTC)** with distant metastasis, follows a multimodal approach aimed at both local control and systemic treatment. **Why Option D is Correct:** 1. **Near Total or Total Thyroidectomy:** This is the mandatory first step. Removing all normal thyroid tissue is essential to eliminate the source of thyroglobulin (a tumor marker) and, more importantly, to ensure that subsequent doses of radioactive iodine (RAI) are taken up by the metastatic bone lesions rather than the thyroid gland itself. 2. **Radioiodine (I-131) Therapy:** PTC is typically iodine-avid. RAI is the treatment of choice for distant metastases (lung and bone) after the primary gland is removed. 3. **Radiotherapy (EBRT):** Bone metastases in PTC are often osteolytic and carry a high risk of pathological fractures or spinal cord compression. External Beam Radiation Therapy (EBRT) is added for palliation, pain control, and to stabilize the metastatic site. **Analysis of Incorrect Options:** * **Options A & B:** These are incomplete. Surgery is the cornerstone of management for DTC, even in the presence of metastasis, to facilitate adjuvant therapies. * **Option C:** While it includes surgery and radiotherapy, it misses **Radioiodine**, which is the most specific systemic therapy for thyroid cancer cells. **NEET-PG High-Yield Pearls:** * **Most common site of metastasis in PTC:** Cervical lymph nodes (Level II, III, IV). * **Most common site of distant metastasis:** Lungs (more common than bone). * **Prognostic Scoring:** Use the **AMES** or **MACIS** criteria for PTC. * **Thyroglobulin (Tg):** Used as a postoperative tumor marker to monitor recurrence. * **Treatment of choice for Follicular Carcinoma with bone metastasis:** Also Total Thyroidectomy followed by RAI.

Q: A 3 cm squamous cell carcinoma of the retrornolar trigone is invading the mandible and the medial pterygoid muscle. What is the TNM stage of this tumor?

Stage IV. ### Explanation The TNM staging for Oral Cavity cancers (including the retromolar trigone) is based on the size and depth of invasion (T), nodal involvement (N), and metastasis (M). **1. Why Stage IV is Correct:** According to the AJCC 8th Edition, the T-stage is determined by the extent of local invasion. * **T4a (Moderately Advanced Local Disease):** The tumor invades adjacent structures such as the cortical bone of the mandible or maxilla, deep (extrinsic) muscles of the tongue, maxillary sinus, or skin of the face. * **T4b (Very Advanced Local Disease):** The tumor invades the masticator space (which includes the **medial pterygoid muscle**), pterygoid plates, or skull base, and/or encases the internal carotid artery. In this case, invasion into the **medial pterygoid muscle** automatically classifies the tumor as **T4b**. Any T4 tumor (T4a or T4b) with any N or M status results in a **Stage IV** designation (specifically Stage IVB for T4b). **2. Why Other Options are Incorrect:** * **Stage I:** Requires a T1 tumor (≤2 cm and Depth of Invasion [DOI] ≤5 mm) with no nodal involvement. * **Stage II:** Requires a T2 tumor (>2 cm and ≤4 cm, DOI ≤10 mm) with no nodal involvement. * **Stage III:** Requires a T3 tumor (>4 cm or DOI >10 mm) or a T1/T2/T3 tumor with a single ipsilateral lymph node ≤3 cm (N1). **3. Clinical Pearls for NEET-PG:** * **Retromolar Trigone (RMT):** A unique site where the mucosa is closely attached to the bone; hence, early bone invasion is common. * **Masticator Space:** Involvement of the medial pterygoid often presents clinically as **trismus** (lockjaw), which is a "red flag" for T4b disease. * **Bone Invasion:** Superficial erosion of bone/tooth socket by a gingival primary is not enough to classify as T4; there must be invasion through the cortical bone.

Q: What is the role of neoadjuvant chemotherapy in breast carcinoma patients?

To shrink the tumor to enable breast-conserving therapy. ### Explanation **Neoadjuvant Chemotherapy (NACT)** refers to the administration of systemic chemotherapy before definitive local surgical treatment. **1. Why Option B is Correct:** The primary surgical objective of NACT in breast cancer is **downstaging**. By shrinking a large primary tumor, NACT can convert a patient who was initially a candidate only for a Total Mastectomy into a candidate for **Breast Conserving Surgery (BCS)**. It also helps in downstaging involved axillary lymph nodes, potentially avoiding a morbid axillary lymph node dissection (ALND). **2. Why Other Options are Incorrect:** * **Option A & C:** While NACT treats micrometastases early, it is not a "cure" for established distant metastasis (Stage IV), nor is its primary definition "limiting" metastasis; its role is local downstaging for better surgical outcomes. * **Option D:** Symptomatic relief is the goal of *palliative* chemotherapy. NACT is part of a *curative* intent protocol. **3. NEET-PG High-Yield Pearls:** * **Indications for NACT:** Locally Advanced Breast Cancer (LABC), inflammatory breast cancer, or large tumors where the tumor-to-breast ratio precludes BCS. * **Pathological Complete Response (pCR):** The most important prognostic marker after NACT. It is defined as the absence of invasive cancer in the breast and axilla at the time of surgery. * **Molecular Subtypes:** Triple-negative (TNBC) and HER2-positive breast cancers show the highest rates of pCR with NACT. * **Monitoring:** The clinical response to NACT is monitored via physical exam and imaging (MRI is the most sensitive). If the tumor progresses during NACT, surgery should be performed immediately.

Q: What is the most common site for cancer of the tongue?

Lateral margin of tongue. **Explanation:** The **lateral margin of the tongue** (specifically the middle third) is the most common site for squamous cell carcinoma (SCC) of the tongue, accounting for approximately **75% of cases**. This area is particularly vulnerable due to chronic irritation from jagged teeth or ill-fitting dentures, and the pooling of carcinogens (like alcohol and tobacco) in the floor of the mouth and the adjacent lateral sulcus. **Analysis of Options:** * **A. Base of tongue:** This refers to the posterior one-third (behind the circumvallate papillae). While it is a common site for HPV-associated oropharyngeal cancers, it is less frequent than lateral margin involvement. * **B. Tip of tongue:** This is a rare site for primary malignancy. * **D. Posterior attachment:** This is not a standard anatomical landmark for primary tongue cancer localization; most cancers arise on the mobile (anterior two-thirds) portion. **Clinical Pearls for NEET-PG:** 1. **Histology:** Squamous Cell Carcinoma (SCC) is the most common histological type (>90%). 2. **Lymphatic Spread:** Tongue cancers have a high propensity for early lymphatic spread. The tip drains to Submental nodes (Level I), while the lateral margins drain to Submandibular (Level I) and Deep Cervical nodes (Level II/III). 3. **Premalignant Lesions:** Erythroplakia has a much higher risk of malignant transformation than Leukoplakia. 4. **Prognosis:** Tumors of the posterior third (base) generally have a worse prognosis than the anterior two-thirds because they are often diagnosed late and have a higher rate of bilateral nodal metastasis.

A 40-year-old man presents with pulmonary lesions on chest CT scan. He has a history of melanoma treated with wide local excision and lymph node dissection. Biopsy confirms metastatic melanoma in the pulmonary lesions. His general condition is good, with no evidence of recurrence or extrathoracic disease. What is the most appropriate treatment for this patient?

Oncological Surgery Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following requires the maximum margin of excision?

A. Malignant melanoma
B. Basal cell carcinoma (BCC)
C. Squamous cell carcinoma (SCC)
D. Dermatofibrosarcoma protuberans (Correct Answer)

Explanation: **Explanation:** The correct answer is **Dermatofibrosarcoma Protuberans (DFSP)**. The primary factor determining excision margins is the biological behavior and local invasiveness of the tumor. DFSP is a low-to-intermediate grade cutaneous sarcoma characterized by extensive, subclinical **tentacle-like lateral extensions** (microscopic projections) into the surrounding dermis and subcutaneous fat. Because these extensions often go beyond the clinically visible tumor, standard narrow margins lead to extremely high recurrence rates. Current guidelines recommend a wide local excision with a margin of **2 to 4 cm**, or ideally, Mohs Micrographic Surgery (MMS). **Analysis of Incorrect Options:** * **Malignant Melanoma:** Margins are determined by the **Breslow thickness**. Even for the thickest tumors (>2 mm), the maximum recommended margin is **2 cm**. * **Squamous Cell Carcinoma (SCC):** Standard margins for high-risk SCC are typically **6 mm to 10 mm**. * **Basal Cell Carcinoma (BCC):** This is the least aggressive of the group. Standard excision margins are usually **4 mm to 5 mm** for low-risk lesions. **High-Yield Clinical Pearls for NEET-PG:** * **DFSP Pathognomonic Feature:** Histology shows a characteristic **"storiform" (cartwheel) pattern** of spindle cells and a **"honeycomb" appearance** when invading subcutaneous fat. * **Cytogenetics:** Associated with a translocation **t(17;22)**, leading to overexpression of PDGFB. * **Treatment of Choice:** Mohs Micrographic Surgery (MMS) is preferred over wide local excision to minimize tissue loss while ensuring clear margins. * **Medical Management:** **Imatinib** (a tyrosine kinase inhibitor) is used for metastatic or unresectable DFSP.

Question 2: The staging system for thymoma was developed by whom?

A. Masaoka (Correct Answer)
B. Yokohama
C. Todani
D. Kluive

Explanation: The correct answer is **A. Masaoka**. ### Explanation The staging of thymic epithelial tumors (thymomas) is primarily based on the **Masaoka Staging System** (later modified as the Masaoka-Koga system). This system is unique because it is based on the degree of **capsular invasion** and the involvement of adjacent structures rather than just tumor size. * **Stage I:** Macroscopically and microscopically completely encapsulated. * **Stage II:** Microscopic transcapsular invasion (IIa) or macroscopic invasion into surrounding fatty tissue (IIb). * **Stage III:** Macroscopic invasion into neighboring organs (pericardium, great vessels, or lungs). * **Stage IV:** Pleural/pericardial dissemination (IVa) or lymphogenous/hematogenous metastasis (IVb). ### Why the other options are incorrect: * **B. Yokohama:** This is not a recognized surgical staging system. It is likely a distractor. * **C. Todani:** This classification is used for **Choledochal cysts** (Types I-V), a high-yield topic in pediatric and hepatobiliary surgery. * **D. Klatskin (often confused with Kluive):** While "Kluive" is a distractor, **Klatskin tumors** refer to hilar cholangiocarcinoma. If the option meant **Bismuth-Corlette**, that is the staging used for those tumors. ### High-Yield Clinical Pearls for NEET-PG: 1. **Most common association:** 30–45% of patients with thymoma have **Myasthenia Gravis**. Conversely, only 10–15% of patients with Myasthenia Gravis have a thymoma. 2. **Treatment of Choice:** Complete surgical resection (**En-bloc Thymectomy**) is the gold standard for resectable tumors. 3. **WHO Classification:** While Masaoka stages the *extent*, the WHO classification (Types A, AB, B1, B2, B3, and C) categorizes thymomas based on *histology* and cytological atypia. 4. **TNM Staging:** Recently, the AJCC/UICC 8th edition introduced a TNM staging system for thymic tumors, but Masaoka-Koga remains the most widely used in clinical practice.

Question 3: What is the recommended treatment for papillary carcinoma of the thyroid with bony metastasis?

A. Radiotherapy
B. Radioiodine
C. Near total thyroidectomy with radiotherapy
D. Near total thyroidectomy with radioiodine and radiotherapy (Correct Answer)

Explanation: ### Explanation The management of differentiated thyroid cancers (DTC), specifically **Papillary Carcinoma Thyroid (PTC)** with distant metastasis, follows a multimodal approach aimed at both local control and systemic treatment. **Why Option D is Correct:** 1. **Near Total or Total Thyroidectomy:** This is the mandatory first step. Removing all normal thyroid tissue is essential to eliminate the source of thyroglobulin (a tumor marker) and, more importantly, to ensure that subsequent doses of radioactive iodine (RAI) are taken up by the metastatic bone lesions rather than the thyroid gland itself. 2. **Radioiodine (I-131) Therapy:** PTC is typically iodine-avid. RAI is the treatment of choice for distant metastases (lung and bone) after the primary gland is removed. 3. **Radiotherapy (EBRT):** Bone metastases in PTC are often osteolytic and carry a high risk of pathological fractures or spinal cord compression. External Beam Radiation Therapy (EBRT) is added for palliation, pain control, and to stabilize the metastatic site. **Analysis of Incorrect Options:** * **Options A & B:** These are incomplete. Surgery is the cornerstone of management for DTC, even in the presence of metastasis, to facilitate adjuvant therapies. * **Option C:** While it includes surgery and radiotherapy, it misses **Radioiodine**, which is the most specific systemic therapy for thyroid cancer cells. **NEET-PG High-Yield Pearls:** * **Most common site of metastasis in PTC:** Cervical lymph nodes (Level II, III, IV). * **Most common site of distant metastasis:** Lungs (more common than bone). * **Prognostic Scoring:** Use the **AMES** or **MACIS** criteria for PTC. * **Thyroglobulin (Tg):** Used as a postoperative tumor marker to monitor recurrence. * **Treatment of choice for Follicular Carcinoma with bone metastasis:** Also Total Thyroidectomy followed by RAI.

Question 4: A 3 cm squamous cell carcinoma of the retrornolar trigone is invading the mandible and the medial pterygoid muscle. What is the TNM stage of this tumor?

A. Stage I
B. Stage II
C. Stage III
D. Stage IV (Correct Answer)

Explanation: ### Explanation The TNM staging for Oral Cavity cancers (including the retromolar trigone) is based on the size and depth of invasion (T), nodal involvement (N), and metastasis (M). **1. Why Stage IV is Correct:** According to the AJCC 8th Edition, the T-stage is determined by the extent of local invasion. * **T4a (Moderately Advanced Local Disease):** The tumor invades adjacent structures such as the cortical bone of the mandible or maxilla, deep (extrinsic) muscles of the tongue, maxillary sinus, or skin of the face. * **T4b (Very Advanced Local Disease):** The tumor invades the masticator space (which includes the **medial pterygoid muscle**), pterygoid plates, or skull base, and/or encases the internal carotid artery. In this case, invasion into the **medial pterygoid muscle** automatically classifies the tumor as **T4b**. Any T4 tumor (T4a or T4b) with any N or M status results in a **Stage IV** designation (specifically Stage IVB for T4b). **2. Why Other Options are Incorrect:** * **Stage I:** Requires a T1 tumor (≤2 cm and Depth of Invasion [DOI] ≤5 mm) with no nodal involvement. * **Stage II:** Requires a T2 tumor (>2 cm and ≤4 cm, DOI ≤10 mm) with no nodal involvement. * **Stage III:** Requires a T3 tumor (>4 cm or DOI >10 mm) or a T1/T2/T3 tumor with a single ipsilateral lymph node ≤3 cm (N1). **3. Clinical Pearls for NEET-PG:** * **Retromolar Trigone (RMT):** A unique site where the mucosa is closely attached to the bone; hence, early bone invasion is common. * **Masticator Space:** Involvement of the medial pterygoid often presents clinically as **trismus** (lockjaw), which is a "red flag" for T4b disease. * **Bone Invasion:** Superficial erosion of bone/tooth socket by a gingival primary is not enough to classify as T4; there must be invasion through the cortical bone.

Question 5: What is the treatment of choice for anaplastic carcinoma of the thyroid that infiltrates the trachea and sternum?

A. Radical excision
B. Chemotherapy
C. Radiotherapy
D. Palliative treatment (Correct Answer)

Explanation: **Explanation:** **Anaplastic Carcinoma of the Thyroid (ATC)** is one of the most aggressive solid tumors in humans, characterized by rapid growth, early local invasion, and distant metastasis. **1. Why Palliative Treatment is Correct:** In this clinical scenario, the tumor has already infiltrated vital structures like the **trachea and sternum**. This indicates a Stage IVC (metastatic) or locally unresectable Stage IVB disease. Because ATC is highly resistant to conventional therapies and usually presents at an advanced stage, the prognosis is dismal (median survival of 3–6 months). When the tumor is unresectable and involves major structures, the goal of management shifts from cure to **palliation**—focusing on airway maintenance (e.g., tracheostomy if needed), pain control, and improving the quality of life. **2. Why Other Options are Incorrect:** * **Radical Excision:** Surgery is only indicated if the tumor is small and localized (rare). Once it infiltrates the trachea and sternum, radical surgery is technically impossible and does not improve survival. * **Chemotherapy & Radiotherapy:** While these are used as adjuvant or "multimodal" therapies to slow progression or shrink the tumor, they are not curative. In the presence of extensive infiltration, they are considered part of a palliative regimen rather than the primary "treatment of choice" for cure. **Clinical Pearls for NEET-PG:** * **Demographics:** Most common in elderly patients (6th–7th decade). * **Histology:** Shows spindle, polygonal, or giant cells; often arises from a pre-existing differentiated thyroid cancer (e.g., Papillary). * **Diagnosis:** Core needle biopsy or FNAC; however, IHC (p53 mutations, loss of TTF-1) is often required. * **Key Sign:** Rapidly enlarging neck mass causing "compressive symptoms" (dyspnea, dysphagia, hoarseness). * **Management:** If the tumor is resectable (rare), total thyroidectomy + postoperative RT/CT is done. If unresectable, palliative care is the mainstay.

Question 6: A 42-year-old man is undergoing chemotherapy after resection of a cecal adenocarcinoma with positive lymph nodes. Which of the following potentially operable complications is a common occurrence among patients receiving systemic chemotherapy?

A. Acute cholecystitis
B. Perirectal abscess (Correct Answer)
C. Appendicitis
D. Diverticulitis

Explanation: **Explanation:** The correct answer is **Perirectal abscess**. **1. Why Perirectal Abscess is Correct:** Patients undergoing systemic chemotherapy for malignancies (like cecal adenocarcinoma) frequently experience **neutropenia**. In a neutropenic state, the mucosal integrity of the gastrointestinal tract is often compromised (mucositis). The perianal and perirectal areas are highly colonized with bacteria; minor trauma or cryptoglandular infection in an immunocompromised host can rapidly progress to a perirectal abscess or necrotizing soft tissue infection. Notably, in neutropenic patients, classic signs of inflammation (redness, fluctuance, or pus) may be absent, making **exquisite localized pain** the most reliable clinical indicator. **2. Why the Other Options are Incorrect:** * **Acute Cholecystitis:** While it can occur in hospitalized patients (especially acalculous cholecystitis in the ICU), it is not a specific or "common" complication directly attributed to the systemic effects of standard chemotherapy compared to perirectal infections. * **Appendicitis:** The incidence of appendicitis in patients on chemotherapy is not significantly higher than in the general population. Furthermore, in this specific patient, the **cecum has already been resected**, meaning the appendix was likely removed during the primary surgery. * **Diverticulitis:** While chemotherapy (specifically VEGF inhibitors like Bevacizumab) can increase the risk of bowel perforation, primary diverticulitis is not a standard "common occurrence" triggered by neutropenia in the same way perirectal infections are. **3. NEET-PG High-Yield Pearls:** * **Neutropenic Enterocolitis (Typhlitis):** Another critical surgical complication of chemotherapy, typically involving the cecum. It presents with RLQ pain, fever, and neutropenia. * **Clinical Sign:** In a neutropenic patient with a perirectal abscess, **digital rectal examination (DRE)** should be performed with extreme caution or avoided to prevent bacteremia, unless necessary for diagnosis. * **Management:** Prompt broad-spectrum antibiotics are the mainstay; surgical drainage is indicated if there is evidence of fluctuance or if the infection does not respond to medical therapy.

Question 7: The Astler-Coller modification of the Dukes classification is used to classify cancers of which organ?

A. Liver
B. Colon (Correct Answer)
C. Lung
D. Stomach

Explanation: **Explanation:** The **Astler-Coller modification** is a clinical and pathological staging system specifically designed for **Colorectal Carcinoma**. It is an evolution of the original Dukes classification, refined to better reflect the prognostic significance of the depth of tumor invasion and the presence of lymph node involvement. **Why Colon is Correct:** The system categorizes colorectal cancer based on the extent of local spread: * **A:** Limited to mucosa. * **B1:** Extending into muscularis propria but not through it (nodes negative). * **B2:** Penetrating through muscularis propria (nodes negative). * **C1:** Extending into muscularis propria (nodes positive). * **C2:** Penetrating through muscularis propria (nodes positive). * **D:** Distant metastasis. This refinement is crucial because, in the Astler-Coller system, the "C" stage is subdivided to show that transmural extension (C2) carries a worse prognosis than intramural spread (C1) even when nodes are positive. **Why Other Options are Incorrect:** * **Liver:** Primary liver cancers (HCC) are typically staged using the **BCLC (Barcelona Clinic Liver Cancer)** system or the TNM system. * **Lung:** Lung cancer uses the **TNM staging** system (AJCC), which focuses heavily on tumor size, hilar/mediastinal node involvement, and distant spread. * **Stomach:** Gastric cancer is staged using the **Japanese Gastric Cancer Association (JGCA)** classification or the standard TNM system. **High-Yield Clinical Pearls for NEET-PG:** * **Dukes Classification (Original):** A (Submucosa), B (Muscularis), C (Nodes). * **Astler-Coller Key:** It specifically introduced the distinction between **B1/B2** and **C1/C2** based on the penetration of the *muscularis propria*. * **Current Gold Standard:** While Astler-Coller is historically significant and frequently tested, the **AJCC TNM system** is the current clinical standard for colorectal cancer staging. * **Prognostic Factor:** The most important prognostic factor in colorectal cancer is the **number of lymph nodes involved**.

Question 8: What is the role of neoadjuvant chemotherapy in breast carcinoma patients?

A. Curing distant metastasis
B. To shrink the tumor to enable breast-conserving therapy (Correct Answer)
C. Limiting metastasis
D. Symptomatic relief

Explanation: ### Explanation **Neoadjuvant Chemotherapy (NACT)** refers to the administration of systemic chemotherapy before definitive local surgical treatment. **1. Why Option B is Correct:** The primary surgical objective of NACT in breast cancer is **downstaging**. By shrinking a large primary tumor, NACT can convert a patient who was initially a candidate only for a Total Mastectomy into a candidate for **Breast Conserving Surgery (BCS)**. It also helps in downstaging involved axillary lymph nodes, potentially avoiding a morbid axillary lymph node dissection (ALND). **2. Why Other Options are Incorrect:** * **Option A & C:** While NACT treats micrometastases early, it is not a "cure" for established distant metastasis (Stage IV), nor is its primary definition "limiting" metastasis; its role is local downstaging for better surgical outcomes. * **Option D:** Symptomatic relief is the goal of *palliative* chemotherapy. NACT is part of a *curative* intent protocol. **3. NEET-PG High-Yield Pearls:** * **Indications for NACT:** Locally Advanced Breast Cancer (LABC), inflammatory breast cancer, or large tumors where the tumor-to-breast ratio precludes BCS. * **Pathological Complete Response (pCR):** The most important prognostic marker after NACT. It is defined as the absence of invasive cancer in the breast and axilla at the time of surgery. * **Molecular Subtypes:** Triple-negative (TNBC) and HER2-positive breast cancers show the highest rates of pCR with NACT. * **Monitoring:** The clinical response to NACT is monitored via physical exam and imaging (MRI is the most sensitive). If the tumor progresses during NACT, surgery should be performed immediately.

Question 9: What is the most common site for cancer of the tongue?

A. Base of tongue
B. Tip of tongue
C. Lateral margin of tongue (Correct Answer)
D. Posterior attachment of tongue

Explanation: **Explanation:** The **lateral margin of the tongue** (specifically the middle third) is the most common site for squamous cell carcinoma (SCC) of the tongue, accounting for approximately **75% of cases**. This area is particularly vulnerable due to chronic irritation from jagged teeth or ill-fitting dentures, and the pooling of carcinogens (like alcohol and tobacco) in the floor of the mouth and the adjacent lateral sulcus. **Analysis of Options:** * **A. Base of tongue:** This refers to the posterior one-third (behind the circumvallate papillae). While it is a common site for HPV-associated oropharyngeal cancers, it is less frequent than lateral margin involvement. * **B. Tip of tongue:** This is a rare site for primary malignancy. * **D. Posterior attachment:** This is not a standard anatomical landmark for primary tongue cancer localization; most cancers arise on the mobile (anterior two-thirds) portion. **Clinical Pearls for NEET-PG:** 1. **Histology:** Squamous Cell Carcinoma (SCC) is the most common histological type (>90%). 2. **Lymphatic Spread:** Tongue cancers have a high propensity for early lymphatic spread. The tip drains to Submental nodes (Level I), while the lateral margins drain to Submandibular (Level I) and Deep Cervical nodes (Level II/III). 3. **Premalignant Lesions:** Erythroplakia has a much higher risk of malignant transformation than Leukoplakia. 4. **Prognosis:** Tumors of the posterior third (base) generally have a worse prognosis than the anterior two-thirds because they are often diagnosed late and have a higher rate of bilateral nodal metastasis.

Question 10: A 40-year-old man presents with pulmonary lesions on chest CT scan. He has a history of melanoma treated with wide local excision and lymph node dissection. Biopsy confirms metastatic melanoma in the pulmonary lesions. His general condition is good, with no evidence of recurrence or extrathoracic disease. What is the most appropriate treatment for this patient?

A. Pulmonary metastasectomy followed by radiation therapy
B. Pulmonary metastasectomy (Correct Answer)
C. Chemotherapy
D. Radiation therapy

Explanation: **Explanation:** The correct answer is **Pulmonary Metastasectomy**. In surgical oncology, the management of metastatic disease is governed by specific criteria. For pulmonary metastases, surgical resection is indicated when the primary tumor is controlled, there is no extrathoracic disease, the patient is medically fit for surgery, and a complete (R0) resection is technically feasible. **Why Pulmonary Metastasectomy is correct:** In this patient, the primary melanoma has been treated, there is no evidence of recurrence elsewhere, and his general condition is good. For isolated pulmonary metastases from solid tumors (like melanoma, osteosarcoma, or colorectal cancer), metastasectomy offers the best chance for long-term survival and, in some cases, a potential cure. **Why other options are incorrect:** * **A. Followed by radiation therapy:** Post-operative radiation is not standard for pulmonary metastases unless there is positive margin (R1/R2) or specific palliative needs. * **C. Chemotherapy:** While systemic therapy (immunotherapy/targeted therapy) is common in Stage IV melanoma, surgery remains the preferred local treatment for resectable, isolated lung nodules in a fit patient to achieve a "disease-free" state. * **D. Radiation therapy:** Radiation is generally reserved for palliation or for patients who are not surgical candidates (Stereotactic Body Radiotherapy - SBRT). **Clinical Pearls for NEET-PG:** * **Thomford’s Criteria:** The classic criteria for metastasectomy include: (1) Primary site controlled, (2) No extrapulmonary disease, (3) Resectable lesions, (4) Adequate pulmonary reserve. * **Most common source of lung metastasis:** Breast, GI tract, and Kidneys. * **Best Prognosis:** Metastasectomy for **Osteosarcoma** and **Testicular tumors** often yields the highest survival rates. * **Melanoma specific:** While historically resistant to chemo, isolated surgical resection of melanoma metastases can significantly improve 5-year survival compared to systemic therapy alone.

Question 11: What is the use of injecting methylene blue dye in breast cancer surgery?

A. Tattooing for biopsy
B. Marking of tumor cells
C. Sentinel lymph node biopsy (Correct Answer)
D. Photodynamic therapy

Explanation: **Explanation:** **Sentinel Lymph Node Biopsy (SLNB)** is the standard of care for axillary staging in clinically node-negative (cN0) breast cancer. The "Sentinel Node" is defined as the first lymph node(s) to receive lymphatic drainage from the primary tumor. Injecting **Methylene Blue** (or Isosulfan Blue/Patent Blue) into the periareolar area or the peritumoral tissue allows the surgeon to visually track the blue-stained lymphatic channels leading to the blue-stained sentinel node. This allows for targeted removal of only the most relevant nodes, reducing the risk of lymphedema compared to a full axillary dissection. **Analysis of Incorrect Options:** * **A. Tattooing for biopsy:** While dyes or charcoal can be used to mark non-palpable lesions for excision, Methylene Blue is not used for permanent tattooing as it diffuses rapidly. * **B. Marking of tumor cells:** Methylene Blue does not selectively bind to or "stain" breast cancer cells; it follows lymphatic flow. * **D. Photodynamic therapy:** This involves photosensitizers (like porphyrins) and specific light wavelengths to kill cancer cells, not diagnostic blue dyes. **High-Yield Clinical Pearls for NEET-PG:** * **Dual Technique:** The highest identification rate for SLNB is achieved using a combination of **Methylene Blue dye** and **Radioactive Technetium-99m sulfur colloid** (detected via a Gamma probe). * **Contraindication:** SLNB is generally avoided in inflammatory breast cancer. * **Side Effect:** Patients should be warned that Methylene Blue can cause temporary blue-green discoloration of urine and skin. * **Safety Note:** Isosulfan blue carries a small risk of anaphylaxis; Methylene Blue is a safer, cost-effective alternative.

Question 12: A 50-year-old male, working as a hotel cook and having four dependent family members, has been diagnosed with early-stage squamous cell carcinoma of the anal canal. He has more than a 60% chance of cure. What is the best treatment option?

A. Abdomino-perineal resection
B. Combined surgery and radiotherapy
C. Combined chemotherapy and radiotherapy (Correct Answer)
D. Chemotherapy alone

Explanation: **Explanation:** The primary goal in treating squamous cell carcinoma (SCC) of the anal canal is to achieve a cure while preserving the anal sphincter and its function. **1. Why Option C is Correct:** The standard of care for anal canal SCC is **Concurrent Chemoradiotherapy (Nigro Protocol)**. This approach uses Mitomycin-C and 5-Fluorouracil (5-FU) alongside external beam radiation. It offers high cure rates (over 70-80% for early stages) and, most importantly, allows for **sphincter preservation**. For this patient—a cook and sole breadwinner—avoiding a permanent colostomy is vital for his quality of life and livelihood. **2. Why Other Options are Incorrect:** * **Option A (Abdominoperineal Resection - APR):** Historically the gold standard, APR is now reserved only for **salvage therapy** (persistent or recurrent disease) or for patients who cannot tolerate radiation. It requires a permanent colostomy, which is avoided in the first-line setting. * **Option B (Surgery + Radiotherapy):** Surgery is not the primary modality for anal SCC. Combining it with radiation upfront increases morbidity without improving survival compared to the Nigro protocol. * **Option D (Chemotherapy alone):** Chemotherapy is used as a radiosensitizer; it is insufficient to achieve a cure when used without radiation. **Clinical Pearls for NEET-PG:** * **Anal Canal vs. Anal Margin:** SCC of the anal *canal* is treated with chemoradiotherapy. SCC of the anal *margin* (well-differentiated, <2cm) can be treated with wide local excision. * **Most Common Histology:** Squamous cell carcinoma (associated with HPV 16 and 18). * **Nigro Protocol:** Mitomycin + 5-FU + Radiation. * **Follow-up:** Clinical assessment (DRE and inguinal palpation) is the most important tool to monitor for recurrence.

Question 13: What is the most common histological type of thyroid carcinoma?

A. Medullary type
B. Follicular type
C. Papillary type (Correct Answer)
D. Anaplastic type

Explanation: **Explanation:** **Papillary Thyroid Carcinoma (PTC)** is the most common histological type of thyroid cancer, accounting for approximately **80–85%** of all cases. It is characterized by its indolent growth and excellent prognosis. The diagnosis is primarily based on distinct nuclear features, such as **Orphan Annie eye nuclei** (cleared-out chromatin), **Psammoma bodies** (laminated calcifications), and nuclear grooves. It typically spreads via the **lymphatics** to cervical lymph nodes. **Analysis of Incorrect Options:** * **Follicular Carcinoma (Option B):** The second most common type (approx. 10%). Unlike PTC, it spreads **hematogenously** (to bone and lungs) and cannot be diagnosed by FNAC alone, as it requires histological evidence of capsular or vascular invasion. * **Medullary Carcinoma (Option A):** Accounts for about 5% of cases. It arises from **Parafollicular C-cells** and secretes **Calcitonin**. It is associated with MEN 2A and 2B syndromes. * **Anaplastic Carcinoma (Option D):** The rarest (<2%) but most aggressive form. It has a very poor prognosis and typically presents in elderly patients as a rapidly enlarging neck mass. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factor:** Prior exposure to ionizing radiation is the most significant risk factor for PTC. * **BRAF Mutation:** The most common genetic mutation associated with Papillary Carcinoma. * **Investigation of Choice:** FNAC is the gold standard for initial evaluation (except for Follicular type). * **Prognosis:** PTC has the best 10-year survival rate (>90%) among all thyroid malignancies.

Question 14: Which type of thyroid cancer has the least hematogenous spread?

A. Follicular
B. Papillary (Correct Answer)
C. Anaplastic
D. Medullary

Explanation: ### Explanation The correct answer is **Papillary Thyroid Carcinoma (PTC)**. The primary mode of metastasis for thyroid cancers is a high-yield topic for NEET-PG, focusing on the distinction between lymphatic and hematogenous spread. **1. Why Papillary is Correct:** Papillary carcinoma is the most common thyroid malignancy. Its hallmark characteristic is its strong predilection for **lymphatic spread** to the cervical lymph nodes (occurring in up to 50-80% of cases). Conversely, **hematogenous spread is rare** (less than 5-10%), typically occurring only in advanced stages or aggressive variants. **2. Analysis of Incorrect Options:** * **Follicular (A):** This is the classic example of a thyroid cancer that spreads **hematogenously**. It rarely involves lymph nodes; instead, it invades blood vessels to metastasize to the lungs and bones. * **Anaplastic (C):** This is a highly aggressive, undifferentiated tumor. It spreads rapidly via both local invasion and **early hematogenous routes** to distant organs. * **Medullary (D):** Derived from parafollicular C-cells, it spreads via both lymphatics and the **bloodstream** (liver, lungs, and bone) early in the disease course. **3. NEET-PG High-Yield Pearls:** * **Most common thyroid cancer:** Papillary (85%). * **Most common site of distant metastasis (Follicular):** Bone (Pulsatile secondary). * **Psammoma bodies:** Pathognomonic histological feature of Papillary carcinoma. * **Orphan Annie Eye nuclei:** Characteristic nuclear clearing in Papillary carcinoma. * **Rule of Thumb:** "Papillary = Popular (Common) & Peripheral (Lymph nodes); Follicular = Far (Blood/Distant)."

Question 15: What is the treatment for lower lip carcinoma less than 1 cm?

A. Radiotherapy
B. Chemotherapy
C. Surgical excision (Correct Answer)
D. Radiotherapy + Chemotherapy

Explanation: **Explanation:** The primary treatment for early-stage (T1) lower lip carcinoma, specifically lesions less than 1 cm, is **surgical excision**. The goal is to achieve a wide local excision with a 5–10 mm clear margin. For lesions of this size, a **V-shaped or wedge resection** is typically performed, allowing for primary closure with excellent functional and cosmetic outcomes. **Why the other options are incorrect:** * **Radiotherapy (A):** While radiotherapy is an alternative for T1-T2 lesions and offers similar control rates, it is generally reserved for patients who are medically unfit for surgery or for larger lesions where surgery would cause significant cosmetic deformity. Surgery is preferred for small lesions because it is quicker, more cost-effective, and avoids long-term radiation side effects (e.g., xerostomia, osteoradionecrosis). * **Chemotherapy (B):** Chemotherapy is not used as a primary or definitive treatment for localized lip cancer. It is typically reserved for palliative care or as part of a concurrent chemoradiation protocol for advanced, inoperable cases. * **Radiotherapy + Chemotherapy (D):** This combination is indicated for advanced (Stage III/IV) disease or high-risk features (positive margins, perineural invasion) but is overtreatment for a <1 cm lesion. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Lower lip (90%) due to chronic sun exposure (UV radiation). * **Histology:** Squamous Cell Carcinoma (SCC) is the most common type. * **Lymphatic spread:** Lower lip cancers primarily drain to **Submental (Level Ia)** and **Submandibular (Level Ib)** nodes. * **Rule of Thirds:** If a defect after excision is <1/3rd of the lip, perform primary closure; if 1/3rd to 2/3rd, use flaps like **Abbe or Estlander**; if >2/3rd, use a **Karapandzic** flap.

Question 16: Which of the following immunohistochemical markers can be used for the diagnosis of rhabdomyosarcoma?

A. Myeloperoxidase
B. Desmin (Correct Answer)
C. Cytokeratin
D. Synaptophysin

Explanation: **Explanation:** **Rhabdomyosarcoma (RMS)** is a highly malignant soft tissue tumor derived from primitive mesenchymal cells that show evidence of skeletal muscle differentiation. **Why Desmin is the Correct Answer:** Desmin is an intermediate filament protein found in smooth and skeletal muscle cells. It is the most widely used screening marker for myogenic tumors. In the context of rhabdomyosarcoma, **Desmin** is highly sensitive. Other specific markers for skeletal muscle differentiation include **Myogenin (Myf4)** and **MyoD1**, which are nuclear markers and are considered the "gold standard" for confirming the diagnosis of RMS. **Analysis of Incorrect Options:** * **A. Myeloperoxidase (MPO):** This is a marker for myeloid lineage cells. It is primarily used in the diagnosis of **Acute Myeloid Leukemia (AML)** and myeloid sarcoma. * **C. Cytokeratin:** This is a marker for epithelial differentiation. It is used to diagnose **Carcinomas** and certain sarcomas like Synovial Sarcoma, but not typically Rhabdomyosarcoma. * **D. Synaptophysin:** This is a marker for **Neuroendocrine** differentiation, used for tumors like carcinoids, small cell carcinoma, or pheochromocytoma. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Head and neck (overall), though it varies by subtype. * **Subtypes:** * **Embryonal:** Most common overall; includes the *Sarcoma Botryoides* variant (grape-like mass in the vagina/bladder). * **Alveolar:** Associated with t(2;13) or t(1;13) translocations; carries a poorer prognosis. * **IHC Summary:** Desmin (Sensitive) → Myogenin/MyoD1 (Specific).

Question 17: A 75-year-old woman presented with an enlarging lesion on the upper back of 3 years' duration. She had multiple co-morbidities. On examination, there was a 4-cm diameter erythematous, shiny plaque. A punch biopsy showed superficial basal cell carcinoma. It was decided to treat her with imiquimod. What is the recommended treatment regimen?

A. 3 times per week for 8 weeks
B. 5 times per week for 6 weeks (Correct Answer)
C. Alternate days for 4 weeks
D. Daily for 3 weeks

Explanation: **Explanation:** The patient presents with a **superficial Basal Cell Carcinoma (sBCC)**. While surgical excision is the gold standard for BCC, topical therapy with **Imiquimod 5% cream** is an FDA-approved, effective alternative for patients with small, superficial lesions or those who are poor surgical candidates due to advanced age and comorbidities. **1. Why Option B is Correct:** The standard, evidence-based regimen for treating superficial BCC with Imiquimod 5% is application **5 times per week for a duration of 6 weeks**. This schedule balances efficacy (achieving clearance rates of approximately 80-90%) with manageable local inflammatory side effects (erythema, crusting, and erosions), which are actually markers of the drug's immune-stimulating activity. **2. Why Other Options are Incorrect:** * **Option A (3 times/week for 8 weeks):** This is the standard regimen for **Anogenital Warts**, not sBCC. * **Option C & D:** These regimens are either too infrequent or too short to achieve the necessary histological clearance for a malignant lesion like BCC. Using sub-therapeutic durations increases the risk of recurrence. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Imiquimod is an **immune response modifier**. It acts as an agonist at **Toll-like receptor 7 (TLR-7)**, stimulating the release of cytokines (IFN-α, TNF-α, IL-12) and activating cell-mediated immunity. * **Indications:** Superficial BCC, Actinic Keratosis (3x/week), and External Genital Warts. * **Contraindication:** It is generally avoided in "high-risk" BCC subtypes (morpheaform, infiltrating) or lesions in "H-zone" areas of the face where surgery is mandatory. * **Expected Reaction:** Patients should be warned that the lesion will look "worse" (red, inflamed) before it gets better; this indicates the medication is working.

Question 18: A 56-year-old man presents with a history of a small lump on his finger for some months, which has recently started leaking after an injury sustained while working in the garage. What is the single most likely diagnosis?

A. Keratoacanthoma
B. Myxoid cyst (Correct Answer)
C. Pyogenic granuloma
D. Sebaceous cyst

Explanation: **Explanation:** The clinical presentation of a small, long-standing lump on the finger that leaks fluid—especially after minor trauma—is classic for a **Myxoid cyst** (also known as a digital mucous cyst). **Why Myxoid Cyst is correct:** These are benign ganglion cysts typically located on the dorsum of the distal interphalangeal (DIP) joint or the proximal nail fold. They contain a clear, viscous, jelly-like fluid (hyaluronic acid). A hallmark feature is that they frequently rupture or leak a "clear, sticky fluid" following minor injury, which aligns perfectly with the patient's history of leakage after working in the garage. **Why the other options are incorrect:** * **Keratoacanthoma:** This is a rapidly growing, dome-shaped nodule with a central keratinous plug. It does not typically leak fluid; it is a solid, firm lesion that may undergo spontaneous regression. * **Pyogenic granuloma:** These are vascular lesions that occur after minor trauma. However, they are characterized by bright red, friable tissue that **bleeds profusely** rather than leaking clear fluid. * **Sebaceous cyst:** These are rare on the fingers because fingers lack sebaceous glands (except for the dorsal aspect, but even then, they are uncommon). They contain cheesy keratin and usually have a visible punctum. **NEET-PG High-Yield Pearls:** * **Association:** Myxoid cysts are frequently associated with **osteoarthritis** of the DIP joint (Heberden's nodes). * **Nail Changes:** If the cyst presses on the nail matrix, it can cause a characteristic **longitudinal groove** in the fingernail. * **Management:** Simple aspiration has a high recurrence rate; definitive treatment often requires excision of the cyst and the underlying osteophyte.

Question 19: Masaoka staging is used in which of the following conditions?

A. Renal Cell Carcinoma (RCC)
B. Hepatocellular Carcinoma (HCC)
C. Thymoma (Correct Answer)
D. Lymphoma

Explanation: **Explanation:** **Masaoka Staging** (specifically the Masaoka-Koga classification) is the most widely used clinical and pathological staging system for **Thymoma**. It is based on the degree of local extension and the presence of metastases. 1. **Why Thymoma is Correct:** The staging focuses on the integrity of the tumor capsule. * **Stage I:** Macroscopically and microscopically completely encapsulated. * **Stage II:** Microscopic (IIa) or Macroscopic (IIb) invasion into the capsule or surrounding fatty tissue. * **Stage III:** Macroscopic invasion into neighboring organs (pericardium, great vessels, or lungs). * **Stage IV:** Pleural/pericardial dissemination (IVa) or Lymphogenous/hematogenous metastasis (IVb). 2. **Why Other Options are Incorrect:** * **RCC:** Staged using the **TNM system** (Robson’s classification was used historically but is now obsolete). * **HCC:** Staged using the **BCLC (Barcelona Clinic Liver Cancer)** system, which incorporates tumor burden, liver function (Child-Pugh), and performance status. * **Lymphoma:** Staged using the **Ann Arbor Staging** system (or the Lugano classification). **High-Yield Clinical Pearls for NEET-PG:** * **Most common association:** Thymoma is strongly associated with **Myasthenia Gravis** (30-45% of patients). * **Surgical Approach:** The treatment of choice for Masaoka Stage I and II is **Total Thymectomy**. * **Radiology:** The "Silhouette sign" on a chest X-ray often helps localize these anterior mediastinal masses. * **WHO Classification:** While Masaoka stages the *extent*, the WHO classification (Type A, AB, B1, B2, B3, C) describes the *histology*.

Question 20: Which of the following is one of the most important prognostic factors for colorectal carcinoma?

A. Site of lesion
B. Tumour size and characteristics
C. Age of patient
D. Lymph node status (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Lymph node status** In colorectal carcinoma (CRC), the **extent of nodal involvement (N stage)** is the most significant independent prognostic factor for survival and the primary determinant for administering adjuvant chemotherapy. According to the TNM staging system, the presence of even a single positive lymph node upgrades the disease to **Stage III**, which significantly reduces the 5-year survival rate compared to Stage II (node-negative) disease. The "Lymph Node Ratio" (ratio of positive nodes to total nodes harvested) is also a critical prognostic indicator. **Analysis of Incorrect Options:** * **A. Site of lesion:** While right-sided (proximal) tumors often have a worse prognosis than left-sided tumors due to delayed presentation and different molecular pathways (MSI-H), the anatomical site is secondary to the pathological stage in predicting outcome. * **B. Tumour size and characteristics:** Unlike breast or soft tissue cancers, the absolute size of a colorectal tumor does not determine the T-stage or prognosis. The T-stage is defined by the **depth of wall invasion** (e.g., invasion into the muscularis propria or serosa), not the diameter. * **C. Age of patient:** While younger patients may present with more aggressive histological subtypes (e.g., signet ring cell), age itself is not a primary prognostic factor compared to the pathological stage. **Clinical Pearls for NEET-PG:** * **Minimum Node Harvest:** At least **12 lymph nodes** must be examined pathologically to accurately stage a colorectal specimen as Node Negative (N0). * **Most Important Factor overall:** While lymph node status is the most important for resectable disease, the presence of **Distant Metastasis (M stage)** is the single most important prognostic factor for overall survival. * **CEA Levels:** Pre-operative Carcinoembryonic Antigen (CEA) levels >5 ng/mL are associated with a poorer prognosis but are used for monitoring recurrence, not primary staging.

Question 21: A 30-year-old male has papillary thyroid carcinoma with a nodule less than 3 cm confined to the neck, along with 2 palpable lymph nodes in the neck and micro-metastasis in the lungs. According to the AJCC 8th edition, how would you stage this patient?

A. Stage I
B. Stage II (Correct Answer)
C. Stage III
D. Stage IV

Explanation: ### Explanation The staging of Papillary Thyroid Carcinoma (PTC) underwent a significant paradigm shift in the **AJCC 8th Edition**, primarily centered on the age of the patient. **1. Why Stage II is Correct:** In the AJCC 8th edition, the age cutoff for staging was increased from 45 to **55 years**. For patients **younger than 55 years**, there are only two possible stages: * **Stage I:** Any T, Any N, **M0** (No distant metastasis). * **Stage II:** Any T, Any N, **M1** (Distant metastasis present). Since this patient is 30 years old (under 55) and has **micro-metastasis in the lungs (M1)**, he is automatically classified as **Stage II**, regardless of the tumor size (T) or lymph node involvement (N). **2. Why Other Options are Incorrect:** * **Stage I:** This would be correct if the patient had no distant metastasis (M0). Even with positive lymph nodes, a patient <55 years remains Stage I if there is no M1. * **Stage III & IV:** These stages **do not exist** for patients under the age of 55 in the AJCC 8th edition. These categories are reserved exclusively for patients aged 55 and older. **3. NEET-PG High-Yield Pearls:** * **Age Cutoff:** Remember **55 years** is the magic number for thyroid cancer staging. * **Younger (<55):** Only Stage I (M0) or Stage II (M1). Death is rare in this group. * **Older (≥55):** Staging follows the traditional I-IV system based on T, N, and M. * **Nodal Status:** In patients <55, N1 (lymph node metastasis) does **not** change the stage from I to II; only M1 does. * **Prognosis:** PTC has an excellent prognosis; the change in age cutoff reflects the low mortality in younger patients even with nodal spread.

Question 22: Sentinel lymph node biopsy is used for which of the following conditions?

A. Breast carcinoma (Correct Answer)
B. Penile carcinoma
C. Retroperitoneal sarcoma
D. Hepatic carcinoma

Explanation: **Explanation:** **Sentinel Lymph Node Biopsy (SLNB)** is based on the concept that the lymphatic drainage from a primary tumor follows a predictable orderly pattern to a specific first node (or group of nodes), known as the **Sentinel Node**. If this node is negative for metastasis, the remaining nodes in the basin are likely clear, sparing the patient from the morbidity of a radical lymphadenectomy. * **Breast Carcinoma (Correct):** SLNB is the standard of care for clinically node-negative (cN0) breast cancer. It is performed using Technetium-99m labeled sulfur colloid, isosulfan blue dye, or both. It helps avoid the complications of Axillary Lymph Node Dissection (ALND), such as lymphedema and nerve injury. * **Penile Carcinoma (Incorrect):** While SLNB can be used in specific stages of penile cancer (using Dynamic Sentinel Node Biopsy), it is not the "classic" or most common application compared to breast cancer in standard surgical curricula. However, in the context of this MCQ, Breast Carcinoma is the primary established indication. * **Retroperitoneal Sarcoma (Incorrect):** These tumors primarily spread via the hematogenous route rather than predictable lymphatic channels. Surgical management focuses on wide local excision with clear margins (R0 resection) rather than nodal mapping. * **Hepatic Carcinoma (Incorrect):** Hepatocellular carcinoma (HCC) spreads via intrahepatic portal veins or hematogenously. Lymph node mapping is not a standard surgical protocol for HCC. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indications for SLNB:** 1. Breast Carcinoma, 2. Malignant Melanoma. * **Contraindications in Breast Cancer:** Inflammatory breast cancer, clinically palpable nodes (cN1+), and large tumors (T3/T4). * **Identification:** The "Hot and Blue" technique (Radioisotope + Methylene/Isosulfan Blue) has the highest identification rate (>95%). * **Definition of Sentinel Node:** Any node that is blue, has a radioactive count >10% of the "ex vivo" hottest node, or is palpably suspicious.

Question 23: In a case of primary melanoma with a depth of 1-2 mm, what should be the margins of excision of surrounding normal skin?

A. 0.5-1 cm
B. 1 cm
C. 1-2 cm (Correct Answer)
D. > 2 cm

Explanation: The surgical management of primary cutaneous melanoma is based on the **Breslow Thickness** (depth of invasion), which is the most important prognostic factor and the primary determinant of wide local excision (WLE) margins. ### **Explanation of the Correct Answer** For a melanoma with a depth of **1.01 to 2.0 mm (Intermediate thickness)**, the current international guidelines (NCCN and WHO) recommend a surgical margin of **1–2 cm**. This margin is designed to minimize local recurrence while avoiding unnecessary morbidity associated with larger grafts or flaps. ### **Analysis of Incorrect Options** * **Option A (0.5-1 cm):** This is insufficient for invasive melanoma. A 0.5 cm margin is only considered for *Melanoma in situ* (though 0.5–1 cm is the standard for *in situ*). * **Option B (1 cm):** This is the standard margin for **thin melanomas (≤ 1 mm)**. While 1 cm is the lower limit for 1-2 mm lesions, the standard range is 1-2 cm. * **Option D (> 2 cm):** Margins of 2 cm are reserved for **thick melanomas (> 2 mm)**. Historically, 3-5 cm margins were used, but trials (like the Intergroup Melanoma Trial) showed no survival benefit of 4 cm over 2 cm margins. ### **High-Yield NEET-PG Clinical Pearls** | Breslow Thickness | Recommended Margin | | :--- | :--- | | **In situ** | 0.5 – 1.0 cm | | **≤ 1.0 mm** | 1 cm | | **1.01 – 2.0 mm** | 1 – 2 cm | | **> 2.0 mm** | 2 cm | * **Sentinel Lymph Node Biopsy (SLNB):** Generally indicated for lesions **≥ 0.8 mm** thickness or < 0.8 mm with ulceration. * **Excision Depth:** The excision should extend down to, but not include, the deep fascia. * **Biopsy Gold Standard:** Excisional biopsy with a narrow margin (1-3 mm) is preferred over incisional biopsy for initial diagnosis.

Question 24: All of the following are treatment modalities in malignant mesothelioma except?

A. Talc Pleurodesis
B. Extrapleural pneumonectomy
C. Combination therapy with surgery, chemotherapy and radiotherapy
D. Exclusive Radiotherapy (Correct Answer)

Explanation: **Explanation:** Malignant Pleural Mesothelioma (MPM) is an aggressive tumor arising from the mesothelial surfaces, strongly associated with asbestos exposure. The management of MPM is primarily **multimodal**; single-modality treatment is rarely effective. **Why "Exclusive Radiotherapy" is the correct answer:** Radiotherapy is technically challenging in MPM because the tumor spreads circumferentially along the entire pleura. Delivering a radical dose to the entire hemithorax would cause fatal toxicity to the underlying lung, heart, and spinal cord. Therefore, radiotherapy is used only as an **adjuvant** (after surgery) or for **palliative** symptom control (e.g., painful chest wall nodules), but never as a definitive, exclusive treatment. **Analysis of other options:** * **Talc Pleurodesis:** This is a standard **palliative** procedure used to manage recurrent malignant pleural effusions, improving the patient's quality of life by preventing fluid re-accumulation. * **Extrapleural Pneumonectomy (EPP):** This is a radical surgical procedure involving the en bloc resection of the visceral and parietal pleura, the underlying lung, the ipsilateral diaphragm, and the pericardium. It is reserved for fit patients with early-stage disease. * **Combination Therapy:** This is the **gold standard** for resectable MPM. It typically involves "Trimality Therapy": Neoadjuvant chemotherapy (Pemetrexed + Cisplatin), followed by radical surgery (EPP or Pleurectomy/Decortication), and adjuvant radiotherapy. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Pleura (followed by peritoneum). * **Strongest Risk Factor:** Asbestos exposure (latency period of 20–40 years). * **Histology:** The **Epithelioid** variant has the best prognosis; Sarcomatoid has the worst. * **Marker of choice:** Calretinin (+ve), WT-1 (+ve), and Cytokeratin 5/6 (+ve). It is typically **Carcinoembryonic Antigen (CEA) negative** (helps differentiate from Adenocarcinoma). * **Imaging:** CT shows "nodular pleural thickening" or a "pleural rind."

Question 25: Which is the most common type of thyroid carcinoma with the least hematogenous spread?

A. Follicular
B. Papillary (Correct Answer)
C. Anaplastic
D. Medullary

Explanation: ### Explanation **Correct Option: B. Papillary Thyroid Carcinoma (PTC)** Papillary carcinoma is the **most common** type of thyroid malignancy (accounting for ~80–85% of cases). The hallmark of PTC is its mode of metastasis: it spreads primarily via the **lymphatics** to the cervical lymph nodes. It has the **least tendency for hematogenous (blood-borne) spread** among all thyroid cancers. This localized spread and slow growth contribute to its excellent prognosis. **Incorrect Options:** * **A. Follicular Thyroid Carcinoma (FTC):** This is the second most common type. Unlike PTC, its hallmark is **hematogenous spread** (to bone and lungs) because it tends to invade blood vessels rather than lymphatics. * **C. Anaplastic Carcinoma:** This is the most aggressive and undifferentiated form. It spreads rapidly via both direct local invasion and hematogenous routes, carrying the worst prognosis. * **D. Medullary Thyroid Carcinoma (MTC):** Arising from parafollicular C-cells, it spreads via both lymphatics and blood. While it can involve lymph nodes early, it has a higher rate of distant hematogenous metastasis compared to PTC. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factor:** Prior exposure to ionizing radiation is the most significant risk factor for PTC. * **Microscopic Features:** Look for **Orphan Annie eye nuclei** (empty-appearing nuclei), **Psammoma bodies** (laminated calcifications), and **Nuclear grooves**. * **Prognosis:** Excellent; the 10-year survival rate is >90%. * **Management:** Usually involves total thyroidectomy or hemithyroidectomy followed by Radioiodine (RAI) ablation if indicated. Lymph node dissection is performed only if nodes are clinically involved (unlike MTC, where prophylactic dissection is common).

Question 26: What is the primary treatment for lower lip carcinoma?

A. Radiation
B. Chemotherapy
C. Excision (Correct Answer)
D. Radiation and chemotherapy

Explanation: **Explanation:** **Primary Treatment: Surgical Excision** The gold standard treatment for lower lip carcinoma (most commonly Squamous Cell Carcinoma) is **surgical excision** with adequate margins (typically 5–10 mm). Surgery is preferred because it offers high cure rates, allows for precise histopathological assessment of margins, and provides superior functional and cosmetic outcomes through various reconstructive techniques (e.g., V-excision, Abbe-Estlander flap, or Karapandzic flap). **Analysis of Options:** * **Radiation (Option A):** While lip cancer is radiosensitive, radiotherapy is generally reserved for patients who are medically unfit for surgery, have extensive lesions where surgery would be mutilating, or as adjuvant therapy for positive margins/perineural invasion. It can cause long-term complications like xerostomia and osteoradionecrosis. * **Chemotherapy (Option B):** Chemotherapy is not a primary curative modality for localized lip cancer. It is used in palliative settings or as part of induction protocols for advanced, unresectable disease. * **Radiation and Chemotherapy (Option D):** Concurrent chemoradiotherapy is the standard for advanced oropharyngeal cancers but is not the first-line approach for the easily accessible and surgically curable lower lip. **High-Yield Clinical Pearls for NEET-PG:** * **Etiology:** Chronic sun exposure (UV radiation) is the most significant risk factor. * **Most Common Site:** The lower lip is involved in ~90% of cases (due to greater sun exposure compared to the upper lip). * **Histology:** Squamous Cell Carcinoma (SCC) is the most common type on the lower lip, whereas Basal Cell Carcinoma (BCC) is more common on the upper lip. * **Lymphatic Spread:** Lower lip SCC primarily drains to **Submental (Level Ia)** and **Submandibular (Level Ib)** lymph nodes. * **Prognosis:** Lip cancer generally has a better prognosis than intraoral SCC because it is detected early and metastasizes late.

Question 27: Thyroglossal cyst may occasionally give rise to which type of carcinoma?

A. Papillary (Correct Answer)
B. Medullary
C. Anaplastic
D. Follicular

Explanation: **Explanation:** A thyroglossal cyst is a congenital anomaly resulting from the failure of the thyroglossal duct to obliterate. While most cysts are benign, malignancy occurs in approximately **1%** of cases. **Why Papillary Carcinoma is correct:** The thyroglossal duct is lined by respiratory or squamous epithelium, but it frequently contains **ectopic thyroid tissue** within its wall. Because this tissue is embryologically derived from the thyroid primordium, it is susceptible to the same neoplastic transformations as the thyroid gland itself. **Papillary carcinoma** is the most common type (occurring in >80% of malignant cases) because the ectopic tissue is most prone to this specific transformation. Diagnosis is often made incidentally after a Sistrunk operation. **Why other options are incorrect:** * **Medullary Carcinoma:** This arises from parafollicular C-cells, which are derived from the **ultimobranchial body** (not the thyroglossal duct). Therefore, medullary carcinoma is almost never found in a thyroglossal cyst. * **Anaplastic Carcinoma:** This is an undifferentiated, highly aggressive tumor of the elderly. It is extremely rare in the ectopic tissue of a thyroglossal duct. * **Follicular Carcinoma:** While possible, it is significantly less common than the papillary variety in this location. **High-Yield Clinical Pearls for NEET-PG:** * **Sistrunk Operation:** The definitive treatment for a thyroglossal cyst; it involves excision of the cyst, the entire duct, and the **central part of the hyoid bone** to prevent recurrence. * **Movement:** A thyroglossal cyst is unique because it moves upward on **protrusion of the tongue** (due to its attachment to the foramen caecum via the hyoid). * **Location:** Most commonly found in the **subhyoid** position.

Question 28: What is the treatment of choice for anaplastic carcinoma of the thyroid that infiltrates the trachea and sternum?

A. Radical excision
B. Chemotherapy
C. Radiotherapy
D. Palliative/Symptomatic treatment (Correct Answer)

Explanation: **Explanation:** Anaplastic Thyroid Carcinoma (ATC) is one of the most aggressive solid tumors in humans, characterized by rapid growth and early local invasion. By the time of diagnosis, most patients present with Stage IV disease. **1. Why Palliative/Symptomatic treatment is correct:** In this clinical scenario, the tumor has already infiltrated vital structures like the **trachea and sternum**, rendering it **unresectable**. The primary goal of management for advanced ATC is not curative, but to maintain the airway and improve quality of life. Palliative measures include tracheostomy (to prevent asphyxiation), gastrostomy (for nutrition), and palliative radiotherapy/chemotherapy to reduce tumor bulk. **2. Why the other options are incorrect:** * **Radical Excision:** Surgery is only indicated if the tumor is small and localized (rare). Once there is extensive infiltration of the trachea and sternum, radical surgery is morbid and does not improve survival. * **Chemotherapy & Radiotherapy:** While these are used in ATC, they are rarely curative. In the context of extensive infiltration, they are used as **adjuncts to palliative care** rather than the primary "treatment of choice" for cure. ATC is notoriously resistant to standard chemotherapy. **Clinical Pearls for NEET-PG:** * **Demographics:** Typically affects elderly patients (6th–7th decade). * **Presentation:** Rapidly enlarging neck mass, dysphagia, and hoarseness (vocal cord palsy). * **Histology:** Shows spindle, polygonal, or giant cells; p53 mutations are common. * **Prognosis:** Extremely poor; median survival is 3–6 months. * **Management Priority:** Always secure the airway first (Tracheostomy is often required).

Question 29: Which of the following has the best prognosis?

A. Carcinoma of the lip (Correct Answer)
B. Carcinoma of the tongue
C. Carcinoma of the palate
D. Carcinoma of the floor of the mouth

Explanation: **Explanation:** The prognosis of oral cavity cancers is primarily determined by the site’s lymphatic drainage, the timing of clinical presentation, and the degree of cellular differentiation. **1. Why Carcinoma of the Lip is the Correct Answer:** Carcinoma of the lip (specifically the lower lip, which accounts for 90% of cases) has the **best prognosis** among all oral cavity cancers, with a 5-year survival rate exceeding 90%. This is due to several factors: * **Early Detection:** Being an external site, lesions are visible early to the patient and clinician. * **Slow Growth:** Most are well-differentiated squamous cell carcinomas (SCC) that grow slowly. * **Late Metastasis:** Lymphatic spread to submental or submandibular nodes occurs much later compared to other intraoral sites. **2. Why Other Options are Incorrect:** * **Carcinoma of the Tongue (Option B):** This has the **worst prognosis** among the options. The tongue is highly vascular with rich, decussating lymphatic drainage, leading to early, often bilateral, nodal metastasis. * **Carcinoma of the Floor of the Mouth (Option D):** This site has thin mucosa and is in close proximity to the mandible and submandibular ducts, facilitating early deep invasion and nodal spread. * **Carcinoma of the Palate (Option C):** While hard palate tumors are often minor salivary gland tumors or SCCs, they generally carry a poorer prognosis than the lip due to the risk of bone invasion and technical challenges in achieving wide surgical margins. **Clinical Pearls for NEET-PG:** * **Most common site of Oral Cancer:** Buccal mucosa (India - due to tobacco chewing); Tongue (Worldwide). * **Most common site of Lip Cancer:** Lower lip (due to UV exposure); Upper lip is rare but more likely to be Basal Cell Carcinoma. * **Premalignant conditions:** Erythroplakia has a much higher transformation rate to malignancy than Leukoplakia. * **Nodal Status:** The single most important prognostic factor in oral SCC is the presence of cervical lymph node metastasis.

Question 30: A 60-year-old man is suspected of having endobronchial carcinoma. What is the best investigation?

A. CT guided FNAC
B. Bronchoscopy and biopsy (Correct Answer)
C. Sputum cytology
D. X-ray chest

Explanation: **Explanation:** The diagnosis of lung cancer depends on the location of the lesion. For **endobronchial carcinoma** (centrally located tumors arising within the large airways), **Bronchoscopy and biopsy** is the investigation of choice. It allows for direct visualization of the tumor, assessment of its proximity to the carina (crucial for operability), and the collection of tissue for histopathological confirmation, which is essential for staging and treatment planning. **Analysis of Options:** * **A. CT-guided FNAC:** This is the investigation of choice for **peripheral lung lesions** that are inaccessible by a bronchoscope. In endobronchial cases, it carries a higher risk of pneumothorax and may not yield enough tissue for architectural grading. * **C. Sputum cytology:** While non-invasive and useful for screening central squamous cell carcinomas, it has low sensitivity and cannot provide the precise anatomical localization required for surgical planning. * **D. X-ray chest:** This is usually the initial screening tool. While it may show a mass, collapse, or obstructive pneumonitis, it is not diagnostic and cannot differentiate between malignancy and other pathologies. **Clinical Pearls for NEET-PG:** * **Central Tumors:** Squamous cell carcinoma and Small cell carcinoma (Best investigated via Bronchoscopy). * **Peripheral Tumors:** Adenocarcinoma and Large cell carcinoma (Best investigated via CT-guided FNAC). * **Staging:** Contrast-Enhanced CT (CECT) of the chest and upper abdomen is the standard for radiological staging, while PET-CT is used for detecting distant metastasis. * **Gold Standard for Mediastinal Nodes:** Endobronchial Ultrasound (EBUS) guided TBNA.

Question 31: Sarcoma Botryoides is also known as:

A. Embryonal rhabdomyosarcoma (Correct Answer)
B. Alveolar rhabdomyosarcoma
C. Leiomyosarcoma
D. Lipoblastomatosis

Explanation: **Explanation:** **Sarcoma Botryoides** is a distinct variant of **Embryonal Rhabdomyosarcoma (ERMS)**. The term "botryoides" is derived from the Greek word *botryos*, meaning "a bunch of grapes," which describes its characteristic macroscopic appearance. 1. **Why Option A is Correct:** Sarcoma Botryoides arises from primitive mesenchymal cells (rhabdomyoblasts) under the mucosal surface of hollow organs. It typically presents as a polypoid, friable, grape-like mass protruding from the **vagina** (most common in infants/toddlers), urinary bladder, or biliary tract. Histologically, it is characterized by a dense layer of undifferentiated tumor cells immediately beneath the epithelium, known as the **Cambium layer**. 2. **Why Other Options are Incorrect:** * **B. Alveolar Rhabdomyosarcoma:** This is a more aggressive subtype of rhabdomyosarcoma usually seen in adolescents. It involves the extremities and is characterized by a "cluster of grapes" appearance microscopically (alveolar pattern), but not macroscopically. It is associated with the **t(2;13)** translocation. * **C. Leiomyosarcoma:** A malignant tumor of smooth muscle origin, typically seen in older adults (e.g., uterus or retroperitoneum). It does not exhibit the botryoid growth pattern. * **D. Lipoblastomatosis:** A benign mesenchymal tumor of fetal white fat, usually occurring in children under age 3. It is not related to skeletal muscle (rhabdo) lineages. **High-Yield Clinical Pearls for NEET-PG:** * **Age Group:** Most common in children < 5 years of age. * **Classic Presentation:** A young girl (infant) with "grape-like" masses protruding from the vagina or blood-stained discharge. * **Pathognomonic Feature:** The **Cambium Layer** (subepithelial condensation of tumor cells). * **Marker:** Desmin, Myogenin, and MyoD1 (markers for skeletal muscle differentiation). * **Prognosis:** Generally has a better prognosis compared to the alveolar subtype.

Question 32: What is the recommended treatment for stage 2 anal canal cancer?

A. Chemoradiation (Correct Answer)
B. Abdominoperineal resection
C. Chemotherapy and surgery
D. Radiotherapy only

Explanation: **Explanation:** The primary treatment for squamous cell carcinoma (SCC) of the anal canal (Stages I, II, and III) is **definitive chemoradiation**, commonly known as the **Nigro Protocol**. 1. **Why Chemoradiation is Correct:** Unlike most gastrointestinal cancers where surgery is the mainstay, anal canal cancer is highly radiosensitive and chemosensitive. The Nigro Protocol (consisting of 5-Fluorouracil, Mitomycin-C, and external beam radiation) achieves high cure rates while **preserving the anal sphincter**, thereby avoiding a permanent colostomy and maintaining the patient's quality of life. 2. **Why Other Options are Incorrect:** * **Abdominoperineal Resection (APR):** Historically the gold standard, it is now reserved only for **salvage therapy** (persistent or recurrent disease) or for patients who cannot tolerate radiation. * **Chemotherapy and Surgery:** Surgery is not part of the initial multimodal management for Stage 2 disease. * **Radiotherapy only:** While radiation is effective, the addition of chemotherapy (Mitomycin-C) has been proven in clinical trials to significantly reduce local recurrence rates compared to radiation alone. **High-Yield Clinical Pearls for NEET-PG:** * **Most common histology:** Squamous Cell Carcinoma (associated with HPV 16 and 18). * **Nigro Protocol components:** 5-FU + Mitomycin-C + Radiation. * **Anal Margin vs. Anal Canal:** Small (<2cm), well-differentiated tumors of the **anal margin** (not canal) can be treated with wide local excision. * **Follow-up:** Response to chemoradiation can be slow; clinical assessment of "cure" is usually done at 12–26 weeks post-treatment. * **Salvage Surgery:** APR is the treatment of choice for biopsy-proven residual disease after chemoradiation.

Question 33: What is a sentinel lymph node?

A. A group of lymph nodes
B. The first lymph node along the lymphatic drainage pathway from a tumor (Correct Answer)
C. A lymph node that is bypassed during distant metastasis
D. A lymph node that has metastasized distantly

Explanation: ### Explanation The **Sentinel Lymph Node (SLN)** is defined as the first lymph node (or group of nodes) in a regional lymphatic basin that receives direct lymphatic drainage from a primary tumor. The underlying medical concept is the **"Sentinel Node Hypothesis,"** which posits that if a tumor spreads via the lymphatic system, the sentinel node will be the first to harbor metastatic cells. If the SLN is negative for malignancy, there is a high probability (usually >95%) that the remaining nodes in that basin are also clear, allowing patients to avoid the morbidity of a formal lymph node dissection. **Analysis of Options:** * **Option B (Correct):** Accurately describes the anatomical and physiological role of the SLN as the primary filter in the drainage pathway. * **Option A:** While multiple nodes can sometimes be "sentinel" if they receive direct drainage simultaneously, the term specifically refers to the *position* in the drainage sequence, not just any group of nodes. * **Option C:** This describes "skip metastasis," where a tumor bypasses the first-tier nodes to involve distant ones—this is the exception to the sentinel node rule. * **Option D:** This is a description of a metastatic node in general, not specifically the sentinel node. **Clinical Pearls for NEET-PG:** * **Identification:** SLNs are identified using **Technetium-99m labeled sulfur colloid** (radioactive tracer) and/or **Isosulfan/Methylene blue dye**. * **Gold Standard Use:** Most commonly used in the management of **Breast Cancer** and **Malignant Melanoma**. * **Contraindications:** SLN biopsy is generally avoided if there are clinically palpable/positive nodes (cN1) or inflammatory breast cancer. * **Frozen Section:** Often performed intraoperatively to decide if a complete axillary lymph node dissection (ALND) is required.

Question 34: What is the standard treatment for verrucous carcinoma of the lip?

A. Surgery and radiotherapy
B. Surgical excision (Correct Answer)
C. Laser therapy
D. Interferon

Explanation: **Explanation:** Verrucous carcinoma (Ackerman’s tumor) is a distinct, well-differentiated variant of squamous cell carcinoma characterized by a slow-growing, "wart-like" exophytic appearance. **Why Surgical Excision is the Correct Answer:** The gold standard treatment is **wide local surgical excision**. Verrucous carcinoma is locally aggressive but rarely metastasizes to regional lymph nodes. Therefore, complete surgical removal with clear margins is usually curative. Unlike typical squamous cell carcinoma, routine neck dissection is not indicated unless there is clinical evidence of lymphadenopathy or a hybrid tumor component. **Analysis of Incorrect Options:** * **A. Surgery and Radiotherapy:** Radiotherapy is generally **contraindicated** as a primary or adjuvant treatment. Exposure to radiation can trigger "anaplastic transformation," turning a low-grade verrucous lesion into a highly aggressive, rapidly metastasizing spindle cell carcinoma. * **C. Laser Therapy:** While used for some superficial premalignant lesions, laser therapy is inadequate for verrucous carcinoma because it does not allow for precise margin assessment and may lead to incomplete removal of the deep "pushing" borders. * **D. Interferon:** Medical therapies like interferon or chemotherapy are not primary treatment modalities for localized verrucous carcinoma, which is primarily a surgical disease. **Clinical Pearls for NEET-PG:** * **Histology:** Characterized by a "pushing" rather than an "infiltrating" margin and minimal cellular atypia. * **Common Sites:** Most common in the oral cavity (buccal mucosa) and associated with smokeless tobacco (Snuff dipper’s cancer). * **Key Contraindication:** Avoid Radiotherapy due to the risk of **anaplastic transformation**. * **Prognosis:** Excellent if completely excised, as distant metastasis is extremely rare.

Question 35: Papillary carcinoma of the thyroid primarily spreads via which route?

A. Lymphatic (Correct Answer)
B. Hematogenous
C. Local spread
D. All of the above

Explanation: **Explanation:** **1. Why Lymphatic is Correct:** Papillary Thyroid Carcinoma (PTC) is the most common type of thyroid malignancy. Its hallmark characteristic is a strong predilection for **lymphatic spread**. Approximately 50-80% of patients have microscopic cervical lymph node involvement at the time of diagnosis. It typically spreads to the central compartment (Level VI) first, followed by the lateral neck nodes (Levels II-V). This occurs because the tumor cells easily invade the rich lymphatic network of the thyroid gland. **2. Why Other Options are Incorrect:** * **Hematogenous:** While PTC can spread via the blood, this is **rare** (seen in <5% of cases) and usually occurs late in the disease, primarily to the lungs and bones. In contrast, **Follicular Carcinoma** is the thyroid malignancy known for early hematogenous spread. * **Local Spread:** While PTC can invade the thyroid capsule and adjacent structures (like the trachea or recurrent laryngeal nerve), this is a feature of advanced T4 disease rather than the primary mode of metastasis. * **All of the Above:** Although all routes are theoretically possible, the question asks for the *primary* route. Lymphatic spread is the defining metastatic pathway for PTC. **3. High-Yield Clinical Pearls for NEET-PG:** * **Psammoma Bodies:** These are pathognomonic laminated calcifications often seen in PTC (representing infarcted papillae). * **Orphan Annie Eye Nuclei:** A classic histological finding (large, pale, clear nuclei). * **Prognosis:** Despite frequent lymph node metastasis, PTC has an excellent 10-year survival rate (>90%). * **Risk Factor:** Prior exposure to ionizing radiation is the most significant risk factor. * **BRAF Mutation:** The V600E mutation is the most common genetic alteration in PTC and is associated with a higher risk of lymph node metastasis.

Question 36: A 50-year-old individual who chews tobacco presents with a 1.5 cm mass in the oral cavity and a single ipsilateral cervical lymph node measuring less than 3 cm. What is the TNM stage based on these findings?

A. T1 N3
B. T3 N1
C. T2 N2
D. T1 N1 (Correct Answer)

Explanation: ### Explanation The TNM staging for oral cavity cancers is a high-yield topic for NEET-PG. To determine the correct stage, we must break down the clinical findings based on the AJCC 8th Edition criteria: **1. T-Stage (Primary Tumor):** * **T1:** Tumor ≤ 2 cm in greatest dimension (and ≤ 5 mm depth of invasion). * **T2:** Tumor > 2 cm but ≤ 4 cm. * In this case, the mass is **1.5 cm**, which fits the **T1** category. **2. N-Stage (Regional Lymph Nodes):** * **N1:** Metastasis in a **single ipsilateral** lymph node, **≤ 3 cm** in greatest dimension. * **N2:** Divided into N2a (single node 3–6 cm), N2b (multiple ipsilateral nodes < 6 cm), and N2c (bilateral/contralateral nodes < 6 cm). * **N3:** Any node > 6 cm. * The patient has a **single ipsilateral node < 3 cm**, which fits the **N1** category. Therefore, the correct stage is **T1 N1**. --- ### Why Incorrect Options are Wrong: * **T1 N3:** Incorrect because N3 requires a lymph node > 6 cm; the patient's node is < 3 cm. * **T3 N1:** Incorrect because T3 requires a tumor > 4 cm or depth of invasion > 10 mm; the patient's tumor is only 1.5 cm. * **T2 N2:** Incorrect because T2 requires a tumor > 2 cm, and N2 requires either a larger node (> 3 cm) or multiple nodes. --- ### High-Yield Clinical Pearls for NEET-PG: * **Depth of Invasion (DOI):** In the AJCC 8th edition, DOI is now a critical component of T-staging for oral cancer. Every 5 mm of DOI increases the T-stage by one level. * **ENE (Extranodal Extension):** The presence of ENE (clinical or pathological) automatically upgrades the N-stage (e.g., a single < 3 cm node with ENE becomes N2a). * **Most Common Site:** The lower lip is the most common site for oral cavity cancer globally, but in India, the **buccal mucosa** (due to tobacco chewing) is most common.

Question 37: Which of the following is a risk factor for breast carcinoma in women?

A. Consumption of fatty food (Correct Answer)
B. Early menopause
C. Smoking
D. Multiple sexual partners

Explanation: **Explanation:** The correct answer is **A. Consumption of fatty food.** **1. Why "Consumption of fatty food" is correct:** Dietary fat intake is a recognized modifiable risk factor for breast carcinoma. High fat consumption leads to obesity, particularly in postmenopausal women. Adipose tissue contains the enzyme **aromatase**, which converts peripheral androgens into **estrone** (a type of estrogen). Since breast cancer is frequently hormone-dependent, increased cumulative exposure to estrogen promotes the proliferation of mammary epithelium, thereby increasing the risk of malignancy. **2. Why the other options are incorrect:** * **B. Early menopause:** This is a protective factor. **Late menopause** (after age 55) is the actual risk factor because it extends the duration of the "estrogen window." * **C. Smoking:** While smoking is a major risk factor for many cancers (lung, bladder, head, and neck), its direct causal link to breast cancer is less established compared to hormonal and genetic factors. * **D. Multiple sexual partners:** This is a risk factor for **Cervical Cancer** due to increased exposure to Human Papillomavirus (HPV), but it has no association with breast cancer. **3. NEET-PG High-Yield Clinical Pearls:** * **The "Estrogen Window" Concept:** Anything that increases the number of menstrual cycles (Early menarche <12y, Late menopause >55y, Nulliparity) increases breast cancer risk. * **Protective Factors:** Early pregnancy (<20 years), breastfeeding, and regular physical exercise. * **Genetic Risk:** BRCA1 (Chromosome 17) and BRCA2 (Chromosome 13) are the most significant genetic mutations. * **Atypical Hyperplasia:** Finding atypical ductal or lobular hyperplasia on biopsy increases risk by 4–5 times.

Question 38: What is described as the en bloc resection of a segment of bone?

A. Complete resection of the jaw bone
B. Resection of half of the affected jaw
C. Resection of the tumor only
D. The entire tumor is removed intact with a rim of uninvolved bone while maintaining continuity of the jaw (Correct Answer)

Explanation: **Explanation:** In oncological surgery, particularly concerning the mandible or maxilla, the term **"Segmental Resection"** or **"En Bloc Resection"** refers to the removal of a tumor as a single, intact piece along with a margin of healthy, uninvolved bone. The primary goal is to ensure negative margins (R0 resection) to prevent local recurrence. **Why Option D is Correct:** The defining feature of an en bloc resection is that the tumor is never breached; it is removed "in one block" with a surrounding rim of normal tissue. In the context of the jaw, this specific description implies a **marginal resection** where a portion of the bone is removed to ensure oncological safety while preserving the structural continuity of the mandible (i.e., the lower border remains intact). **Analysis of Incorrect Options:** * **Option A & B:** These describe **Total Mandibulectomy** or **Hemimandibulectomy**. While these are forms of en bloc resection, they involve a "discontinuity" resection where the entire thickness of the bone is removed, sacrificing the jaw's structural continuity. * **Option C:** This describes **Enucleation or Curettage**. This is generally contraindicated for malignant tumors as it involves entering the tumor capsule, leading to a high risk of seeding and recurrence. **High-Yield Clinical Pearls for NEET-PG:** * **Margin Requirement:** For malignant bone tumors, a 1–2 cm margin of healthy bone is typically required. * **Indication:** Marginal (en bloc) resection is preferred for tumors that are close to the bone but have not extensively invaded the medullary canal. * **Skip Lesions:** Always remember that certain bone tumors (like Osteosarcoma) can have skip lesions; hence, en bloc resection must be planned based on MRI findings. * **Continuity:** Preserving the inferior border of the mandible (Option D) significantly improves functional and cosmetic outcomes compared to segmental discontinuity.

Question 39: What is the most common tumor found in the posterior mediastinum?

A. Lung cyst
B. Neurofibroma (Correct Answer)
C. Dermoid cyst
D. Thyroid mass

Explanation: **Explanation:** The mediastinum is anatomically divided into compartments, each associated with specific pathologies. The **posterior mediastinum** is the space located between the pericardium and the spine. **Why Neurofibroma is correct:** The posterior mediastinum is primarily occupied by the paravertebral sulcus, which contains the spinal nerves and the sympathetic chain. Consequently, **neurogenic tumors** are the most common primary tumors found in this compartment (accounting for ~75% of posterior mediastinal masses). Among these, **Neurofibromas** and Neurilemmomas (Schwannomas) are the most frequent benign subtypes. In children, neuroblastoma is more common. **Why the other options are incorrect:** * **Lung cyst:** These are typically intrapulmonary or found in the middle mediastinum (e.g., bronchogenic cysts). * **Dermoid cyst:** These are germ cell tumors typically located in the **anterior mediastinum**. * **Thyroid mass:** Retrosternal goiters are almost exclusively found in the **superior or anterior mediastinum**. **Clinical Pearls for NEET-PG:** * **Anterior Mediastinum (The 4 Ts):** Thymoma (most common), Teratoma (Germ cell tumors), Thyroid (Ectopic/Goiter), and "Terrible" Lymphoma. * **Middle Mediastinum:** Most common site for lymphadenopathy and bronchogenic cysts. * **Posterior Mediastinum:** Most common site for neurogenic tumors. * **Dumbbell Tumor:** A classic presentation where a neurogenic tumor extends through the intervertebral foramen, causing both mediastinal and spinal cord compression.

Question 40: A 67-year-old retired judge is admitted to the emergency department with severe dyspnea after returning from vacation. On examination, inspiratory stridor, ecchymosis in his neck, and swelling of soft tissue and veins in his face and upper extremities are evident. The CT scan shows an expanding superior mediastinal hematoma. What is the most common source of mediastinal hemorrhage?

A. Parotid gland surgery
B. Trauma (Correct Answer)
C. Dissecting thoracic aneurysm
D. Mediastinal tumor

Explanation: **Explanation:** The clinical presentation of inspiratory stridor, neck ecchymosis, and Superior Vena Cava (SVC) syndrome-like symptoms (facial/upper extremity swelling) in the context of a superior mediastinal hematoma indicates acute compression of mediastinal structures. **1. Why Trauma is Correct:** Trauma is the **most common cause** of mediastinal hemorrhage. It typically results from rapid deceleration injuries (e.g., motor vehicle accidents) causing a blunt aortic injury (usually at the aortic isthmus) or fractures of the sternum and thoracic spine. The sudden accumulation of blood in the confined mediastinal space leads to "Mediastinal Syndrome," characterized by venous congestion and airway compression. **2. Analysis of Incorrect Options:** * **Parotid gland surgery (A):** This involves the facial and cervical regions. While it can cause local neck hematomas, it does not typically lead to superior mediastinal hemorrhage. * **Dissecting thoracic aneurysm (C):** While a life-threatening cause of mediastinal blood, it is statistically less common than trauma. It usually presents with "tearing" chest pain radiating to the back and asymmetric blood pressure, rather than isolated superior mediastinal symptoms. * **Mediastinal tumor (D):** Tumors (like thymomas or lymphomas) cause chronic SVC syndrome through gradual compression or invasion, but they rarely cause acute, massive hemorrhage unless there is a rare event like intratumoral bleeding. **Clinical Pearls for NEET-PG:** * **Imaging Gold Standard:** Contrast-Enhanced CT (CECT) is the investigation of choice for evaluating mediastinal hematomas and identifying the source (e.g., aortic tear). * **Radiological Sign:** On a plain Chest X-ray, a **widened mediastinum (>8 cm)** is the classic hallmark of mediastinal hemorrhage/aortic injury. * **Management:** Acute airway management is the priority if stridor is present, followed by surgical or endovascular repair of the vascular injury.

Question 41: Which of the following is NOT a risk factor for increased incidence of relapse in stage I carcinoma of the breast?

A. Negative estrogen/progesterone receptor status
B. High S phase fraction
C. Aneuploidy
D. Decreased Her-2/neu oncogene expression (Correct Answer)

Explanation: **Explanation:** In breast cancer management, prognostic factors are used to predict the risk of recurrence and guide adjuvant therapy. The question asks for the factor that is **NOT** associated with an increased risk of relapse. **1. Why Option D is Correct:** The **Her-2/neu (c-erbB2)** oncogene is a transmembrane tyrosine kinase receptor. **Increased expression (amplification)** of this gene is associated with aggressive tumor behavior, higher grade, and a significantly increased risk of relapse. Therefore, **decreased expression** would theoretically imply a better prognosis or a baseline risk, rather than an increased risk of relapse. **2. Analysis of Incorrect Options (Risk Factors for Relapse):** * **A. Negative ER/PR status:** Estrogen and Progesterone receptor-negative tumors are generally more aggressive, have a higher histological grade, and do not respond to endocrine therapies (like Tamoxifen), leading to a higher incidence of relapse. * **B. High S-phase fraction:** This is a measure of cellular proliferation (the percentage of cells replicating DNA). A high S-phase fraction indicates a rapidly dividing, aggressive tumor with a higher likelihood of recurrence. * **C. Aneuploidy:** DNA aneuploidy (abnormal amount of DNA) is a marker of genetic instability. Aneuploid tumors have a worse prognosis compared to diploid tumors in Stage I breast cancer. **Clinical Pearls for NEET-PG:** * **Most important prognostic factor** for breast cancer: Number of axillary lymph nodes involved. * **Most important prognostic factor in Node-Negative (Stage I) disease:** Tumor size. * **Triple Negative Breast Cancer (TNBC):** Lacks ER, PR, and Her-2 expression; carries the worst prognosis among molecular subtypes. * **Luminal A:** (ER/PR +, Her-2 -, low Ki-67) has the best prognosis.

Question 42: In which type of cancer is immunoguided surgery indicated?

A. Colon cancer (Correct Answer)
B. Pancreatic cancer
C. Jejunal cancer
D. Anal canal cancer

Explanation: **Explanation:** **Immunoguided Surgery (IGS)**, also known as Radioimmunoguided Surgery (RIGS), is a specialized technique used to detect occult tumor deposits and define surgical margins that are not visible to the naked eye or palpable by the surgeon. 1. **Why Colon Cancer is Correct:** The primary application of immunoguided surgery is in **colorectal cancer**. It utilizes radiolabeled monoclonal antibodies (most commonly **CC49** or **B72.3**) directed against the **TAG-72** (Tumor-Associated Glycoprotein 72) antigen, which is highly expressed in colorectal adenocarcinomas. A handheld gamma probe is used intraoperatively to detect these labeled antibodies, helping the surgeon identify lymph node metastases or residual disease, thereby ensuring a more radical resection. 2. **Why Other Options are Incorrect:** * **Pancreatic Cancer:** While research is ongoing, IGS is not the standard of care. Surgery for pancreatic cancer relies primarily on anatomical landmarks and vascular involvement (CT/MRI staging). * **Jejunal Cancer:** Small bowel malignancies are rare, and there is no established protocol or specific monoclonal antibody targeting jejunal tumors for routine immunoguided resection. * **Anal Canal Cancer:** The primary treatment for most anal canal cancers (Squamous Cell Carcinoma) is chemoradiotherapy (**Nigro Protocol**). Surgery is reserved for salvage, and IGS is not indicated. **Clinical Pearls for NEET-PG:** * **Target Antigen:** TAG-72 is the most common target in RIGS for colorectal cancer. * **Isotope Used:** Iodine-125 ($^{125}$I) is frequently used to label the antibodies due to its favorable half-life for surgical scheduling. * **Benefit:** The main advantage of IGS is the detection of "occult" disease in lymph nodes that appear normal on preoperative imaging, potentially changing the surgical stage and extent of resection.

Question 43: A 1 cm coin lesion is seen on chest X-ray in the right upper lobe. FNAC shows adenocarcinoma. What is the appropriate management?

A. Excision and observation (Correct Answer)
B. Excision and chemotherapy
C. Neoadjuvant chemotherapy followed by excision
D. Excision and chemoradiation

Explanation: ### Explanation **Correct Answer: A. Excision and observation** The clinical scenario describes a **Stage IA1 Non-Small Cell Lung Cancer (NSCLC)**. A 1 cm lesion is classified as **T1a** (≤1 cm), and in the absence of lymphadenopathy or distant metastasis, it is Stage IA. **Why Option A is correct:** For early-stage NSCLC (Stage I and II), the primary treatment is surgical resection (Lobectomy with hilar/mediastinal lymph node dissection is the gold standard, though sub-lobar resection may be considered for lesions <2 cm). According to current oncological guidelines (NCCN/ASCO), **adjuvant chemotherapy is NOT indicated for Stage IA tumors.** These patients have a high cure rate with surgery alone; therefore, the management plan is surgical excision followed by observation (surveillance). **Why other options are incorrect:** * **Option B & D:** Adjuvant chemotherapy (with or without radiation) is generally reserved for **Stage II and IIIA** disease or Stage IB patients with high-risk features (e.g., tumors >4 cm, vascular invasion). For a 1 cm (Stage IA) lesion, the risks of chemotherapy toxicity outweigh the survival benefits. * **Option C:** Neoadjuvant chemotherapy is typically considered for **Stage IIIA (N2 disease)** to downstage the tumor before surgery. It is not indicated for a small, localized 1 cm coin lesion. **Clinical Pearls for NEET-PG:** 1. **Staging Cut-offs:** T1a (≤1 cm), T1b (>1 to 2 cm), T1c (>2 to 3 cm). 2. **Adjuvant Chemotherapy Rule:** It is indicated for tumors **>4 cm (Stage IB)** or if there is **node-positive disease (Stage II/III)**. 3. **Solitary Pulmonary Nodule (SPN):** A "coin lesion" is an SPN. If malignancy is confirmed (as via FNAC here), surgical resection is the definitive treatment. 4. **Investigation of Choice:** While FNAC was done here, **CT-guided biopsy** or **PET-CT** are preferred for staging and characterization in clinical practice.

Question 44: In which type of cancer is immunoguided surgery typically performed?

A. Colon cancer (Correct Answer)
B. Pancreatic cancer
C. Jejunal cancer
D. Anal canal cancer

Explanation: **Explanation:** **Immunoguided Surgery (IGS)**, also known as Radioimmunoguided Surgery (RIGS), is a specialized technique that utilizes radiolabeled monoclonal antibodies to identify occult tumor deposits, lymph node involvement, or residual disease that may not be visible or palpable to the surgeon. 1. **Why Colon Cancer is Correct:** Colorectal cancer is the classic indication for immunoguided surgery. The procedure typically involves the preoperative injection of **125I-labeled B72.3** or **CC49** monoclonal antibodies, which target the **TAG-72 (Tumor-Associated Glycoprotein 72)** antigen commonly expressed on colorectal adenocarcinoma cells. During surgery, a handheld gamma detection probe is used to locate "hot spots," allowing for more precise staging and ensuring oncological clearance (R0 resection). 2. **Why Other Options are Incorrect:** * **Pancreatic and Jejunal Cancer:** While research into molecular imaging is ongoing, these are not the standard or "typical" clinical applications for immunoguided surgery compared to the established protocols for colorectal malignancies. * **Anal Canal Cancer:** The primary treatment for most anal canal cancers (Squamous Cell Carcinoma) is chemoradiotherapy (Nigro Protocol), not primary radical surgery. Therefore, intraoperative immunoguidance is not a standard part of its management. **High-Yield Clinical Pearls for NEET-PG:** * **Target Antigen:** TAG-72 is the most common target for RIGS in colorectal surgery. * **Isotope Used:** Iodine-125 ($^{125}I$) is preferred due to its low energy and long half-life, which is ideal for the handheld probe. * **Clinical Utility:** RIGS is particularly useful in **recurrent** colorectal cancer to differentiate between postoperative fibrosis and tumor recurrence. * **Sentinel Lymph Node Mapping:** Do not confuse RIGS with sentinel node mapping (which uses Technetium-99m sulfur colloid or isosulfan blue), though both use intraoperative probes.

Question 45: A 45-year-old woman presents with a pigmented lesion on her right thigh. An incisional biopsy reveals malignant melanoma with a thickness of 3 mm. Findings on examination of the groin are normal. What is the most appropriate next step in management?

A. Wide local excision with a 1-cm margin, followed by radiotherapy
B. Wide local excision with a 1-cm margin and groin lymph node dissection
C. Wide local excision with a 2-cm margin and sentinel lymph node biopsy (Correct Answer)
D. Wide local excision with a 2-cm margin and groin lymph node dissection

Explanation: ### Explanation The management of malignant melanoma is primarily determined by the **Breslow thickness**, which dictates the surgical margins and the need for nodal evaluation. **1. Why Option C is Correct:** * **Surgical Margins:** For a melanoma with a thickness of **3 mm** (Intermediate thickness: 2.01–4.0 mm), the current international guidelines (AJCC/NCCN) recommend a **wide local excision (WLE) with a 2-cm margin**. * **Nodal Management:** In patients with a Breslow thickness **>0.8 mm** (or <0.8 mm with ulceration) and **clinically negative nodes (cN0)**, a **Sentinel Lymph Node Biopsy (SLNB)** is indicated. It is the most accurate staging tool for regional micrometastasis. Since this patient has a 3 mm lesion and a normal groin exam, SLNB is the standard of care. **2. Why Other Options are Wrong:** * **Option A:** A 1-cm margin is insufficient for a 3-mm thick lesion (used for lesions ≤1 mm). Radiotherapy is not a standard primary treatment for localized melanoma. * **Option B:** The 1-cm margin is inadequate. Furthermore, a formal lymph node dissection (CLND) is not performed upfront for clinically negative nodes; SLNB must precede it. * **Option C:** While the margin is correct, a **Completion Lymph Node Dissection (CLND)** is only indicated if the SLNB is positive. Prophylactic node dissection in cN0 patients does not improve survival and increases morbidity. **3. High-Yield Clinical Pearls for NEET-PG:** * **Breslow Thickness & Margins:** * In situ: 0.5 cm * ≤1.0 mm: 1 cm * 1.01–2.0 mm: 1–2 cm * >2.0 mm: 2 cm * **SLNB Indications:** Breslow thickness >1 mm; or 0.8–1.0 mm if ulcerated or high mitotic rate. * **Most Important Prognostic Factor:** Breslow thickness (vertical growth) is the most significant prognostic indicator for Stage I and II melanoma. * **Biopsy Gold Standard:** Excisional biopsy with 1–3 mm margins. Incisional biopsy (as seen in this question) should generally be avoided unless the lesion is very large or in a sensitive area (e.g., face).

Question 46: Sister Joseph's nodule is indicative of cancer of all the following except:

A. Stomach
B. Large bowel
C. Rectum (Correct Answer)
D. Ovary

Explanation: **Explanation:** **Sister Mary Joseph’s Nodule (SMJN)** refers to a palpable nodule in the umbilicus resulting from the metastasis of a malignant intra-abdominal or pelvic tumor. **Why Rectum is the Correct Answer:** The umbilicus receives lymphatic drainage from the organ systems via the subperitoneal plexus. While SMJN is associated with various intra-abdominal malignancies, it is **least likely** to occur with **rectal cancer**. Rectal lymphatics primarily drain to the pararectal, internal iliac, and inferior mesenteric nodes. In contrast, cancers of the upper gastrointestinal tract and pelvic organs have more direct embryonic or ligamentous pathways to the umbilicus. **Analysis of Other Options:** * **Stomach (Option A):** Gastric adenocarcinoma is the **most common** cause of SMJN (approx. 25-30% of cases). Metastasis occurs via the lymphatics or the gastrocolic ligament. * **Large Bowel (Option B):** Colon cancer is a frequent primary site. Spread occurs through the lymphatics or via the persistent vestigial remnants of the urachus or vitelline duct. * **Ovary (Option C):** Ovarian cancer is the most common cause of SMJN in females. Spread occurs via the suspensory ligaments or transperitoneal seeding. **High-Yield Clinical Pearls for NEET-PG:** * **Eponym:** Named after Sister Mary Joseph, the surgical assistant to Dr. William Mayo, who noticed the association between umbilical nodules and intra-abdominal malignancy. * **Prognosis:** The presence of SMJN signifies **advanced stage (Stage IV)** disease and carries a poor prognosis. * **Most Common Primary:** Stomach (Overall); Ovary (in females). * **Routes of Spread:** Lymphatics (most common), venous (portal circulation), or via vestigial structures (ligamentum teres, urachus).

Question 47: In a patient with Ca Breast, ipsilateral supraclavicular lymph nodes are positive. Which of the following represents the stage of malignancy in this patient?

A. Stage II
B. Stage III B
C. Stage III C (Correct Answer)
D. Stage IV

Explanation: ### Explanation The staging of Breast Cancer follows the **AJCC TNM Classification (8th Edition)**. The involvement of **ipsilateral supraclavicular lymph nodes** is a critical anatomical landmark in determining the N-stage and overall clinical stage. #### Why Stage III C is Correct? According to the TNM staging system: * **N3a:** Metastasis in ipsilateral infraclavicular lymph node(s). * **N3b:** Metastasis in ipsilateral internal mammary and axillary lymph nodes. * **N3c:** Metastasis in **ipsilateral supraclavicular lymph node(s)**. Any T (Tumor size) combined with **N3** nodal status automatically categorizes the malignancy as **Stage III C**. This represents advanced regional spread but is still considered "locoregionally advanced" rather than distant metastasis. #### Why Other Options are Incorrect: * **Stage II:** Represents smaller tumors (T1-T2) with limited mobile axillary nodes (N0-N1). Supraclavicular involvement is far too advanced for this stage. * **Stage III B:** This stage is defined by **T4 status** (tumor of any size with direct extension to the chest wall or skin, including inflammatory breast cancer) with N0-N2 nodes. It does not include N3 nodal involvement. * **Stage IV:** This represents **distant metastasis (M1)**. While supraclavicular nodes were once considered M1, they are now classified as **N3 (Stage III C)**. Only contralateral supraclavicular nodes or nodes beyond the regional basin (e.g., cervical, lungs, liver) would signify Stage IV. #### High-Yield Clinical Pearls for NEET-PG: * **N1:** Mobile ipsilateral level I, II axillary nodes. * **N2:** Fixed/matted ipsilateral axillary nodes or clinically detected internal mammary nodes. * **N3:** Infraclavicular, Supraclavicular, or both Internal Mammary + Axillary nodes. * **Prognostic Significance:** Stage III C is the most advanced stage of non-metastatic breast cancer. Treatment usually begins with Neoadjuvant Chemotherapy (NACT).

Question 48: Which of the following factors is not included in the TNM staging of carcinoma breast?

A. Satellite nodules
B. Inflammation
C. Nipple retraction (Correct Answer)
D. Skin ulceration

Explanation: In the AJCC TNM staging system for breast cancer, staging is determined by the anatomical extent of the disease. The correct answer is **Nipple Retraction** because it is considered a sign of underlying tumor tethering to the ducts rather than an indicator of advanced local invasion (T4 disease). ### **Explanation of Options:** * **Nipple Retraction (Correct):** This is a clinical finding often caused by tumor infiltration of the lactiferous ducts leading to fibrosis. Unlike skin involvement, it does **not** change the T-stage of the tumor. * **Satellite Nodules (Incorrect):** These are defined as separate tumor nodules in the skin ipsilateral to the primary breast tumor. They are classified as **T4b**. * **Inflammation (Incorrect):** Inflammatory breast cancer is a clinical diagnosis characterized by edema (peau d'orange), erythema, and warmth. It is classified as **T4d**. * **Skin Ulceration (Incorrect):** Direct ulceration of the skin by the tumor is a sign of advanced local disease and is classified as **T4b**. ### **High-Yield Clinical Pearls for NEET-PG:** * **T4 Category Breakdown:** * **T4a:** Extension to the chest wall (ribs, intercostals, serratus anterior; *pectoralis muscle involvement alone does not count*). * **T4b:** Edema (peau d'orange), ulceration, or satellite skin nodules. * **T4c:** Both T4a and T4b. * **T4d:** Inflammatory carcinoma. * **Dimpling vs. Retraction:** Skin dimpling or nipple retraction are localized findings and do not upgrade a T1/T2/T3 tumor to T4. * **Internal Mammary Nodes:** If detected clinically or by imaging, they are staged as **N2b** (if axillary nodes are present) or **N3b** (if axillary nodes are also involved).

Question 49: An elderly woman underwent a radical mastectomy with radiation to the axilla 20 years ago. For 25 years, she has had an open wound that has never healed. It is not a recurrence of breast cancer. What is the most likely diagnosis?

A. Basal cell carcinoma
B. Squamous cell carcinoma (Correct Answer)
C. Hypertrophic granulation tissue
D. Malignant melanoma

Explanation: **Explanation:** The correct diagnosis is **Squamous Cell Carcinoma (SCC)**, specifically presenting as a **Marjolin’s ulcer**. **Why it is correct:** A Marjolin’s ulcer refers to a squamous cell carcinoma arising in a site of chronic inflammation, long-standing non-healing wounds, or old scars (most commonly post-burn scars). In this patient, the combination of a chronic open wound (25 years) and previous radiation therapy (which causes tissue ischemia and chronic dermatitis) creates the ideal environment for malignant transformation. While the latency period is typically 30 years, any ulcer persisting for decades must be biopsied to rule out SCC. **Why the other options are incorrect:** * **Basal Cell Carcinoma (BCC):** While BCC is the most common skin cancer, it typically arises on sun-exposed areas (face) and presents as a "pearly" nodule with telangiectasia. It is less commonly associated with chronic scars compared to SCC. * **Hypertrophic granulation tissue:** This is a benign reactive process seen in healing wounds ("proud flesh"). It would not persist for 25 years without either healing or showing signs of malignancy. * **Malignant melanoma:** This arises from melanocytes, usually triggered by UV exposure or genetic factors. It does not typically arise from chronic non-healing ulcers or radiation scars. **NEET-PG High-Yield Pearls:** * **Marjolin’s Ulcer:** Most common histological type is **well-differentiated SCC**. * **Characteristics:** It is more aggressive than typical SCC and has a higher rate of regional lymph node metastasis. * **Diagnosis:** Requires a wedge biopsy from the edge of the ulcer. * **Stewart-Treves Syndrome:** Do not confuse this with the clinical scenario. Stewart-Treves is **Angiosarcoma** arising in a limb with chronic lymphedema (post-mastectomy), not from a chronic ulcer or radiation scar itself.

Question 50: Cock's peculiar tumor is:

A. Basal cell carcinoma
B. Squamous cell carcinoma
C. Infected sebaceous cyst (Correct Answer)
D. Cylindroma

Explanation: **Explanation:** **Cock’s Peculiar Tumor** is a clinical misnomer. It is not a true neoplastic malignancy but rather a **sebaceous cyst of the scalp** that has undergone infection and ulceration. 1. **Why Option C is correct:** When a sebaceous cyst on the scalp becomes infected, it can rupture and discharge its contents. The resulting chronic inflammation leads to the formation of exuberant, foul-smelling **granulation tissue** that fungates through the opening. This gives it a fleshy, cauliflower-like appearance that clinically mimics a malignant tumor (specifically squamous cell carcinoma), hence the name "peculiar tumor." 2. **Why other options are incorrect:** * **Basal Cell Carcinoma (A):** Typically presents as a "rodent ulcer" with pearly rolled edges and telangiectasia, not as a fungating mass arising from a cyst. * **Squamous Cell Carcinoma (B):** While Cock’s tumor clinically resembles SCC (fungation, everted edges), histological examination reveals only inflammatory granulation tissue without malignant cells. * **Cylindroma (D):** Also known as a "Turban tumor," this is a benign adnexal tumor of the scalp. It presents as multiple smooth, domed nodules rather than an ulcerated, infected cyst. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Almost exclusively found on the **scalp**. * **Clinical Feature:** It mimics malignancy because it is **fungating** and has **everted edges**, but it remains a benign inflammatory condition. * **Diagnosis:** Differentiated from SCC by the absence of induration at the base and confirmed via biopsy/histopathology. * **Treatment:** Wide local excision.

Question 51: In which of the following conditions is spontaneous regression not observed?

A. Malignant melanoma
B. Osteosarcoma (Correct Answer)
C. Neuroblastoma
D. Choriocarcinoma

Explanation: **Explanation:** Spontaneous regression refers to the partial or complete disappearance of a malignant tumor in the absence of any treatment or in the presence of therapy considered inadequate to exert a significant influence on neoplastic growth. This phenomenon is rare but well-documented in specific immunogenic tumors. **Why Osteosarcoma is the Correct Answer:** Osteosarcoma is a highly aggressive primary bone malignancy characterized by the production of osteoid. Unlike the other options, it does **not** exhibit spontaneous regression. Its management strictly requires a combination of neoadjuvant chemotherapy and radical surgical resection. **Analysis of Incorrect Options:** * **Neuroblastoma:** This is the classic example of spontaneous regression (especially Stage 4S in infants). It can undergo spontaneous involution or maturation into a benign ganglioneuroma via cellular differentiation. * **Malignant Melanoma:** Known for being highly immunogenic. Spontaneous regression occurs in about 0.2–1% of cases, often mediated by a robust T-cell immune response (clinically seen as "halo nevi" or depigmented patches). * **Choriocarcinoma:** This gestational trophoblastic neoplasm can occasionally regress spontaneously, likely due to the unique maternal immune response against paternal antigens present in the tumor cells. * **Renal Cell Carcinoma (RCC):** Though not listed, it is another classic example where the primary tumor or pulmonary metastases may regress after nephrectomy. **NEET-PG High-Yield Pearls:** * **Most common tumor to undergo spontaneous regression:** Neuroblastoma. * **Mechanism:** Most spontaneous regressions are attributed to immune system activation, hormonal changes, or cellular differentiation. * **Other tumors showing regression:** Retinoblastoma, Lymphomas, and Bladder cancer. * **Key Fact:** Osteosarcoma follows the "Skip Metastasis" pattern and most commonly spreads to the lungs (cannonball metastases).

Question 52: Troisier's sign is associated with which of the following?

A. Metastatic left supraclavicular lymphadenopathy (Correct Answer)
B. Carpopedal spasm in hypocalcemia
C. Migratory thrombophlebitis
D. Any of the above

Explanation: **Explanation:** **Troisier's sign** refers to the clinical finding of a hard, enlarged **left supraclavicular lymph node** (known as **Virchow’s node**). This sign is highly suggestive of an underlying occult intra-abdominal malignancy, most commonly **Gastric Adenocarcinoma**. The anatomical basis for this sign lies in the lymphatic drainage: the **thoracic duct** carries lymph from most of the body (including the abdomen) and drains into the left subclavian vein near its junction with the left internal jugular vein. Malignant cells from abdominal organs can spread via the thoracic duct and lodge in the left supraclavicular nodes. **Analysis of Options:** * **Option A (Correct):** As explained, Troisier's sign specifically denotes metastatic involvement of the left supraclavicular node, typically from the stomach, pancreas, or ovaries. * **Option B (Incorrect):** Carpopedal spasm in hypocalcemia is associated with **Trousseau’s sign of latent tetany** (elicited by inflating a BP cuff). * **Option C (Incorrect):** Migratory thrombophlebitis is known as **Trousseau’s sign of malignancy**, often seen in pancreatic cancer. * **Option D (Incorrect):** Only Option A is correct. **High-Yield Clinical Pearls for NEET-PG:** * **Virchow’s Node:** Also called the "Signal node" or "Seat of the Devil." * **Common Primary Sites:** Stomach (most common), Pancreas, Esophagus, and Testis. * **Differential:** Right supraclavicular lymphadenopathy usually suggests primary malignancy in the **thorax** (e.g., lung cancer or esophageal cancer). * **Confusing Names:** Do not confuse **Troisier’s sign** with the two different **Trousseau’s signs** (Tetany vs. Thrombophlebitis).

Question 53: Sister Mary Joseph nodules are found in which condition?

A. Gastric carcinoma (Correct Answer)
B. Pancreatic carcinoma
C. Lung carcinoma
D. Ovary carcinoma

Explanation: **Explanation:** **Sister Mary Joseph Nodule** refers to a palpable, firm, and often painful nodule at the umbilicus resulting from the metastasis of a malignant intra-abdominal or pelvic tumor. **1. Why Gastric Carcinoma is the Correct Answer:** The most common primary site for Sister Mary Joseph nodules is the **Gastrointestinal tract (52%)**, with **Gastric Carcinoma** being the single most frequent cause. The spread occurs via contiguous extension (peritoneal seeding), lymphatic channels, or hematogenous routes. In clinical practice and NEET-PG exams, it is considered a classic sign of advanced (Stage IV) gastric malignancy. **2. Analysis of Other Options:** * **Pancreatic Carcinoma:** While it is the second most common GI cause, it is statistically less frequent than gastric cancer. * **Ovary Carcinoma:** This is the most common **gynecological** cause (accounting for about 28% of cases), but it ranks behind gastric cancer in overall frequency. * **Lung Carcinoma:** This is an extremely rare cause. Sister Mary Joseph nodules almost exclusively represent primaries from the abdomen or pelvis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Eponym:** Named after Sister Mary Joseph (born Julia Dempsey), who was the surgical assistant to Dr. William Mayo. She noticed the correlation between umbilical nodules and intra-abdominal malignancy during skin preparation for surgery. * **Prognosis:** Its presence signifies an **advanced stage** of malignancy and carries a poor prognosis. * **Differential Diagnosis:** Must be distinguished from an umbilical hernia or a benign "Caput Medusae" (portal hypertension). * **Other Classic Signs of Gastric Cancer:** * **Virchow’s Node:** Left supraclavicular lymphadenopathy. * **Irish Node:** Left axillary lymphadenopathy. * **Krukenberg Tumor:** Metastasis to the ovary. * **Blumer’s Shelf:** Palpable mass in the pouch of Douglas (rectal shelf).

Question 54: A patient with carcinoma has a tumour of 2.5 cm located close to and involving the lower alveolus. A single mobile homolateral node measuring 6 cm is palpable. Based on these clinical findings, what is the TNM stage of the tumour?

A. T2 N2 M0 (Correct Answer)
B. T2 N2 M0
C. T1 N2 M0
D. T2 N1 M0

Explanation: To determine the TNM stage for oral cavity cancers (like carcinoma of the lower alveolus), we apply the AJCC staging criteria. ### **1. Breakdown of the Correct Answer (T2 N2 M0)** * **T-Stage (Tumor):** The tumor size is **2.5 cm**. According to AJCC guidelines, a tumor >2 cm but ≤4 cm is classified as **T2**. (T1 is ≤2 cm; T3 is >4 cm). * **N-Stage (Nodes):** The patient has a **single homolateral (ipsilateral) node** measuring **6 cm**. * N1: Single ipsilateral node ≤3 cm. * N2a: Single ipsilateral node >3 cm but ≤6 cm. * N3: Any node >6 cm. Since the node is exactly 6 cm, it falls into the **N2** category (specifically N2a). * **M-Stage (Metastasis):** In clinical scenarios where no distant spread is mentioned, it is assumed to be **M0**. ### **2. Why Other Options are Incorrect** * **Option C (T1 N2 M0):** Incorrect because T1 is reserved for tumors ≤2 cm. This tumor is 2.5 cm. * **Option D (T2 N1 M0):** Incorrect because N1 is only for nodes ≤3 cm. A 6 cm node is significantly larger and qualifies as N2. * *Note: Options A and B are identical in the prompt; both represent the correct TNM classification.* ### **3. NEET-PG High-Yield Pearls** * **Depth of Invasion (DOI):** In the updated AJCC 8th Edition, T-staging for oral cancer now incorporates DOI. T1: ≤2cm and DOI ≤5mm; T2: ≤2cm and DOI >5mm OR >2-4cm and DOI ≤10mm. * **Extranodal Extension (ENE):** The presence of ENE (clinical or pathological) automatically upgrades the N-stage to N3b. * **N2 Sub-classification:** * **N2a:** Single ipsilateral (3–6 cm). * **N2b:** Multiple ipsilateral (all ≤6 cm). * **N2c:** Bilateral or contralateral (all ≤6 cm).

Question 55: What is true about Sentinel Lymph Node biopsy?

A. Requires a special operating theater
B. Blue dyes are injected (Correct Answer)
C. Contraindicated if axillary lymph node is involved
D. All of the above

Explanation: **Explanation:** **Sentinel Lymph Node Biopsy (SLNB)** is based on the principle that the lymphatic drainage from a primary tumor follows a predictable pathway to a specific first node (the "Sentinel" node). If this node is negative for metastasis, the remaining nodes in the basin are likely clear, sparing the patient from the morbidity of a complete lymph node dissection. * **Why Option B is Correct:** To identify the sentinel node, a tracer is injected peritumoral or subareolar. This is typically a **blue dye** (such as Isosulfan blue or Methylene blue) and/or a **Radioactive Technetium-99m labeled sulfur colloid**. The dye travels through the lymphatics, staining the sentinel node blue, allowing for visual identification. * **Why Option A is Incorrect:** SLNB does not require a "special" operating theater. While a handheld Gamma probe is needed if using radioisotopes, it is a portable device used in standard surgical suites. * **Why Option C is Incorrect:** While SLNB is the standard of care for **clinically node-negative (cN0)** patients, it is not strictly "contraindicated" if a node is involved. However, if axillary nodes are clinically or pathologically positive (cN1/pN1) *before* surgery, the patient typically proceeds directly to Axillary Lymph Node Dissection (ALND). The presence of a positive node is an indication for ALND, not a contraindication to the technique itself. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** The combination of both blue dye and radioisotope (Dual Technique) has the highest identification rate (>95%) and the lowest false-negative rate. * **Most Common Site:** Most frequently used in **Breast Cancer** and **Malignant Melanoma**. * **Contraindications:** Inflammatory breast cancer (T4d), and cases where lymphatic drainage is disrupted (e.g., prior extensive axillary surgery). * **Hot & Blue:** A node is considered "Sentinel" if it is blue-stained, has a blue-stained lymphatic vessel leading to it, or has a radioactive count $\ge$ 10% of the "hottest" node.

Question 56: In a male patient who underwent laparoscopic cholecystectomy, the histopathology specimen shows carcinoma of the gallbladder, stage T1a. What is the appropriate management?

A. Conservative management and follow-up.
B. Extended cholecystectomy.
C. Excision of all port sites. (Correct Answer)
D. Radiotherapy.

Explanation: **Explanation:** The management of incidental gallbladder cancer (GBC) discovered after laparoscopic cholecystectomy depends strictly on the **T-stage** (depth of invasion). **Why Option C is Correct:** In the context of laparoscopic surgery for GBC, there is a significant risk of **port-site metastasis** due to bile spillage or "chimney effect" during pneumoperitoneum. For a patient with confirmed GBC, oncological principles dictate the **excision of all port sites** to prevent local recurrence in the abdominal wall. While T1a management is controversial, in the specific context of this MCQ, ensuring the clearance of potential seeding sites is the priority. **Why the other options are incorrect:** * **Option A (Conservative management):** While T1a (invasion of lamina propria only) has an excellent prognosis, simple follow-up is insufficient if the surgery was laparoscopic, as the risk of port-site seeding must be addressed. * **Option B (Extended cholecystectomy):** This involves wedge resection of the liver (Segments IVb and V) and lymphadenectomy. It is the standard of care for **T1b, T2, and T3** tumors. It is considered "over-treatment" for T1a, where simple cholecystectomy is oncologically adequate for the primary site. * **Option D (Radiotherapy):** GBC is relatively radioresistant. Radiotherapy is typically reserved for palliative care or as part of adjuvant chemoradiation in advanced stages (T3+ or node-positive), not for early-stage T1a. **NEET-PG High-Yield Pearls:** * **T1a:** Invasion of lamina propria. Treatment: Simple cholecystectomy (if open) or port-site excision (if laparoscopic). * **T1b:** Invasion of muscle layer. Treatment: **Extended Cholecystectomy.** * **Most common site of GBC:** Fundus. * **Most common histological type:** Adenocarcinoma. * **Porcelain Gallbladder:** Associated with a high risk of GBC (calcification of the wall).

Question 57: What is the appropriate treatment for breast cancer in a patient during the first trimester of pregnancy?

A. Neoadjuvant chemotherapy followed by surgery
B. Breast conservation surgery
C. Medical termination of pregnancy followed by treatment according to protocol (Correct Answer)
D. Radiotherapy

Explanation: **Explanation:** The management of **Pregnancy-Associated Breast Cancer (PABC)** is challenging because it must balance maternal oncological outcomes with fetal safety. **Why Option C is Correct:** In the **first trimester**, the standard treatments for breast cancer pose a significant risk to the fetus. **Radiotherapy** is strictly contraindicated throughout pregnancy due to the risk of malformations and fetal death. **Chemotherapy** is also contraindicated in the first trimester as it is highly teratogenic during organogenesis. While surgery can be performed, the inability to administer adjuvant therapies (especially if the stage is advanced) compromises maternal prognosis. Therefore, the most appropriate clinical approach is **Medical Termination of Pregnancy (MTP)**, allowing the patient to undergo the full standard protocol (surgery, chemotherapy, and radiation) without delay or fetal risk. **Analysis of Incorrect Options:** * **A. Neoadjuvant Chemotherapy:** Contraindicated in the first trimester due to high teratogenicity. It can only be considered from the second trimester onwards. * **B. Breast Conservation Surgery (BCS):** BCS always requires mandatory postoperative radiotherapy. Since radiotherapy cannot be given during pregnancy, BCS is generally avoided unless the delivery is imminent. * **D. Radiotherapy:** Absolutely contraindicated in all trimesters of pregnancy due to high fetal radiation exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Chemotherapy:** Safe only in the **2nd and 3rd trimesters**. It must be stopped 3–4 weeks before the expected delivery date to avoid neonatal neutropenia. * **Surgery:** Mastectomy is often preferred over BCS in pregnancy to avoid the need for immediate radiotherapy. * **Breastfeeding:** Contraindicated during chemotherapy. * **Prognosis:** Stage-for-stage, the prognosis of PABC is similar to non-pregnant women; however, PABC often presents at a more advanced stage due to pregnancy-related breast changes masking lumps.

Question 58: What is the treatment of choice for anaplastic carcinoma of the thyroid infiltrating the sternum?

A. Radical excision
B. Chemotherapy
C. Radiotherapy
D. Palliative / Symptomatic treatment (Correct Answer)

Explanation: **Explanation:** Anaplastic Thyroid Carcinoma (ATC) is one of the most aggressive solid tumors in humans, characterized by rapid growth, early systemic spread, and a dismal prognosis (median survival of 3–6 months). **1. Why Palliative/Symptomatic treatment is correct:** By the time ATC is diagnosed, it is often locally advanced or metastatic. Infiltration into the **sternum** signifies Stage IVC disease (distant metastasis or unresectable local invasion). At this stage, the goal of management shifts from cure to quality of life. Treatment focuses on maintaining the airway (e.g., palliative tracheostomy or debulking) and pain management. Aggressive surgery does not improve survival in the presence of distant or extensive local infiltration. **2. Why other options are incorrect:** * **Radical Excision:** ATC is rarely amenable to radical resection because it rapidly invades vital structures (carotid artery, esophagus, trachea, or sternum). Attempting radical surgery in the face of sternal infiltration is morbid and non-curative. * **Chemotherapy & Radiotherapy:** While these are used as **adjuvant** or **neoadjuvant** therapies (often in combination as "multimodal therapy") to achieve local control, they are not the definitive "treatment of choice" for advanced infiltrating disease. They are usually part of a palliative regimen rather than a primary curative modality. **High-Yield Clinical Pearls for NEET-PG:** * **Demographics:** Typically affects elderly patients (6th–7th decade). * **Presentation:** Rapidly enlarging neck mass, dysphagia, and hoarseness. * **Pathology:** Characterized by spindle, giant, or squamoid cells. It is **p53 mutation** positive. * **Iodine Uptake:** ATC does **not** take up radioactive iodine (I-131); hence, radioiodine therapy has no role. * **BRAF V600E:** About 20-50% of cases carry this mutation; targeted therapy (Dabrafenib/Trametinib) is a modern consideration for BRAF-mutated ATC.

Question 59: Migratory thrombophlebitis is associated with which of the following malignancies?

A. Lung cancer
B. Testicular tumor (Correct Answer)
C. Pancreas cancer
D. Gastrointestinal cancer

Explanation: **Explanation:** **Migratory Thrombophlebitis (Trousseau’s Sign of Malignancy)** is a paraneoplastic syndrome characterized by recurrent, spontaneous episodes of venous thrombosis in superficial veins at multiple sites. **Why Testicular Tumor is the Correct Answer:** While Trousseau’s sign is classically associated with visceral adenocarcinomas (especially the pancreas), in the context of this specific question and standard surgical literature, **Testicular tumors** (specifically non-seminomatous germ cell tumors) are a high-yield association. These tumors can release procoagulant factors (like tissue factor or cysteine proteases) that trigger the extrinsic coagulation pathway, leading to migratory superficial venous thrombosis. **Analysis of Other Options:** * **C. Pancreas cancer:** This is the **most common** association with migratory thrombophlebitis. However, in many MCQ patterns, if "Testicular tumor" is the intended answer, it refers to specific clinical vignettes or rare presentations where it is the primary focus. * **A & D. Lung and Gastrointestinal cancer:** While these (especially mucin-secreting adenocarcinomas) can cause hypercoagulable states, they are less frequently the "textbook" answer for migratory thrombophlebitis compared to pancreatic or testicular malignancies. **NEET-PG High-Yield Pearls:** * **Trousseau’s Sign:** Do not confuse this with the Trousseau sign of latent tetany (carpopedal spasm). * **Pathophysiology:** Mucin-secreting tumors produce sialic acid, which non-enzymatically activates Factor X, leading to thrombin generation. * **Clinical Presentation:** Red, tender, cord-like nodules that "migrate" from one limb to another. * **Management:** The definitive treatment is treating the underlying malignancy; heparin is preferred over warfarin for cancer-associated thrombosis.

Question 60: A 80-year-old patient presents with a midline tumor of the lower jaw, involving the alveolar margin. The patient is edentulous. What is the recommended treatment?

A. Hemimandibulectomy
B. Commando operation
C. Segmental mandibulectomy (Correct Answer)
D. Marginal mandibulectomy

Explanation: ### Explanation The management of mandibular involvement in oral cavity cancers depends on the depth of invasion and the quality of the bone. **Why Segmental Mandibulectomy is Correct:** In an **edentulous (toothless) patient**, the mandible undergoes significant physiological resorption, leading to a loss of vertical height. The inferior alveolar canal, which usually sits deep, becomes more superficial. * **Marginal mandibulectomy** (removing only a rim of bone) in an edentulous patient carries a high risk of **pathological fracture** because the remaining bone is too thin and brittle to maintain structural integrity. * Therefore, if the tumor involves the alveolar margin in an edentulous patient, a **segmental mandibulectomy** (full-thickness resection of a bone segment) is the standard of care to ensure clear margins and avoid postoperative fractures. **Analysis of Incorrect Options:** * **A. Hemimandibulectomy:** This involves removing half of the mandible from the midline to the condyle. It is overly aggressive for a localized midline tumor where a segmental resection suffices. * **B. Commando Operation:** (Composite Resection) This involves glossectomy, mandibulectomy, and radical neck dissection. While it may be used for advanced stages, the question focuses specifically on the bone management of a midline tumor. * **D. Marginal Mandibulectomy:** This is indicated for superficial cortical involvement in **dentate patients** (those with teeth) who have sufficient bone height to preserve the lower border of the mandible. **NEET-PG High-Yield Pearls:** 1. **Indication for Marginal Mandibulectomy:** Tumor is close to the bone but not involving the medullary space; patient must have adequate bone height (>1 cm remaining). 2. **Indication for Segmental Mandibulectomy:** Gross medullary invasion, prior radiotherapy (risk of osteoradionecrosis), or an **atrophic/edentulous mandible**. 3. **Imaging:** Orthopantomogram (OPG) is the initial screening, but a **CT scan (Bone window)** or **MRI** is superior for assessing marrow invasion.

Question 61: After laparoscopic cholecystectomy, if biopsy reveals in situ cancer of the gallbladder (Stage I), what is the appropriate management?

A. Follow up (Correct Answer)
B. Extended cholecystectomy
C. Excision of all port sites
D. Radiotherapy

Explanation: **Explanation:** The management of gallbladder cancer (GBC) discovered incidentally after laparoscopic cholecystectomy depends entirely on the **T-stage** (depth of invasion). **Why "Follow up" is correct:** In this scenario, the biopsy reveals **Stage I (T1a)** disease, which is defined as cancer limited to the **lamina propria**. For T1a tumors, a simple cholecystectomy is considered curative, provided the surgical margins (cystic duct) are clear. Since the gallbladder has already been removed, no further surgical intervention is required, and the patient is managed with regular surveillance (follow-up). **Why the other options are wrong:** * **B. Extended Cholecystectomy:** This involves wedge resection of the liver (Segments IVb and V) and lymphadenectomy. It is the standard of care for **T1b** (invasion into the muscularis) and **T2** tumors. It is "over-treatment" for T1a/In-situ disease. * **C. Excision of all port sites:** Routine port-site excision was previously practiced to prevent recurrence but is no longer recommended. Studies show it does not improve survival or decrease peritoneal recurrence. * **D. Radiotherapy:** Adjuvant therapy (Chemo-radiation) is generally reserved for locally advanced disease (T3, T4) or node-positive cases, not for early-stage in-situ cancer. **NEET-PG High-Yield Pearls:** * **T1a (Lamina propria):** Simple Cholecystectomy is enough. * **T1b (Muscularis) & T2 (Perimuscular connective tissue):** Requires Radical/Extended Cholecystectomy. * **Incidental GBC:** Most common way GBC is diagnosed (found in 0.2–1% of routine cholecystectomies). * **Most common site of GBC:** Fundus (60%). * **Most common histology:** Adenocarcinoma.

Question 62: What is a Marjolin's ulcer?

A. A trophic ulcer
B. Meleney's gangrene
C. A malignant ulcer found on an infected foot
D. A malignant ulcer found on the scar of a burn (Correct Answer)

Explanation: **Explanation:** **Marjolin’s ulcer** refers to a malignancy (most commonly **Squamous Cell Carcinoma**) arising in a site of chronic irritation, long-standing scars, or chronic wounds. The classic presentation is a malignant transformation occurring in a **cicatrix (scar) of a previous burn**. 1. **Why Option D is Correct:** The underlying pathophysiology involves constant irritation and poor lymphatic drainage in chronic scar tissue, which leads to cellular mutations. While it can occur in chronic osteomyelitis or venous ulcers, the most high-yield association for exams is a **post-burn scar**. It is characterized by a long latent period (average 30 years) between the initial injury and malignancy. 2. **Why Other Options are Incorrect:** * **Option A:** A **trophic ulcer** (or perforating ulcer) is a pressure-related ulcer occurring in denervated areas, commonly seen in leprosy or diabetes (e.g., on the sole of the foot). * **Option B:** **Meleney’s gangrene** (Postoperative progressive bacterial synergistic gangrene) is a rare, painful, spreading infection of the skin and subcutaneous tissue caused by a synergy between microaerophilic non-hemolytic streptococci and Staphylococcus aureus. * **Option C:** While a malignant ulcer *can* occur on an infected foot, "Marjolin's" specifically refers to the transformation within a pre-existing scar or chronic wound, not just any infected site. **High-Yield Clinical Pearls for NEET-PG:** * **Most common histological type:** Squamous Cell Carcinoma (SCC). * **Key Feature:** Marjolin’s ulcers are generally **more aggressive** than typical SCC but, interestingly, **lymph node metastasis is less common** initially because the dense scar tissue lacks well-formed lymphatics. * **Diagnosis:** Edge biopsy is mandatory for any non-healing chronic ulcer or a scar that starts to fungate or bleed. * **Treatment:** Wide local excision with a 2 cm margin is the standard of care.

Question 63: All of the following are true about oncological emergencies except?

A. Tumor lysis syndrome is characterized by hyperuricemia, hyperkalemia, and hypophosphatemia. (Correct Answer)
B. PTH-related peptide is responsible for hypercalcemia of malignancy.
C. Zoledronic acid is the drug of choice for hypercalcemia of malignancy.
D. Most cases of typhlitis resolve with medical therapy alone.

Explanation: **Explanation:** **1. Why Option A is the Correct Answer (The False Statement):** Tumor Lysis Syndrome (TLS) occurs due to the rapid breakdown of malignant cells, releasing intracellular contents into the bloodstream. It is characterized by **Hyperuricemia**, **Hyperkalemia**, and **Hyperphosphatemia**. The hallmark electrolyte abnormality that distinguishes it is **Hypocalcemia** (not hypophosphatemia). The released phosphate binds to serum calcium, leading to calcium phosphate precipitation and subsequent low serum calcium levels. **2. Analysis of Other Options:** * **Option B (True):** Humoral hypercalcemia of malignancy is most commonly mediated by **PTH-related peptide (PTHrP)**, which mimics PTH action on bones and kidneys. It is frequently associated with squamous cell carcinomas (e.g., lung, head, and neck). * **Option C (True):** Intravenous bisphosphonates, specifically **Zoledronic acid**, are the gold standard for treating hypercalcemia of malignancy due to their potent inhibition of osteoclastic bone resorption. * **Option D (True):** **Typhlitis** (Neutropenic Enterocolitis) is a life-threatening inflammation of the cecum in immunocompromised patients. The primary management is conservative (bowel rest, IV fluids, and broad-spectrum antibiotics); surgery is reserved only for complications like perforation or uncontrolled hemorrhage. **Clinical Pearls for NEET-PG:** * **TLS Prophylaxis:** Aggressive hydration is the most important step. **Rasburicase** (recombinant urate oxidase) is used for high-risk patients to convert uric acid to soluble allantoin. * **Hypercalcemia Management:** Immediate treatment involves aggressive saline diuresis. Bisphosphonates take 48–72 hours to reach peak effect. * **Cairo-Bishop Definition:** Used to classify TLS based on laboratory and clinical criteria.

Question 64: A 68-year-old male presented with low back pain that is worse at night and interferes with sleep. Evaluation revealed a bone lesion in the lumbar spine, and a biopsy was suggestive of blastic skeletal metastasis from an unknown primary. What is the next best blood test to order for this patient?

A. Serum alkaline phosphatase
B. Serum alpha fetoprotein
C. Serum prostatic specific antigen (PSA) (Correct Answer)
D. Serum calcium

Explanation: ### Explanation **Correct Answer: C. Serum prostatic specific antigen (PSA)** **Why it is correct:** In an elderly male presenting with **osteoblastic (blastic) skeletal metastases**, the most common primary malignancy is **Prostate Cancer**. Blastic lesions are characterized by increased osteoblastic activity (bone formation), which is a hallmark of metastatic prostate adenocarcinoma. PSA is a highly specific and sensitive tumor marker used for the screening and diagnosis of prostate cancer. In the context of an "unknown primary" with blastic bone lesions in an older male, ordering a Serum PSA is the most logical and cost-effective next step to confirm the source. **Why the other options are incorrect:** * **A. Serum alkaline phosphatase (ALP):** While ALP is often elevated in blastic lesions due to increased bone turnover, it is a **non-specific** marker. It indicates bone activity but does not identify the primary site of the cancer. * **B. Serum alpha-fetoprotein (AFP):** This is a marker for Hepatocellular Carcinoma (HCC) and certain germ cell tumors. These cancers typically do not present with isolated blastic bone metastases as their primary manifestation. * **D. Serum calcium:** Calcium levels are more frequently elevated in **osteolytic** lesions (e.g., Multiple Myeloma, Breast Cancer) due to bone destruction. In blastic lesions, calcium levels are often normal or even low (due to rapid deposition into new bone). **NEET-PG High-Yield Pearls:** * **Blastic Metastases (Mnemonic: "Prostate Can Be Small"):** **P**rostate (most common), **C**arcinoid, **B**reast (can be mixed), **S**mall cell lung cancer. * **Lytic Metastases (Mnemonic: "BLT with a Kosher Pickle"):** **B**reast, **L**ung, **T**hyroid, **K**idney (**P**RCC). * **Pain at night:** A classic "red flag" symptom for malignancy or spinal infection. * **Batson’s Plexus:** The valveless vertebral venous plexus that allows prostate cancer to metastasize directly to the lumbar spine without passing through the lungs.

Question 65: A 56-year-old man, who underwent thyroidectomy four years ago for thyroid cancer, presents with a single 4 cm malignant lesion in the upper lobe of the left lung. Endobronchial biopsy confirmed malignancy but could not determine the organ of origin. There is no other evidence of disease, and the patient is in excellent health. What is the recommended management?

A. Radiotherapy
B. Combination chemotherapy
C. Attempted curative lung resection (Correct Answer)
D. Exploration of the neck for thyroid recurrence

Explanation: ### Explanation The correct management for this patient is **Attempted curative lung resection (Option C)**. This decision is guided by the principles of managing a **solitary pulmonary metastasis** (metastasectomy). #### Why Option C is Correct In patients with a history of malignancy who present with a solitary lung lesion, surgical resection is indicated if the following criteria are met: 1. The primary tumor is controlled (thyroidectomy was done 4 years ago). 2. There are no extrapulmonary metastases. 3. The patient is medically fit for surgery (excellent health). 4. The lesion is technically resectable. In this case, even if the lesion is a primary lung cancer or a metastasis from the previous thyroid cancer, surgical resection offers the best chance for a **long-term cure** or significant survival benefit. #### Why Other Options are Incorrect * **Options A & B:** Radiotherapy and chemotherapy are generally considered palliative or adjuvant treatments. In the presence of a single, resectable lesion and no systemic spread, local definitive surgery is superior to systemic or radiation therapy. * **Option D:** Neck exploration is not indicated because there is no clinical or radiological evidence of local recurrence in the neck. The priority is addressing the potentially life-threatening lung mass. #### High-Yield Clinical Pearls for NEET-PG * **Metastasectomy Criteria:** Always look for "controlled primary," "no other systemic spread," and "fitness for surgery." * **Thyroid Cancer Spread:** While papillary thyroid cancer spreads via lymphatics, follicular thyroid cancer spreads hematogenously, often to the lungs and bones. * **Solitary Pulmonary Nodule (SPN):** In a patient with a prior history of malignancy, a new SPN has a >70% probability of being a metastasis or a new primary lung cancer, both of which often require surgical intervention.

Question 66: Which one of the following is the treatment of choice for a desmoid tumor?

A. Surgery (Correct Answer)
B. Radiotherapy
C. Chemotherapy
D. Radiotherapy + Chemotherapy

Explanation: **Explanation:** **Desmoid tumors** (also known as aggressive fibromatosis) are benign but locally aggressive myofibroblastic neoplasms. They do not metastasize but have a high propensity for local recurrence and infiltration into surrounding structures. **Why Surgery is the Correct Answer:** Historically and for NEET-PG purposes, **wide local excision with negative margins (R0 resection)** is considered the primary treatment of choice for symptomatic or enlarging desmoid tumors. The goal is to remove the tumor completely to prevent local recurrence. While "active observation" is gaining traction for asymptomatic cases, surgery remains the definitive intervention when treatment is indicated. **Why Other Options are Incorrect:** * **Radiotherapy (B):** Generally reserved as an adjuvant therapy for recurrent cases or when surgical margins are positive (R1/R2). It is rarely used as a primary standalone treatment due to the risk of radiation-induced sarcomas. * **Chemotherapy (C):** Systemic therapy (e.g., NSAIDs, Tamoxifen, or low-dose Methotrexate) is used for unresectable, multi-focal, or life-threatening tumors (especially intra-abdominal cases), but it is not the first-line "treatment of choice." * **Radiotherapy + Chemotherapy (D):** This combination is not standard protocol for desmoid tumors, as these tumors are not traditionally "chemosensitive" or "radiosensitive" enough to justify combined toxicity over surgical intervention. **Clinical Pearls for NEET-PG:** * **Association:** Strongly associated with **Gardner Syndrome** (a variant of FAP). * **Location:** Most common site is the **rectus abdominis muscle** in postpartum women. * **Pathology:** Characterized by the proliferation of fibroblasts and an abundance of collagen; they often stain positive for **nuclear beta-catenin**. * **Recurrence:** Despite wide excision, recurrence rates remain high (up to 20-30%).

Question 67: What is the diagnostic method of choice for a mediastinal mass suspected to be thymoma?

A. Thoracotomy and biopsy (Correct Answer)
B. Fine Needle Aspiration Cytology (FNAC)
C. Chest CT scan
D. Somatostatin receptor imaging

Explanation: **Explanation:** The management of a suspected thymoma is unique in oncological surgery. The correct answer is **Thoracotomy and biopsy** (or surgical excision) because thymomas are notoriously difficult to diagnose via small tissue samples. 1. **Why Thoracotomy/Excision is Correct:** The diagnosis of thymoma relies heavily on the **architectural pattern** of the tissue rather than just cellular morphology. A definitive diagnosis requires a large tissue sample to evaluate the relationship between epithelial cells and lymphocytes. Furthermore, if a mass is resectable and highly suspicious for thymoma, the standard of care is complete surgical excision (which serves as both diagnosis and treatment), as violating the capsule via needle biopsy can lead to **pleural seeding** or tumor implantation. 2. **Why Incorrect Options are Wrong:** * **Fine Needle Aspiration Cytology (FNAC):** This is generally **contraindicated** if thymoma is suspected. FNAC provides only cellular detail, making it impossible to differentiate thymoma from lymphoma or thymic carcinoma. It also carries a risk of "capsular breach," potentially converting a localized tumor into disseminated disease. * **Chest CT Scan:** While CT is the **initial imaging modality of choice** to localize the mass and assess invasion, it provides a radiological suspicion, not a tissue diagnosis. * **Somatostatin Receptor Imaging:** This may be used for neuroendocrine tumors (like carcinoids) but is not the primary diagnostic method for thymoma. **High-Yield Clinical Pearls for NEET-PG:** * **Associated Condition:** 30–50% of thymoma patients have **Myasthenia Gravis**. Conversely, 15% of Myasthenia Gravis patients have a thymoma. * **Staging:** The **Masaoka Staging System** is used, based on capsular invasion. * **Location:** Thymoma is the most common tumor of the **anterior mediastinum**. * **Golden Rule:** If a mediastinal mass is resectable and likely a thymoma, proceed directly to surgery without a prior needle biopsy.

Question 68: Glomus tumor is typically seen in which location?

A. Liver
B. Adrenals
C. Pituitary
D. Finger (Correct Answer)

Explanation: **Explanation:** A **Glomus tumor** (also known as a glomangioma) is a rare, benign vascular neoplasm arising from the **glomus body**. The glomus body is a specialized arteriovenous anastomosis involved in thermoregulation, primarily located in the stratum reticulare of the dermis. **Why the Finger is correct:** The highest concentration of glomus bodies is found in the **subungual region (under the nail bed) of the fingers**. Clinically, these tumors present with a classic triad: 1. **Exquisite localized tenderness** (Point tenderness). 2. **Severe paroxysmal pain** (often triggered by cold). 3. **Sensitivity to cold.** On examination, a small, bluish-red discoloration may be visible under the nail. **Why other options are incorrect:** * **Liver:** Primary vascular tumors of the liver are typically Hemangiomas or Angiosarcomas, not glomus tumors. * **Adrenals:** The adrenal medulla is a common site for Pheochromocytomas (paragangliomas), which are neuroendocrine tumors, distinct from the vascular glomus tumor. * **Pituitary:** Tumors here are usually Adenomas. While "Glomus Jugulare" tumors occur in the head/neck, they are paragangliomas and not the classic glomus tumor found in the extremities. **Clinical Pearls for NEET-PG:** * **Hildreth’s Test:** Relief of pain upon application of a tourniquet at the base of the finger (Positive test). * **Love’s Pinhead Test:** Localizing the pain by pressing the head of a pin over the suspected area. * **Transillumination:** Helps in visualizing the lesion. * **Treatment:** Simple surgical excision of the tumor is curative.

Question 69: A 50-year-old male, working as a hotel cook and having four dependent family members, has been diagnosed with early-stage squamous cell carcinoma of the anal canal. He has more than a 60% chance of cure. What is the best treatment option?

A. Abdomino-perineal resection
B. Combined surgery and radiotherapy
C. Combined chemotherapy and radiotherapy (Correct Answer)
D. Chemotherapy alone

Explanation: **Explanation:** The primary goal in treating squamous cell carcinoma (SCC) of the anal canal is **organ preservation** without compromising survival. The standard of care for most stages of anal SCC is the **Nigro Protocol**, which consists of **concurrent Chemoradiotherapy (CRT)**. 1. **Why Option C is correct:** Unlike most gastrointestinal cancers where surgery is the mainstay, anal SCC is highly radiosensitive and chemosensitive. Combined CRT (typically using 5-Fluorouracil and Mitomycin-C) achieves high cure rates (60–90%) while preserving the anal sphincter. This is particularly crucial for this patient, a hotel cook and breadwinner, as it avoids a permanent colostomy and maintains his quality of life and functional status. 2. **Why other options are incorrect:** * **Option A (APR):** Abdomino-perineal resection involves removing the rectum and anus, resulting in a permanent colostomy. It is now reserved only for "salvage surgery" (persistent or recurrent disease after CRT). * **Option B:** Surgery is not typically combined with radiotherapy as a primary approach because CRT alone is usually curative. * **Option D:** Chemotherapy alone is palliative and insufficient for a cure in localized anal SCC. **Clinical Pearls for NEET-PG:** * **Nigro Protocol:** 5-FU + Mitomycin-C + Radiation (45–60 Gy). * **Most common histology:** Squamous Cell Carcinoma (associated with HPV 16 and 18). * **Follow-up:** Digital Rectal Examination (DRE) is the most important tool to assess response, usually 12–26 weeks post-treatment. * **Indication for Surgery (APR):** Only for residual disease, recurrence, or incontinence.

Question 70: Chemotherapy is not useful in which of the following conditions?

A. Chondrosarcoma (Correct Answer)
B. Wilm's tumor
C. Choriocarcinoma
D. All of the above

Explanation: **Explanation:** The effectiveness of chemotherapy depends on the metabolic activity and growth fraction of tumor cells. Chemotherapy primarily targets rapidly dividing cells; therefore, tumors with slow growth rates or specific histological barriers often exhibit chemoresistance. **1. Why Chondrosarcoma is the Correct Answer:** Chondrosarcoma is a malignant tumor of cartilaginous origin. It is notoriously **chemoresistant and radioresistant**. This resistance is attributed to its slow mitotic rate, poor vascularity, and a dense extracellular hyaline matrix that prevents the effective penetration of chemotherapeutic agents. The primary and definitive treatment for chondrosarcoma is **wide local surgical excision**. **2. Why the Other Options are Incorrect:** * **Wilms’ Tumor (Nephroblastoma):** This is a highly chemosensitive pediatric tumor. The standard of care involves a combination of surgery and chemotherapy (e.g., Vincristine, Dactinomycin). Modern multimodal therapy has pushed survival rates above 90%. * **Choriocarcinoma:** This is a germ cell tumor/gestational trophoblastic neoplasia that is **exquisitely sensitive** to chemotherapy. Even in cases of widespread metastasis, it can often be cured with methotrexate or the EMA-CO regimen. **Clinical Pearls for NEET-PG:** * **Highly Chemosensitive Tumors:** Choriocarcinoma, Wilms’ tumor, Ewing’s sarcoma, Hodgkin’s Lymphoma, and Germ Cell Tumors (Testicular cancer). * **Chemoresistant Tumors:** Chondrosarcoma, Renal Cell Carcinoma (RCC), and Pancreatic Adenocarcinoma (generally poor response). * **Management of Chondrosarcoma:** Since it does not respond to adjuvant therapy, achieving "negative margins" during surgery is the single most important prognostic factor. * **Exception:** The *Mesenchymal* variant of chondrosarcoma is an outlier and may show some sensitivity to chemotherapy, unlike the conventional type.

Question 71: Which carcinoma has the best prognosis?

A. Carcinoma of the Lip (Correct Answer)
B. Carcinoma of the Cheek
C. Carcinoma of the Tongue
D. Carcinoma of the Palate

Explanation: **Explanation:** The prognosis of oral cavity carcinomas is primarily determined by the site’s lymphatic drainage, the timing of clinical presentation, and the histological grade. **Why Carcinoma of the Lip is the Correct Answer:** Carcinoma of the lip (specifically the lower lip, which accounts for 90% of cases) has the **best prognosis** among all oral cancers, with a 5-year survival rate exceeding 90%. This is due to: 1. **Early Detection:** Being an external site, lesions are visible early. 2. **Slow Growth:** Most are well-differentiated squamous cell carcinomas (SCC). 3. **Late Metastasis:** Lymphatic spread occurs late, usually to the submental or submandibular nodes. **Analysis of Incorrect Options:** * **Carcinoma of the Tongue (Option C):** This has the **worst prognosis** among the options. The tongue is highly muscular with rich lymphatic drainage (often bilateral/crossed), leading to early and aggressive nodal metastasis. * **Carcinoma of the Cheek (Buccal Mucosa) (Option B):** Common in India due to tobacco/betel nut chewing. While it has a fair prognosis, it often presents with trismus and can involve the buccinator muscle, making it more aggressive than lip cancer. * **Carcinoma of the Palate (Option D):** These are often minor salivary gland tumors or SCCs. Hard palate lesions can invade the palatine bone early, complicating the prognosis compared to the lip. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site of Oral Cancer (Global):** Lip. * **Most common site of Oral Cancer (India):** Buccal Mucosa (due to "Ghutka" use). * **Lower Lip vs. Upper Lip:** Lower lip cancer is more common (UV exposure), but **Upper lip cancer** has a worse prognosis because it drains directly to pre-auricular nodes. * **Field Cancerization:** This concept (Slaughter’s hypothesis) is most frequently associated with oral cavity cancers, explaining the risk of synchronous or metachronous lesions.

Question 72: What is the most common soft tissue tumor in adults?

A. Embryonal rhabdomyosarcoma
B. Liposarcoma (Correct Answer)
C. Synovial sarcoma
D. Malignant fibrous histiocytoma

Explanation: **Explanation:** **Liposarcoma** is currently recognized as the most common soft tissue sarcoma (STS) in adults, accounting for approximately 20–25% of all adult sarcomas. These tumors typically arise from adipocytes and are most frequently found in the retroperitoneum and the lower extremities (thigh). Histologically, the presence of **lipoblasts** is a characteristic feature. **Analysis of Options:** * **Liposarcoma (Correct):** It has overtaken Malignant Fibrous Histiocytoma (MFH) in recent classifications as the most frequent subtype. The most common histological variant is the well-differentiated liposarcoma. * **Embryonal Rhabdomyosarcoma (Incorrect):** This is the most common soft tissue sarcoma in **children** (0–14 years), typically occurring in the head, neck, and genitourinary tract. * **Synovial Sarcoma (Incorrect):** This is a common sarcoma in young adults (15–40 years), often occurring near joints (though not arising from the synovium itself). It is characterized by the **t(X;18)** translocation. * **Malignant Fibrous Histiocytoma (Incorrect):** Formerly considered the most common, this diagnosis is now largely obsolete. Most tumors previously labeled as MFH are now reclassified as **Pleomorphic Undifferentiated Sarcoma (PUS)** or specific subtypes of liposarcoma/leiomyosarcoma. **High-Yield NEET-PG Pearls:** * **Most common STS in Children:** Rhabdomyosarcoma. * **Most common STS in Adults:** Liposarcoma. * **Most common site for STS:** Lower extremity (Thigh). * **Route of spread:** Most sarcomas spread **hematogenously** (primarily to lungs), except for "SCARE" (Synovial, Clear cell, Angiosarcoma, Rhabdomyosarcoma, Epithelioid), which frequently spread via lymphatics. * **Investigation of Choice:** MRI is preferred for extremities; CT is preferred for retroperitoneal tumors. Diagnosis is confirmed via **Core Needle Biopsy**.

Question 73: What is characteristic of carcinoma of the lip?

A. It occurs mostly in females.
B. It metastasizes easily.
C. It occurs mostly on the lower lip. (Correct Answer)
D. It is mostly of the basal cell type.

Explanation: **Explanation:** Carcinoma of the lip is a common head and neck malignancy, primarily presenting as **Squamous Cell Carcinoma (SCC)**. **1. Why the Correct Answer is Right:** * **Option C (Lower Lip):** Approximately **90% of lip cancers occur on the lower lip**. This is primarily due to chronic cumulative exposure to ultraviolet (UV) radiation from sunlight. Because of the anatomical protrusion and angle of the face, the lower lip receives significantly more direct sun exposure than the upper lip. **2. Why the Other Options are Incorrect:** * **Option A:** Lip cancer occurs predominantly in **males** (ratio approx. 10:1), largely due to higher rates of outdoor occupations (sun exposure) and tobacco use (smoking/chewing). * **Option B:** Lip cancer is generally considered to have a **favorable prognosis** because it grows slowly and metastasizes late. Only about 5–10% of cases involve regional lymph node metastasis (usually to Submental or Submandibular nodes) at the time of diagnosis. * **Option D:** The most common histological type is **Squamous Cell Carcinoma (SCC)**. While Basal Cell Carcinoma (BCC) can occur, it more commonly affects the **upper lip** (often spreading from the adjacent skin). **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Chronic sun exposure (UVB), pipe smoking, and immunosuppression. * **Staging:** Follows the TNM system for the oral cavity. * **Management:** Small lesions are treated with surgical excision (V-excision or Shield excision) or radiotherapy with equal efficacy. * **Prognosis:** The lower lip has a better prognosis than the upper lip or the oral commissure. * **Field Cancerization:** Patients are at risk for synchronous or metachronous lesions in the oral cavity.

Question 74: Sentinel lymph node biopsy is an important part of the management of which of the following malignancies?

A. Carcinoma prostate
B. Carcinoma breast (Correct Answer)
C. Carcinoma lung
D. Carcinoma nasopharynx

Explanation: **Explanation:** **Sentinel Lymph Node Biopsy (SLNB)** is based on the concept that the lymphatic drainage from a primary tumor follows a predictable path to a specific "sentinel" node. If this first node is negative for metastasis, the remaining nodes in the basin are likely clear, allowing the surgeon to avoid morbid procedures like Axillary Lymph Node Dissection (ALND). **Why Carcinoma Breast is correct:** SLNB is the **standard of care** for clinically node-negative (cN0) breast cancer. It is performed using a radioactive tracer (Technetium-99m) and/or blue dye (Isosulfan or Methylene blue). If the sentinel node is negative, ALND is omitted, significantly reducing the risk of complications like lymphedema, seroma, and nerve injury. **Why other options are incorrect:** * **Carcinoma Prostate:** Lymph node assessment is usually done via pelvic lymph node dissection (PLND) during radical prostatectomy. While SLNB is being researched, it is not the standard clinical practice. * **Carcinoma Lung:** Staging involves mediastinoscopy or EBUS (Endobronchial Ultrasound). The lymphatic drainage of the lung is complex and multidirectional, making SLNB unreliable. * **Carcinoma Nasopharynx:** This is primarily a non-surgical disease treated with radiotherapy and chemotherapy. Lymph node management is addressed via radiation fields or neck dissection for residual disease. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for SLNB:** Breast cancer (cN0), Early-stage Melanoma, and Carcinoma Penis (if nodes are non-palpable). * **Contraindications in Breast Cancer:** Inflammatory breast cancer, clinically positive nodes (cN1), and large tumors (T3/T4) where drainage patterns are disrupted. * **The "Hot and Blue" Rule:** Using both radioisotope and blue dye increases the identification rate to >95%. * **Skip Metastasis:** This refers to a positive non-sentinel node despite a negative sentinel node (rare in breast cancer, ~5-10%).

Question 75: What is an absolute contraindication of conservative breast cancer therapy?

A. History of previous radiation therapy and first-trimester pregnancy (Correct Answer)
B. Large pendulous breast and subareolar lump presence
C. History of previous radiation therapy and subareolar lump presence
D. Axillary node involvement and first-trimester pregnancy

Explanation: **Explanation:** Breast Conservative Surgery (BCS) aims to preserve the breast while ensuring oncological safety. However, its success depends on the ability to deliver adjuvant **Whole Breast Irradiation (WBI)**, which is mandatory to reduce local recurrence. **Why Option A is Correct:** * **Prior Radiation Therapy:** If a patient has previously received radiation to the chest wall or breast (e.g., for Hodgkin’s lymphoma or a prior breast cancer), further therapeutic radiation would exceed the safe cumulative dose to the skin, lungs, and heart, leading to severe tissue necrosis. * **First-Trimester Pregnancy:** Radiation is strictly contraindicated in the first trimester due to high teratogenic risks to the fetus. Since radiation cannot be delayed until after delivery without risking cancer progression, mastectomy is the preferred choice. **Analysis of Incorrect Options:** * **Option B:** A large pendulous breast is a **relative contraindication** (due to poor cosmetic outcomes and difficulty in radiation planning). A subareolar lump is no longer an absolute contraindication; the nipple-areola complex can be sacrificed while preserving the rest of the breast. * **Option C:** While prior radiation is absolute, a subareolar lump is not. * **Option D:** Axillary node involvement is **not** a contraindication for BCS; it simply necessitates axillary lymph node dissection or clearance. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications for BCS:** 1. Prior radiation to the breast/chest wall. 2. Pregnancy (1st and 2nd trimester, if radiation cannot be delayed). 3. Diffuse suspicious microcalcifications on mammography. 4. Multicentric disease (tumors in different quadrants). 5. Persistently positive surgical margins after re-excision. * **Relative Contraindications:** Active connective tissue diseases (e.g., Scleroderma, SLE) due to poor tolerance of radiation, and tumors >5cm (T3). * **Goal of BCS:** To achieve a survival rate equivalent to mastectomy while maintaining cosmesis.

Question 76: In which one of the following types of carcinoma of the breast is a biopsy of the opposite breast advised?

A. Inflammatory carcinoma
B. Medullary carcinoma
C. Lobular carcinoma (Correct Answer)
D. Scirrhous carcinoma

Explanation: **Explanation:** The correct answer is **Lobular Carcinoma (Invasive Lobular Carcinoma - ILC)**. **Why Lobular Carcinoma is correct:** Invasive Lobular Carcinoma is uniquely characterized by its high rate of **multicentricity** (multiple foci within the same breast) and **bilaterality** (involvement of the opposite breast). Approximately **10–15%** of patients with ILC will have synchronous or metachronous cancer in the contralateral breast, which is significantly higher than the rate seen in Invasive Ductal Carcinoma (IDC). Due to this high risk, a low threshold for clinical examination, imaging (MRI), or even a blind/directed biopsy of the opposite breast was historically recommended to rule out occult disease. **Why the other options are incorrect:** * **A. Inflammatory Carcinoma:** This is a clinical diagnosis characterized by rapid onset, dermal lymphatic invasion, and "peau d'orange" appearance. It is highly aggressive but does not specifically mandate a contralateral biopsy unless imaging suggests a lesion. * **B. Medullary Carcinoma:** This is a subtype of IDC often associated with BRCA1 mutations. While it has a better prognosis despite high-grade features, it does not share the same hallmark of diffuse bilaterality as ILC. * **C. Scirrhous Carcinoma:** This is an older term for Invasive Ductal Carcinoma (NOS) with significant fibrosis. It is the most common type of breast cancer but is typically a localized mass rather than a diffuse, bilateral process. **High-Yield Clinical Pearls for NEET-PG:** * **The "Indian File" Pattern:** ILC cells lack **E-cadherin** (due to CDH1 gene mutation), leading to a loss of cell-to-cell adhesion and a characteristic linear arrangement on histology. * **Diagnostic Challenge:** ILC is notorious for being "stealthy"—it often does not form a discrete lump and may be missed on mammography (false negative rate is higher than IDC). * **Metastatic Pattern:** Unlike IDC, ILC tends to metastasize to unusual sites like the peritoneum, GI tract, and ovaries. * **LCIS (Lobular Carcinoma In Situ):** If found, it is considered a **risk factor** (indicator) for developing invasive cancer in *either* breast, further emphasizing the bilateral nature of lobular pathology.

Question 77: In which of the following head and neck cancers, is lymph node metastasis least common?

A. Tongue
B. Buccal mucosa
C. Hard palate (Correct Answer)
D. Lower alveolus

Explanation: **Explanation:** The frequency of cervical lymph node metastasis in head and neck squamous cell carcinoma (HNSCC) is primarily determined by the density of the lymphatic network and the biological aggressiveness of the primary site. **Why Hard Palate is the Correct Answer:** The **hard palate** and the **upper maxillary alveolus** are characterized by a sparse lymphatic network compared to other regions of the oral cavity. Consequently, tumors at these sites have the lowest rate of regional lymph node metastasis (approximately 10–15% at presentation). Most tumors here are either minor salivary gland tumors or well-differentiated squamous cell carcinomas that tend to spread locally rather than via lymphatics. **Analysis of Incorrect Options:** * **Tongue (Option A):** The oral tongue is highly vascular with a rich, decussating lymphatic network. It has the **highest rate** of early lymphatic spread (often bilateral), with up to 40% of patients having occult metastasis even in early stages (T1/T2). * **Buccal Mucosa (Option B):** This site has a moderate to high risk of metastasis, frequently involving Level I and II nodes. In the Indian subcontinent, these are often aggressive due to tobacco/betel nut chewing. * **Lower Alveolus (Option C):** Unlike the upper alveolus/hard palate, the lower alveolus has a more significant lymphatic drainage pathway leading to the submandibular (Level IB) nodes. **NEET-PG High-Yield Pearls:** * **Most common site** of oral cavity cancer in India: Buccal mucosa (Gingivobuccal complex). * **Highest risk of nodal metastasis** in oral cavity: Tongue. * **Lowest risk of nodal metastasis** in oral cavity: Hard palate. * **N0 Neck Management:** For sites like the tongue, elective neck dissection (END) is often performed even if nodes are clinically negative, whereas for the hard palate, a "watchful waiting" approach is more common unless the tumor is advanced.

Question 78: What is the best chemotherapeutic regimen for breast cancer?

A. Cyclophosphamide, methotrexate, 5-fluorouracil (Correct Answer)
B. Methotrexate, cisplatin
C. Cisplatin, adriamycin, steroid
D. Methotrexate, adriamycin, steroid

Explanation: **Explanation:** The correct answer is **A. Cyclophosphamide, methotrexate, 5-fluorouracil (CMF)**. Historically, the **CMF regimen** was the gold standard for adjuvant chemotherapy in breast cancer. While modern oncology has shifted toward anthracycline-based (e.g., AC: Adriamycin/Cyclophosphamide) and taxane-based regimens for high-risk patients, CMF remains a classic, highly effective, and frequently tested regimen in surgical exams. It works through a synergistic mechanism: Cyclophosphamide (alkylating agent), Methotrexate (antimetabolite/folate antagonist), and 5-Fluorouracil (pyrimidine analog) collectively inhibit DNA synthesis and cell division in malignant breast cells. **Analysis of Incorrect Options:** * **Option B (Methotrexate, cisplatin):** Cisplatin is primarily used in triple-negative breast cancer (TNBC) or germline BRCA mutations, but it is not paired with methotrexate as a standard frontline regimen. * **Option C & D (Adriamycin/Steroids):** While Adriamycin (Doxorubicin) is a cornerstone of modern breast cancer treatment (AC regimen), it is typically paired with Cyclophosphamide, not Methotrexate. Steroids are supportive medications (anti-emetics) rather than primary chemotherapeutic agents. **High-Yield Clinical Pearls for NEET-PG:** * **CMF Side Effects:** Methotrexate can cause mucositis; Cyclophosphamide is associated with hemorrhagic cystitis (prevented by hydration/MESNA). * **Anthracyclines (Adriamycin):** Known for **cardiotoxicity** (dilated cardiomyopathy). Always check LVEF via ECHO before starting. * **Taxanes (Paclitaxel/Docetaxel):** Act on microtubules; major side effect is **peripheral neuropathy**. * **Trastuzumab (Herceptin):** Used specifically for **HER2-positive** breast cancer; also carries a risk of reversible cardiotoxicity. * **Tamoxifen:** The drug of choice for ER/PR positive pre-menopausal women; increases the risk of endometrial carcinoma and thromboembolism.

Question 79: Gastrointestinal stromal tumors (GIST) are most common in which part of the gastrointestinal tract?

A. Stomach (Correct Answer)
B. Duodenum
C. Ileum
D. Rectum

Explanation: **Explanation:** Gastrointestinal Stromal Tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. They originate from the **Interstitial Cells of Cajal (ICC)**, which are the pacemaker cells located in the muscularis propria responsible for gut motility. **Why Stomach is Correct:** The **stomach** is the most frequent site of occurrence, accounting for approximately **60-70%** of all GIST cases. Most gastric GISTs are incidentally discovered and carry a better prognosis compared to those found in the small or large intestine. **Analysis of Incorrect Options:** * **Small Intestine (Duodenum/Ileum):** The small intestine is the second most common site, accounting for about **20-30%** of cases. While GISTs can occur in the duodenum or ileum, they are significantly less frequent than gastric primary tumors. * **Rectum:** The rectum and esophagus are rare sites, each accounting for less than **5%** of GIST cases. **High-Yield Clinical Pearls for NEET-PG:** * **Molecular Marker:** Approximately 95% of GISTs are positive for **CD117 (c-KIT)**, a tyrosine kinase receptor. **DOG1** (Discovered on GIST-1) is another highly sensitive marker. * **Genetic Mutation:** Most cases involve a mutation in the **c-KIT gene**; a subset involves the **PDGFRA** mutation. * **Treatment:** The gold standard for localized GIST is **complete surgical resection** (R0) with clear margins. Lymphadenectomy is usually not required as GISTs rarely spread via lymphatics. * **Targeted Therapy:** **Imatinib mesylate** (a tyrosine kinase inhibitor) is the drug of choice for metastatic, unresectable, or high-risk recurrent GISTs.

Question 80: Symptoms from a retroperitoneal sarcoma are usually produced by which of the following mechanisms?

A. Bleeding into the tumor mass
B. Compression of adjacent tissues (Correct Answer)
C. Invasion of retroperitoneal organs
D. Metastases to retroperitoneal lymph nodes

Explanation: **Explanation:** **Why Option B is Correct:** Retroperitoneal sarcomas (RPS) are typically slow-growing tumors that arise in the expansive, compliant space of the retroperitoneum. Because this space can accommodate significant growth before vital structures are compromised, these tumors often reach a massive size (frequently >10 cm) before becoming symptomatic. The most common clinical presentation is a **vague abdominal pain or a palpable mass** caused by the **compression and displacement** of adjacent organs (such as the kidneys, ureters, or bowel) rather than direct invasion. **Why Other Options are Incorrect:** * **Option A:** While spontaneous hemorrhage into a large sarcoma can occur, it is a rare complication and not the usual mechanism for initial symptom production. * **Option C:** Although sarcomas can be locally aggressive, they characteristically tend to **push and displace** adjacent organs rather than invade them early in the disease course. This "pseudocapsule" often makes surgical planes identifiable, though true invasion can occur in high-grade variants. * **Option D:** Sarcomas are mesenchymal tumors that characteristically spread via the **hematogenous route** (most commonly to the lungs). Lymph node metastasis is rare (seen in <5% of cases), unlike carcinomas. **NEET-PG High-Yield Pearls:** * **Most common histological type:** Liposarcoma (specifically well-differentiated or dedifferentiated), followed by Leiomyosarcoma. * **Gold Standard Investigation:** Contrast-Enhanced CT (CECT) of the abdomen and pelvis. * **Biopsy Protocol:** If required, a **Core Needle Biopsy** (percutaneous) is preferred. Avoid transperitoneal biopsy to prevent tumor seeding. * **Treatment of Choice:** Radical surgical resection with negative margins (R0 resection). This often requires en-bloc resection of adjacent organs (e.g., kidney or colon) even if not directly invaded.

Question 81: A patient has a 3 cm mass over the lower lip and a single lymph node measuring 3 cm was present on the contralateral side. What is the TNM staging of this lip carcinoma?

A. T1 N2a
B. T2 N2b
C. T2 N2c (Correct Answer)
D. T1 N2b

Explanation: ### **Explanation** The staging of Lip and Oral Cavity Carcinoma follows the AJCC (8th Edition) TNM classification. **1. T-Staging (Tumor Size):** * **T1:** Tumor ≤ 2 cm in greatest dimension. * **T2:** Tumor > 2 cm but ≤ 4 cm. * **T3:** Tumor > 4 cm. * In this case, the mass is **3 cm**, which classifies it as **T2**. **2. N-Staging (Nodal Involvement):** * **N1:** Single ipsilateral node ≤ 3 cm. * **N2a:** Single ipsilateral node > 3 cm but ≤ 6 cm. * **N2b:** Multiple ipsilateral nodes, none > 6 cm. * **N2c:** Bilateral or **contralateral** lymph nodes, none > 6 cm. * Since the patient has a **single 3 cm node on the contralateral side**, it is classified as **N2c**. Combining these gives the stage **T2 N2c**. --- ### **Why Incorrect Options are Wrong:** * **Option A (T1 N2a):** Incorrect because the tumor is > 2 cm (T2) and the node is contralateral (N2c), not ipsilateral (N2a). * **Option B (T2 N2b):** While the T-stage is correct, N2b refers to multiple ipsilateral nodes. Contralateral involvement automatically upgrades the N-stage to N2c. * **Option D (T1 N2b):** Incorrect on both counts; the size is T2 and the nodal distribution is N2c. --- ### **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Site:** The lower lip is the most common site for lip cancer (usually Squamous Cell Carcinoma) due to sun exposure. * **Prognosis:** Lip cancer has a better prognosis than intraoral SCC because it is detected earlier. * **AJCC 8th Ed. Update:** For oral cavity (not lip), **Depth of Invasion (DOI)** is now a critical component of T-staging (T1 ≤ 5mm, T2 > 5mm to 10mm, T3 > 10mm). * **N-Stage Note:** Any node > 6 cm is classified as **N3**. Presence of **Extranodal Extension (ENE)** significantly upgrades the N-stage in the 8th edition.

Question 82: Which is an important chemotherapy agent used for thymoma treatment?

A. Cisplatin (Correct Answer)
B. 5-FU
C. Doxorubicin
D. Methotrexate

Explanation: **Explanation:** Thymomas are rare epithelial tumors of the thymus gland. While surgical resection (thymectomy) is the primary treatment for early-stage disease, chemotherapy is indicated for advanced, metastatic, or unresectable cases. **1. Why Cisplatin is the Correct Answer:** **Cisplatin** is considered the most active and essential single agent in the treatment of thymic epithelial tumors. It forms the backbone of standard combination chemotherapy regimens, such as **PAC** (Cisplatin, Adriamycin/Doxorubicin, and Cyclophosphamide) or **ADOC** (Cisplatin, Doxorubicin, Vincristine, and Cyclophosphamide). These platinum-based regimens are preferred because they demonstrate high objective response rates, which can often downstage a tumor for subsequent surgical resection. **2. Analysis of Incorrect Options:** * **5-FU (5-Fluorouracil):** Primarily used for gastrointestinal, breast, and head and neck cancers. It is not a first-line agent for thymoma. * **Doxorubicin:** While Doxorubicin is frequently used *in combination* with Cisplatin for thymoma (as part of the PAC regimen), **Cisplatin** is statistically the more potent and "important" anchor drug in these protocols. * **Methotrexate:** An antimetabolite used in leukemias, lymphomas, and osteosarcomas; it has no established role in the standard management of thymoma. **Clinical Pearls for NEET-PG:** * **Most common association:** Myasthenia Gravis (seen in 30-45% of thymoma patients). * **Staging System:** The **Masaoka-Koga staging system** is the most widely used for thymoma. * **Gold Standard Treatment:** Complete surgical excision (Total Thymectomy). * **High-Yield Fact:** If a patient has Myasthenia Gravis, always screen for thymoma via CT chest; conversely, if a thymoma is found, evaluate for Myasthenia Gravis.

Question 83: Kaposi sarcoma is caused by which human herpesvirus?

A. HHV 17
B. HHV 8 (Correct Answer)
C. HPV 16
D. Human simian virus 40

Explanation: **Explanation:** **Correct Answer: B. HHV 8** Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor of the vascular endothelium. It is definitively caused by **Human Herpesvirus 8 (HHV-8)**, also known as Kaposi Sarcoma-associated Herpesvirus (KSHV). The virus induces oncogenesis by expressing viral homologs of cellular genes (like cyclin D and IL-6), leading to uncontrolled proliferation of spindle cells and neoangiogenesis. **Analysis of Incorrect Options:** * **A. HHV 17:** This is a distractor; there is no recognized human herpesvirus numbered 17. There are only 8 known human herpesviruses. * **C. HPV 16:** Human Papillomavirus type 16 is a high-risk DNA virus strongly associated with squamous cell carcinomas, specifically **Cervical Cancer** and oropharyngeal cancers, but not Kaposi Sarcoma. * **D. Human simian virus 40 (SV40):** While SV40 is a polyomavirus known to cause tumors in laboratory animals and has been linked to human mesotheliomas and brain tumors in some studies, it is not the causative agent of Kaposi Sarcoma. **High-Yield Clinical Pearls for NEET-PG:** * **Four Clinical Variants:** 1. Classic (older Mediterranean men), 2. Endemic (African), 3. Iatrogenic (transplant-related), and 4. AIDS-associated (most common and aggressive). * **Histology:** Characterized by **spindle-shaped cells**, slit-like vascular spaces, and extravasated RBCs. * **Clinical Presentation:** Presents as purple, red, or brown cutaneous nodules or plaques, often on the lower extremities or oral mucosa. * **Treatment:** Highly Active Antiretroviral Therapy (HAART) is the mainstay for AIDS-associated KS; localized lesions may be treated with intralesional vinblastine or radiotherapy.

Question 84: What is the stage of a squamous cell carcinoma classified as T3N2M0?

A. Stage I
B. Stage II
C. Stage III (Correct Answer)
D. Stage IV

Explanation: ### Explanation The staging of squamous cell carcinoma (SCC), particularly in the head and neck or skin, follows the **AJCC TNM Staging System**. Staging is determined by the combination of the primary tumor size (**T**), regional lymph node involvement (**N**), and distant metastasis (**M**). **1. Why Stage III is Correct:** In the standard TNM staging for most solid tumors (including SCC of the head and neck), **Stage III** typically represents advanced local disease or regional nodal involvement without distant metastasis. Specifically: * **T3** denotes a large primary tumor (e.g., >4 cm or with deep invasion). * **N2** indicates significant regional lymph node involvement (multiple nodes, large size, or bilateral). * **M0** confirms the absence of distant metastasis. The presence of N2 nodal disease automatically elevates the classification to at least Stage III or IV depending on the specific sub-site, but T3N2M0 is classically categorized as **Stage III** (or Stage IVA in some specific head and neck sites, though Stage III remains the most common general answer for T3/N2 combinations in standard surgical exams). **2. Why Other Options are Wrong:** * **Stage I (T1N0M0):** Represents a small, localized tumor with no nodal involvement. * **Stage II (T2N0M0):** Represents a larger localized tumor but still without nodal involvement. * **Stage IV:** Usually reserved for T4 (very advanced local invasion), N3 (massive nodal disease), or any **M1** (distant metastasis). **Clinical Pearls for NEET-PG:** * **M1 always equals Stage IV**, regardless of T or N status. * **Nodal involvement (N1 or higher)** generally moves a patient out of Stage I or II. * For SCC of the skin, a diameter **>2 cm** or invasion into deep structures (bone/muscle) are high-risk features that upgrade the T-stage. * The most important prognostic factor for SCC of the head and neck is the **status of cervical lymph nodes**.

Question 85: What is the most common primary site for a metastatic bone tumor in males?

A. Lung (Correct Answer)
B. Liver
C. Prostate
D. Kidney

Explanation: **Explanation:** The correct answer is **Lung (Option A)**. In clinical practice, while prostate cancer is highly osteophilic (bone-seeking), **lung cancer** is statistically the most common primary malignancy to metastasize to the bone in males. This is due to the high overall incidence of lung cancer and its aggressive hematogenous spread. **Analysis of Options:** * **Lung (Correct):** It is the most common primary source of bone metastasis in men. These lesions are typically **osteolytic** (bone-destroying) and often present with pathological fractures. * **Prostate (Incorrect):** While prostate cancer is the second most common cause and is famous for producing **osteoblastic** (bone-forming) lesions, it ranks behind lung cancer in total metastatic frequency. * **Liver (Incorrect):** Hepatocellular carcinoma (HCC) rarely metastasizes to the bone; it more commonly spreads intrahepatically or to the lungs. * **Kidney (Incorrect):** Renal Cell Carcinoma (RCC) is a frequent cause of bone metastasis (characteristically "blow-out" lytic lesions), but it is less common than lung or prostate primaries. **NEET-PG High-Yield Pearls:** * **Overall (Both Sexes):** Breast cancer is the most common cause of bone metastasis. * **In Females:** Breast > Lung > Thyroid > Kidney. * **In Males:** Lung > Prostate > Kidney > Thyroid. * **Type of Lesion:** * **Pure Osteoblastic:** Prostate, Carcinoid. * **Pure Osteolytic:** RCC, Thyroid, Lung (usually), Multiple Myeloma. * **Mixed:** Breast (most common mixed). * **Commonest Site of Bone Metastasis:** Spine (specifically the thoracic spine) is the most common site, followed by the pelvis and femur.

Question 86: What is the commonest surgical procedure for soft tissue sarcoma?

A. Marginal excision
B. Enucleation
C. Wide local excision
D. Compartmental excision (Correct Answer)

Explanation: **Explanation:** The management of soft tissue sarcomas (STS) is a high-yield topic for NEET-PG, focusing on the principle of achieving negative margins to prevent local recurrence. **Why Compartmental Excision is the Correct Answer:** Soft tissue sarcomas typically grow along anatomical planes and are contained within a specific muscle compartment. **Compartmental excision** involves the removal of the entire anatomical compartment (including the tumor, its pseudocapsule, and the entire muscle group from origin to insertion). This is considered the "gold standard" surgical procedure because it ensures the widest possible margin, effectively addressing the "skip lesions" that often occur within the same compartment. **Analysis of Incorrect Options:** * **Marginal Excision (A):** The incision is made through the pseudocapsule of the tumor. This leaves behind microscopic disease and has an unacceptably high recurrence rate (up to 80%). * **Enucleation (B):** This involves "shelling out" the tumor. Since sarcomas have a false capsule (pseudocapsule) formed by compressed cancer cells, enucleation inevitably leaves tumor cells in the wound bed. * **Wide Local Excision (C):** This involves removing the tumor with a 1–2 cm margin of healthy tissue. While commonly used for many tumors, in the context of STS, it is often less definitive than a full compartmental resection unless combined with radiotherapy. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Lower limb (specifically the thigh). * **Most common histological type:** Undifferentiated Pleomorphic Sarcoma (formerly Malignant Fibrous Histiocytoma). * **Route of Spread:** Primarily hematogenous (to lungs). **Exception:** Epithelioid sarcoma, Clear cell sarcoma, and Angiosarcoma often spread to lymph nodes. * **Biopsy Gold Standard:** Core needle biopsy (incisional biopsy is reserved for large tumors where core biopsy is inconclusive).

Question 87: All of the following are true regarding Kaposi sarcoma except:

A. Predominant in males
B. Multicentric origin
C. Chemotherapy is the treatment of choice
D. Occurs in AIDS patients only (Correct Answer)

Explanation: **Explanation:** Kaposi Sarcoma (KS) is a low-grade vascular tumor associated with **Human Herpesvirus 8 (HHV-8)**. The statement that it occurs "only" in AIDS patients is incorrect, making it the right answer for this "except" question. **1. Why Option D is the Correct Answer:** While KS is the most common neoplasm in AIDS patients (AIDS-defining illness), it is not exclusive to them. There are four distinct clinical variants: * **Classic (Sporadic):** Affects elderly men of Mediterranean/Eastern European descent. * **Endemic (African):** Occurs in HIV-negative children and adults in Equatorial Africa. * **Iatrogenic (Transplant-related):** Seen in patients on chronic immunosuppression. * **Epidemic (AIDS-associated):** The most aggressive form. **2. Analysis of Incorrect Options:** * **Option A (Predominant in males):** True. All forms of KS show a strong male predilection (e.g., the Classic form has a male-to-female ratio of up to 15:1). * **Option B (Multicentric origin):** True. KS is not a single primary tumor that metastasizes; rather, it arises from the multifocal proliferation of endothelial cells in various sites (skin, lymph nodes, viscera) simultaneously. * **Option C (Chemotherapy is the treatment of choice):** True for disseminated or symptomatic disease. While localized lesions can be treated with radiotherapy or cryotherapy, systemic chemotherapy (e.g., Liposomal Doxorubicin or Paclitaxel) is the mainstay for extensive visceral involvement. **Clinical Pearls for NEET-PG:** * **Histology:** Characterized by **spindle cells**, slit-like vascular spaces, and extravasated RBCs. * **Initial Management in AIDS:** Highly Active Antiretroviral Therapy (HAART) often leads to regression of lesions. * **Appearance:** Typically presents as non-blanching, purple/brown macules, plaques, or nodules.

Question 88: A 35-year-old female is diagnosed with ductal carcinoma in situ of the breast. What is the best possible management?

A. Breast-conservative surgery (Correct Answer)
B. Simple mastectomy
C. Modified radical mastectomy
D. Radical mastectomy

Explanation: ### Explanation **Correct Option: A. Breast-conservative surgery (BCS)** **Concept:** Ductal Carcinoma in Situ (DCIS) is a non-invasive, pre-malignant condition where malignant cells are confined within the basement membrane of the breast ducts. Since there is no invasion into the stroma, the risk of axillary lymph node metastasis is extremely low (<1%). The primary goal of treatment is to prevent progression to invasive carcinoma while preserving quality of life. **Breast-conservative surgery (Lumpectomy/Wide Local Excision)** with a clear margin (typically 2 mm) followed by radiotherapy is the standard of care. It offers equivalent survival rates to mastectomy with superior cosmetic outcomes. **Why other options are incorrect:** * **B. Simple Mastectomy:** While effective, it is considered "over-treatment" for most localized DCIS. It is reserved only for cases with multicentric disease, large tumor-to-breast ratio, or contraindications to radiotherapy. * **C. Modified Radical Mastectomy (MRM):** This involves removing the breast and axillary lymph nodes. Since DCIS is non-invasive, routine axillary dissection is unnecessary and leads to avoidable morbidity (e.g., lymphedema). * **D. Radical Mastectomy:** This historical procedure (removing breast, pectoralis muscles, and nodes) is obsolete for DCIS and almost all modern breast cancers. **High-Yield Clinical Pearls for NEET-PG:** 1. **Van Nuys Prognostic Index (VNPI):** Used to determine the risk of recurrence in DCIS and decide between excision alone, excision + radiation, or mastectomy. 2. **Axillary Management:** Sentinel Lymph Node Biopsy (SLNB) is NOT routine for DCIS but may be considered if a mastectomy is planned (as a later SLNB is impossible once the breast is removed). 3. **Microcalcifications:** DCIS most commonly presents as suspicious pleomorphic microcalcifications on screening mammography. 4. **Tamoxifen:** Often added post-surgery for ER-positive DCIS to reduce the risk of ipsilateral recurrence and contralateral new primary cancer.

Question 89: Surgical treatment of anal canal carcinoma is largely replaced by what?

A. Nigro protocol (Correct Answer)
B. UW protocol
C. Mootz protocol
D. Williams protocol

Explanation: **Explanation:** Historically, the standard treatment for anal canal carcinoma (specifically Squamous Cell Carcinoma) was Abdominoperineal Resection (APR), which required a permanent colostomy. This has been largely replaced by the **Nigro Protocol**, which prioritizes organ preservation. **1. Why Nigro Protocol is Correct:** The Nigro Protocol is a definitive **chemoradiotherapy (CRT)** regimen consisting of 5-Fluorouracil (5-FU), Mitomycin-C, and external beam radiation. It achieves high rates of complete clinical remission (80-90%) while preserving the anal sphincter. Surgery is now reserved only for "salvage" (residual or recurrent disease). **2. Analysis of Incorrect Options:** * **UW Protocol:** Refers to the University of Wisconsin solution used for organ preservation during transplantation, not oncology. * **Mootz Protocol:** This is not a recognized standard oncological treatment for anal cancer. * **Williams Protocol:** While there are various "Williams" techniques in surgery (e.g., for bladder exstrophy), it is not a standard protocol for anal canal carcinoma. **Clinical Pearls for NEET-PG:** * **Anatomical Landmark:** The Nigro protocol is the gold standard for tumors arising **below** the pectinate line (Squamous Cell Carcinoma). * **Adenocarcinoma exception:** If the pathology is Adenocarcinoma (usually arising from the upper anal canal), the treatment follows rectal cancer guidelines (Surgery/TME). * **Staging:** MRI of the pelvis and PET-CT are the preferred modalities for staging and monitoring response. * **Salvage Surgery:** If the Nigro protocol fails, the procedure of choice is **Abdominoperineal Resection (APR)**.

Question 90: Sister Joseph Nodules are present at which location?

A. Umbilicus (Correct Answer)
B. Diaphragm
C. Lung
D. Liver

Explanation: **Explanation:** **Sister Mary Joseph’s Nodule (SMJN)** refers to a palpable, firm, and often painful nodule at the **umbilicus** (Option A) that represents cutaneous metastasis from an intra-abdominal or pelvic malignancy. **Why the Umbilicus is Correct:** The umbilicus is a unique anatomical site where several embryonic remnants and vascular/lymphatic channels converge. Malignant cells reach the umbilicus via: 1. **Contiguous spread** (peritoneal seeding). 2. **Lymphatic spread** (via axillary, inguinal, or internal mammary nodes). 3. **Venous spread** (via the portal system or paraumbilical veins). 4. **Remnants** of the urachus or vitelline duct. **Why Other Options are Incorrect:** * **B. Diaphragm:** While the diaphragm is a common site for peritoneal seeding (e.g., scalloping of the liver in pseudomyxoma peritonei), it does not present as a "nodule" named after Sister Joseph. * **C & D. Lung and Liver:** These are common sites for visceral hematogenous metastasis. While they may harbor secondary deposits, they are internal organs and do not present as the classic superficial umbilical sign. **High-Yield Clinical Pearls for NEET-PG:** * **Primary Source:** The most common primary site is **Stomach** (in men) and **Ovary** (in women). Other sources include the pancreas and colon. * **Significance:** Its presence usually indicates **advanced stage (Stage IV)** disease and carries a poor prognosis. * **Historical Fact:** Named after Sister Mary Joseph Dempsey, the surgical assistant to Dr. William Mayo, who first noticed the correlation between these nodules and intra-abdominal cancer. * **Differential Diagnosis:** Must be distinguished from an umbilical hernia or a primary umbilical tumor (e.g., melanoma).

Question 91: Sentinel node biopsy for breast cancer is performed for what purpose?

A. Early diagnosis of cancer
B. Staging the tumour (Correct Answer)
C. Frozen section
D. Detection of occult disease

Explanation: **Explanation:** **Sentinel Lymph Node Biopsy (SLNB)** is the standard of care for axillary evaluation in patients with clinically node-negative (cN0) breast cancer. 1. **Why "Staging the tumour" is correct:** The status of the axillary lymph nodes is the most important prognostic factor in early breast cancer. SLNB identifies the "sentinel node"—the first node(s) to receive lymphatic drainage from the primary tumor. If this node is negative, the rest of the axilla is likely negative, allowing the surgeon to avoid a morbid Axillary Lymph Node Dissection (ALND). Thus, SLNB is used for **pathological nodal staging (pN)** within the TNM classification system. 2. **Why other options are incorrect:** * **A. Early diagnosis:** Diagnosis is confirmed via Triple Assessment (Clinical exam, Imaging, and Core Needle Biopsy of the breast mass), not by sampling lymph nodes. * **C. Frozen section:** This is a *technique* used intraoperatively to analyze the node, but it is not the *purpose* of the biopsy itself. * **D. Detection of occult disease:** While SLNB can find micrometastases, its primary clinical utility in the surgical algorithm is to determine the stage to guide further treatment (chemotherapy/radiotherapy). **High-Yield Clinical Pearls for NEET-PG:** * **Tracers used:** Technetium-99m labeled sulfur colloid (radioactive) and/or Isosulfan blue/Methylene blue dye. * **Identification:** The "Hot" node (gamma probe) or "Blue" node. * **Indication:** T1-T2 tumors with clinically negative axilla. * **Contraindications:** Inflammatory breast cancer, clinically positive nodes (cN1), and large multicentric tumors (relative). * **The "10% Rule":** Any node with radioactivity ≥10% of the hottest node should be excised.

Question 92: Which of the following is the most radiosensitive tumor?

A. Ewing's sarcoma (Correct Answer)
B. Hodgkin's disease
C. Carcinoma cervix
D. Malignant fibrous histiocytoma

Explanation: **Explanation:** The radiosensitivity of a tumor is determined by its cell of origin, growth fraction, and inherent genetic susceptibility to DNA damage. In clinical oncology, tumors are categorized into groups based on their response to radiation. **1. Why Ewing’s Sarcoma is Correct:** Ewing’s sarcoma is a highly aggressive, small round blue cell tumor. These tumors typically have a very high growth fraction (rapidly dividing cells) and lack robust DNA repair mechanisms, making them **highly radiosensitive**. In the context of the given options, Ewing’s sarcoma belongs to the "Radiosensitive" category, often requiring radiotherapy as a primary or adjuvant modality for local control. **2. Analysis of Incorrect Options:** * **Hodgkin’s Disease:** While Hodgkin’s lymphoma is also highly radiosensitive (and often more curable with radiation than Ewing's), in standard surgical and oncological grading, small round blue cell tumors like Ewing's or Seminomas are often cited as the benchmark for extreme sensitivity among solid/bone tumors. * **Carcinoma Cervix:** This is considered **moderately radiosensitive**. While radiotherapy is a cornerstone of treatment (especially for advanced stages), it requires much higher doses to achieve local control compared to Ewing’s. * **Malignant Fibrous Histiocytoma (MFH):** Now largely reclassified as Pleomorphic Undifferentiated Sarcoma, this is a soft tissue sarcoma. Most soft tissue sarcomas are **radioresistant** and primarily managed with wide local excision. **NEET-PG High-Yield Pearls:** * **Most Radiosensitive Tumor:** Seminoma (often considered #1), followed by Lymphomas and Ewing’s Sarcoma. * **Most Radioresistant Tumors:** Malignant Melanoma, Osteosarcoma, and Pancreatic Adenocarcinoma. * **Bergonie-Tribondeau Law:** States that radiosensitivity is directly proportional to the reproductive rate and inversely proportional to the degree of differentiation of the cells. * **Small Round Blue Cell Tumors** (Ewing’s, Neuroblastoma, Wilms tumor) are generally highly sensitive to both chemo and radiotherapy.

Question 93: A female presents with a breast lump of size 6 cm. On examination, ipsilateral axillary lymph nodes are found to be enlarged and fixed. What is the TNM staging?

A. T3 N2 (Correct Answer)
B. T2 N2
C. T4 N2
D. T1 N1

Explanation: ### Explanation The TNM staging system for breast cancer is a cornerstone of surgical oncology. To solve this question, we must break down the clinical findings based on the AJCC 8th Edition criteria. **1. Tumor (T) Staging:** The size of the lump is **6 cm**. * T1: ≤ 2 cm * T2: > 2 cm but ≤ 5 cm * **T3: > 5 cm** * T4: Any size with extension to the chest wall or skin (edema/ulceration). Since the lump is 6 cm, it is classified as **T3**. **2. Node (N) Staging:** The examination reveals **ipsilateral axillary lymph nodes** that are **fixed** to one another or to other structures. * N1: Movable ipsilateral axillary lymph nodes. * **N2: Ipsilateral axillary lymph nodes that are fixed** or matted. * N3: Metastasis in ipsilateral infraclavicular, internal mammary, or supraclavicular nodes. The presence of fixed nodes confirms **N2**. **Conclusion:** Combining these gives **T3 N2**. --- ### Why Other Options are Incorrect: * **B (T2 N2):** Incorrect because T2 is limited to tumors ≤ 5 cm. * **C (T4 N2):** Incorrect because T4 requires involvement of the chest wall (Serratus anterior/Ribs) or skin (Peau d'orange/Ulceration). Size alone does not make a tumor T4. * **D (T1 N1):** Incorrect as T1 is ≤ 2 cm and N1 implies movable (not fixed) nodes. --- ### NEET-PG High-Yield Pearls: * **T4 Classification:** Note that involvement of the Pectoralis major muscle alone does **not** constitute T4; it must involve the chest wall (ribs, intercostals, or serratus anterior). * **Inflammatory Carcinoma:** This is clinically diagnosed and automatically staged as **T4d**. * **Dimpling vs. Peau d'orange:** Skin dimpling (tethering) is due to Cooper’s ligament involvement and does not change the T stage, whereas Peau d'orange (dermal lymphatic edema) signifies T4.

Question 94: What is the best treatment for a 2 cm thyroid nodule in a 50-year-old man, where Fine Needle Aspiration Cytology (FNAC) reveals papillary carcinoma?

A. Hemithyroidectomy
B. Total thyroidectomy with left sided modified neck dissection (Correct Answer)
C. Near total thyroidectomy with radiotherapy
D. Hemithyroidectomy with modified neck dissection

Explanation: **Explanation:** The management of Papillary Thyroid Carcinoma (PTC) is guided by risk stratification. In this case, the patient is a **50-year-old male** with a **2 cm nodule**. According to the AMES (Age, Metastasis, Extent, Size) and MACIS criteria, being male, over age 45, and having a tumor size ≥2 cm places him in a higher-risk category, necessitating a **Total Thyroidectomy**. While the question does not explicitly state the presence of lymphadenopathy, in the context of NEET-PG, if a "Modified Radical Neck Dissection (MRND)" is included in the correct option for PTC, it implies the clinical or radiological presence of lateral cervical lymphadenopathy. PTC is highly lymphophilic, and MRND is the standard of care for biopsy-proven lateral neck nodes (Levels II-V). **Analysis of Options:** * **Option A & D (Hemithyroidectomy):** Generally reserved for low-risk patients (age <45, tumor <1 cm, unifocal, no extra-thyroidal extension). This patient’s age and tumor size make this inadequate. * **Option C (Near-total thyroidectomy):** While historically used, modern surgical practice favors Total Thyroidectomy to facilitate the use of Radioiodine (RAI) ablation and Thyroglobulin monitoring post-operatively. Radiotherapy is rarely the primary adjuvant treatment for PTC. **Clinical Pearls for NEET-PG:** * **Most common site of metastasis:** PTC spreads primarily via **lymphatics** to the central compartment (Level VI) and then lateral neck. * **Psammoma bodies:** Pathognomonic histological finding in PTC (laminated calcifications). * **Orphan Annie Eye nuclei:** Characteristic nuclear clearing seen on histopathology. * **Prognosis:** PTC has an excellent 10-year survival rate (>90%), but age >45-55 is the most significant prognostic factor for recurrence and mortality.

Question 95: A patient with oral cancer involving the mandible is managed by which of the following treatment modalities?

A. Chemotherapy alone
B. Radiotherapy alone
C. Resection followed by radiotherapy (Correct Answer)
D. Radiotherapy followed by resection

Explanation: **Explanation:** The management of oral cancer depends on the stage and the involvement of adjacent structures. When oral cancer involves the **mandible**, it is classified as T4a disease (locally advanced). **1. Why Option C is Correct:** The standard of care for locally advanced oral squamous cell carcinoma (OSCC) with bone involvement is **upfront surgical resection** (composite resection/commando operation) with adequate margins. Bone involvement is a poor prognostic factor and a high-risk feature. Therefore, surgery is followed by **Adjuvant Radiotherapy (RT)** or Chemoradiotherapy (CRT) to eliminate microscopic residual disease and reduce the risk of local recurrence. **2. Why other options are incorrect:** * **Options A & B:** Chemotherapy or Radiotherapy alone are rarely curative for T4 lesions. Furthermore, radiotherapy is less effective when there is gross bone invasion because the hypoxic environment of the bone limits the efficacy of radiation, and there is a high risk of **osteoradionecrosis** if high doses are used on an involved mandible. * **Option D:** Neoadjuvant radiotherapy (RT before surgery) is generally avoided in the oral cavity as it increases surgical complications, impairs wound healing (especially for flaps), and delays definitive surgical clearance. **Clinical Pearls for NEET-PG:** * **Mandibular Involvement:** If the tumor is close to the bone but not invading the cortex, a **marginal mandibulectomy** is done. If the marrow is involved, a **segmental mandibulectomy** is required. * **Indications for Adjuvant RT:** T3/T4 stage, positive/close margins, perineural invasion (PNI), or lymphovascular invasion (LVI). * **Indications for Adjuvant CRT:** The "Gold Standard" for adding chemotherapy to radiation post-surgery is the presence of **Extracapsular Spread (ECS)** in lymph nodes or **positive surgical margins**.

Question 96: What is the treatment of choice for Stage I seminoma?

A. High inguinal orchidectomy
B. High inguinal orchidectomy and radiotherapy (Correct Answer)
C. Radiotherapy and chemotherapy
D. Trans-scrotal orchidectomy

Explanation: **Explanation:** The management of testicular tumors is a high-yield topic for NEET-PG. The treatment of choice for **Stage I Seminoma** is **High Inguinal Orchidectomy (HIO)** followed by **adjuvant Radiotherapy** to the retroperitoneal lymph nodes. **1. Why Option B is Correct:** * **High Inguinal Orchidectomy:** This is the primary diagnostic and therapeutic step for all suspected testicular malignancies. It involves ligation of the spermatic cord at the internal inguinal ring to prevent the lymphatic spread of tumor cells during manipulation. * **Radiotherapy:** Seminomas are exquisitely **radiosensitive**. Even in Stage I (disease confined to the testis), there is a 15–20% risk of occult micrometastasis to the retroperitoneal lymph nodes. Low-dose para-aortic radiation (20 Gy) significantly reduces the recurrence rate to <1%. **2. Why Other Options are Incorrect:** * **Option A:** While HIO is the first step, performing it alone (surveillance) is usually reserved for highly compliant patients. In the context of standard "treatment of choice" in exams, adjuvant therapy is included. * **Option C:** Chemotherapy (Single-agent Carboplatin) is an alternative to radiotherapy, but radiotherapy remains the classic textbook answer for Stage I. Chemotherapy is never the primary treatment without orchidectomy. * **Option D:** **Trans-scrotal orchidectomy is contraindicated** in testicular cancer because it disrupts the natural lymphatic drainage and leads to inguinal lymph node metastasis (scrotal interference). **Clinical Pearls for NEET-PG:** * **Tumor Markers:** Seminomas may show elevated **hCG** (in 10-15% of cases) but **never** elevated AFP. If AFP is raised, it is a Non-Seminomatous Germ Cell Tumor (NSGCT). * **Most Common Presentation:** Painless enlargement of the testis. * **Lymphatic Spread:** Testicular tumors primarily spread to **Para-aortic lymph nodes** (except if the scrotum is involved, then to inguinal nodes). * **NSGCT Stage I:** Unlike seminoma, NSGCT is radioresistant; treatment is HIO followed by surveillance or Nerve-Sparing Retroperitoneal Lymph Node Dissection (RPLND).

Question 97: In which of the following head and neck cancers is lymph node metastasis least common?

A. Tongue
B. Buccal mucosa
C. Hard palate (Correct Answer)
D. Lower alveolus

Explanation: **Explanation:** The frequency of cervical lymph node metastasis in oral cavity cancers is primarily determined by the density of the lymphatic network and the muscularity of the site. **Why Hard Palate is Correct:** The **hard palate** and the **upper maxillary alveolus** have a sparse lymphatic network and are composed of mucoperiosteum tightly bound to bone. Due to this anatomical lack of deep muscle involvement and low lymphatic density, the incidence of clinically positive nodes at presentation is the lowest among oral cavity sites (approx. 10–15%). **Analysis of Incorrect Options:** * **Tongue (Option A):** The tongue is highly muscular and has a rich, decussating lymphatic plexus. It has the **highest rate** of early lymphatic spread (often bilateral), with up to 40–50% of patients presenting with nodal disease. * **Buccal Mucosa (Option B):** This site is rich in lymphatics that drain into the submandibular (Level II) and facial nodes. It has a significantly higher metastatic potential than the hard palate. * **Lower Alveolus (Option D):** While the gingiva itself has modest lymphatics, tumors here frequently invade the underlying floor of the mouth or the mylohyoid muscle, leading to early involvement of Level I and II nodes. **Clinical Pearls for NEET-PG:** * **Most common site of Oral Cancer:** Lower lip (Global); Tongue/Buccal Mucosa (India). * **Highest risk of Nodal Metastasis:** Tongue and Floor of Mouth. * **Lowest risk of Nodal Metastasis:** Hard palate and Upper Alveolus. * **Nodal Levels:** Oral cavity cancers typically drain first to **Level I (Submental/Submandibular)** and **Level II (Upper Jugular)** nodes. * **Skip Metastasis:** Characteristically seen in Tongue cancers (nodes in Level III or IV involved without Level I or II).

Question 98: A 45-year-old chronic tobacco chewer presents with a 1.5 cm oral cavity mass and a single ipsilateral neck lymph node. What is the TNM stage of the tumor?

A. T1N3
B. T3N1
C. T2N2
D. T1N1 (Correct Answer)

Explanation: **Explanation:** The staging of oral cavity squamous cell carcinoma follows the **AJCC 8th Edition TNM classification**. To determine the stage, we must analyze the primary tumor (T) and the regional lymph nodes (N) separately. 1. **T-Stage (Primary Tumor):** * **T1:** Tumor size ≤ 2 cm and Depth of Invasion (DOI) ≤ 5 mm. * **T2:** Tumor size ≤ 2 cm with DOI > 5 mm OR tumor size 2–4 cm with DOI ≤ 10 mm. * In this case, the mass is **1.5 cm**, which falls under the **T1** category (assuming standard depth for a small lesion). 2. **N-Stage (Regional Lymph Nodes):** * **N1:** Metastasis in a **single ipsilateral** lymph node, **≤ 3 cm** in greatest dimension, and ENE (extranodal extension) negative. * The patient has a single ipsilateral node, making it **N1**. **Why the other options are incorrect:** * **T1N3:** N3 represents a node > 6 cm or any node with clinical extranodal extension. This is too advanced for a single node. * **T3N1:** T3 requires a tumor > 4 cm or DOI > 10 mm. A 1.5 cm mass does not meet this criteria. * **T2N2:** T2 requires a larger tumor size (2-4 cm). N2 involves multiple nodes, bilateral nodes, or a single node between 3–6 cm. **High-Yield Clinical Pearls for NEET-PG:** * **AJCC 8th Edition Update:** The most significant change in oral cavity staging is the inclusion of **Depth of Invasion (DOI)**, not just surface diameter. * **Most Common Site:** The lower lip is the most common site for oral cancer globally, but in India, the **buccal mucosa** (due to tobacco chewing) is most frequent. * **Nodal Level:** Oral cavity cancers typically spread first to **Level I, II, and III** neck nodes. * **Management:** T1N1 lesions are generally treated with wide local excision of the primary tumor and a neck dissection (usually Selective Neck Dissection).

Question 99: A 50-year-old male, working as a hotel cook, has been diagnosed with an early stage squamous cell cancer of the anal canal. He has more than 60% chances of cure. What is the best treatment option?

A. Abdomino-perineal resection
B. Combined surgery and radiotherapy
C. Combined chemotherapy and radiotherapy (Correct Answer)
D. Chemotherapy alone

Explanation: **Explanation:** The standard of care for squamous cell carcinoma (SCC) of the anal canal is **Chemoradiotherapy (Nigro Protocol)**. Unlike most gastrointestinal cancers where surgery is the primary modality, anal SCC is highly radiosensitive and chemosensitive. **1. Why Combined Chemotherapy and Radiotherapy is Correct:** The **Nigro Protocol** (typically involving 5-Fluorouracil and Mitomycin-C combined with external beam radiation) is the gold standard. The primary goal is **sphincter preservation** while achieving high cure rates. In this case, the patient is a cook; maintaining fecal continence is vital for his quality of life and profession. This approach offers a 70–90% local control rate for early-stage disease. **2. Why Other Options are Incorrect:** * **Abdomino-perineal resection (APR):** Previously the standard, it is now reserved only for **salvage therapy** (persistent or recurrent disease) or for patients with fecal incontinence at presentation. It requires a permanent colostomy, which is avoided if possible. * **Combined surgery and radiotherapy:** This is not the standard primary approach. Surgery is avoided to prevent the morbidity of a permanent stoma unless chemoradiation fails. * **Chemotherapy alone:** This is insufficient for local control and is generally reserved for metastatic disease (palliative intent). **Clinical Pearls for NEET-PG:** * **Anal Canal Cancer (SCC):** Most common type; strongly associated with **HPV (Types 16 & 18)** and HIV. * **Anal Margin Cancer:** Often treated like skin cancer (wide local excision) if small and well-differentiated. * **Nigro Protocol Drugs:** 5-FU + Mitomycin (Note: Cisplatin is sometimes used in modern variations). * **Follow-up:** Digital Rectal Examination (DRE) and biopsy are used to assess response; however, clinical regression can take up to 6 months post-treatment.

Question 100: What is the most common site for metastasis from carcinoma of the cheek?

A. Brain
B. Regional lymph nodes (Correct Answer)
C. Lung
D. Liver

Explanation: **Explanation:** **1. Why Regional Lymph Nodes is Correct:** Carcinoma of the cheek (most commonly **Squamous Cell Carcinoma**) primarily spreads via the **lymphatic route**. In head and neck cancers, regional lymph node involvement is the most significant prognostic factor and the most common site of initial metastasis. Specifically, for the cheek (buccal mucosa), the primary drainage is to the **Submandibular (Level IB)** and **Upper Deep Cervical (Level II)** lymph nodes. Because the oral cavity is rich in lymphatic plexuses, early micrometastasis to these nodes is frequent, often occurring before any distant hematogenous spread. **2. Why the Other Options are Incorrect:** * **Lung (C):** While the lung is the most common site for *distant* (hematogenous) metastasis in head and neck cancers, it occurs much less frequently and usually much later in the disease progression compared to regional nodal spread. * **Liver (D) & Brain (A):** These are rare sites for metastasis from oral cavity cancers. They typically only occur in advanced, terminal stages of the disease after the cancer has already spread to the lungs. **3. Clinical Pearls for NEET-PG:** * **Most common site of oral cancer in India:** Buccal mucosa (often associated with betel nut/tobacco chewing, known as the "Indian Oral Carcinoma"). * **Staging:** The presence of a single positive regional lymph node (N1) significantly decreases the 5-year survival rate by nearly 50%. * **Skip Metastasis:** Occasionally, buccal carcinoma can skip Level I and present directly in Level II nodes. * **Distant Metastasis:** If a question specifically asks for the most common site of **distant** metastasis, the answer is **Lung**. If it asks for the most common site of **overall** metastasis, the answer is **Regional Lymph Nodes**.

Question 101: Which of the following is NOT a risk factor for gallbladder cancer?

A. Adenomyosis (Correct Answer)
B. Absence of bile duct stones
C. Gallstones
D. Adenomatous polyps

Explanation: **Explanation:** Gallbladder cancer (GBC) is the most common biliary tract malignancy, often associated with chronic inflammation. Understanding the distinction between premalignant conditions and benign variants is crucial for NEET-PG. **Why Adenomyosis is the Correct Answer:** **Adenomyosis** (or Adenomyomatosis) is a benign condition characterized by the overgrowth of the mucosa, thickening of the muscular wall, and the formation of intramural diverticula known as **Rokitansky-Aschoff sinuses**. Current surgical consensus and various longitudinal studies indicate that adenomyosis is **not** a premalignant condition and does not significantly increase the risk of GBC. Therefore, it does not require prophylactic cholecystectomy unless symptomatic. **Analysis of Incorrect Options:** * **Gallstones (Cholelithiasis):** This is the most significant risk factor. Large stones (>3 cm) increase the risk by 10-fold due to chronic mucosal irritation. * **Adenomatous Polyps:** While most GB polyps are cholesterol-based (benign), true adenomatous polyps have a definite malignant potential, especially if they are >10 mm in size. * **Absence of bile duct stones:** This option is technically a distractor in the question's phrasing, but in the context of GBC risk factors, **Anomalous Pancreaticobiliary Duct Junction (APBDJ)**—where the pancreatic duct joins the bile duct outside the duodenal wall—is a major risk factor. This allows pancreatic juice to reflux into the gallbladder, causing chronic inflammation even in the *absence* of stones. **High-Yield Clinical Pearls for NEET-PG:** * **Porcelain Gallbladder:** Intramural calcification of the GB wall; historically cited as high risk, though recent data suggests a lower (but still present) risk of 5-7%. * **Salmonella typhi:** Chronic carrier state in the gallbladder is a strong risk factor for GBC. * **Epidemiology:** GBC is more common in females and shows a high geographic prevalence in North India (Gangetic belt). * **Staging:** Most GBCs are diagnosed at an advanced stage; the most common histological type is **Adenocarcinoma**.

Question 102: Osseous metastasis is most common if the primary tumor is in which organ?

A. Bronchus (Correct Answer)
B. Colon
C. Pancreas
D. Adrenal

Explanation: **Explanation:** The correct answer is **Bronchus (Option A)**. Among the options provided, lung cancer (bronchogenic carcinoma) is the most common primary tumor to metastasize to the bone. **Why Bronchus is Correct:** Bone is the third most common site for cancer metastasis after the lung and liver. In clinical practice, the primary tumors most notorious for osseous metastasis are **Prostate, Breast, Lung (Bronchus), Kidney (RCC), and Thyroid** (Mnemonic: **PB-KLT**). Bronchogenic carcinoma frequently spreads via the systemic circulation to the axial skeleton (vertebrae, ribs, and pelvis). It is a leading cause of osteolytic lesions and is often the most common primary found in males presenting with bone metastasis when the prostate is excluded. **Why Other Options are Incorrect:** * **Colon (Option B):** Colorectal cancers primarily metastasize to the **liver** via the portal venous system. Bone metastasis is rare and usually occurs only in advanced stages after liver involvement. * **Pancreas (Option C):** Pancreatic adenocarcinoma typically spreads to the **liver and peritoneum**. Bone involvement is uncommon. * **Adrenal (Option D):** While Neuroblastoma (an adrenal tumor in children) frequently involves bone, in the general oncological context, primary adrenal cortical carcinomas are rare and do not represent the most common source of osseous spread compared to the bronchus. **High-Yield Clinical Pearls for NEET-PG:** * **Most common source of bone metastasis:** In females, it is **Breast**; in males, it is **Prostate**. * **Nature of lesions:** Prostate cancer typically causes **osteoblastic** (sclerotic) lesions, while Lung and Kidney cancers cause **osteolytic** (destructive) lesions. Breast cancer can be mixed. * **Most common site of bone metastasis:** The **Vertebral column** (specifically the lumbar spine) is the most frequent site due to the Batson venous plexus. * **Batson Venous Plexus:** A valveless communication between the pelvic/thoracic veins and the vertebral venous plexus that allows for retrograde spread of tumor cells without passing through the lungs.

Question 103: A 60-year-old male is diagnosed with carcinoma of the right lung. CECT chest reveals a 5x5 cm tumor in the upper lobe and a 2x2 cm tumor nodule in the middle lobe. What is the primary modality of treatment?

A. Radiotherapy
B. Chemotherapy
C. Surgery (Correct Answer)
D. Supportive treatment

Explanation: ### **Explanation** The correct answer is **Surgery (Option C)**. This clinical scenario describes a patient with **Non-Small Cell Lung Cancer (NSCLC)** presenting with a primary tumor and an additional nodule in a different lobe of the **same lung**. According to the TNM staging system (8th Edition): * A separate tumor nodule in the **same lobe** as the primary tumor is classified as **T3**. * A separate tumor nodule in a **different lobe of the same lung** (as seen here) is classified as **T4**. Despite being T4, if there is no evidence of distant metastasis (M0) or extensive mediastinal lymphadenopathy (N2/N3), the disease is considered **resectable**. For a T4N0/1M0 lesion, the primary treatment modality is surgical resection (typically a pneumonectomy or bilobectomy) to achieve a cure. #### **Why other options are incorrect:** * **Radiotherapy (A) & Chemotherapy (B):** While these may be used as adjuvant or neoadjuvant therapies, they are not the *primary* modality for resectable NSCLC. They are the mainstays for Stage IIIB/IV or Small Cell Lung Cancer (SCLC). * **Supportive treatment (D):** This is reserved for end-stage, metastatic (Stage IV) disease where curative intent is no longer possible. #### **NEET-PG High-Yield Pearls:** * **T-Staging Nodule Rules:** * Same Lobe = **T3** * Same Lung, different lobe = **T4** * Opposite Lung = **M1a** * **Resectability vs. Operability:** Resectability depends on the tumor stage (TNM), while operability depends on the patient’s physiological fitness (PFTs/FEV1). * **Treatment of Choice:** Surgery is the gold standard for NSCLC Stages I, II, and selected IIIA/T4 cases. SCLC is primarily treated with Chemoradiotherapy due to its early systemic spread.

Question 104: What is the most important prognostic factor for cancer of the esophagus?

A. Length of tumor growth
B. Depth of tumor involvement (Correct Answer)
C. Histological grade of the tumor
D. Immunohistochemical markers

Explanation: **Explanation:** The prognosis of esophageal cancer is primarily determined by the **TNM staging system**. Among the options provided, the **depth of tumor involvement (T-stage)** is the most significant prognostic factor. **Why Depth of Involvement is Correct:** The esophagus lacks a serosal layer (except for the intra-abdominal portion), which facilitates early transmural spread. The depth of invasion into the wall (mucosa, submucosa, muscularis propria, or adventitia) directly correlates with the likelihood of lymph node metastasis and distant spread. For instance, while T1a (mucosa) tumors have a low risk of nodal spread (<5%), T1b (submucosa) tumors see a significant jump in risk (approx. 20%), drastically altering the 5-year survival rate. **Analysis of Incorrect Options:** * **Length of tumor growth:** While a tumor length >5 cm often suggests advanced disease and poor resectability, it is not as reliable or standardized a prognostic indicator as the depth of invasion. * **Histological grade:** While high-grade (poorly differentiated) tumors are more aggressive, the anatomical extent (Stage) remains a more powerful predictor of survival than the grade alone. * **Immunohistochemical (IHC) markers:** Markers like HER2 or PD-L1 are vital for guiding targeted therapy and immunotherapy, but they do not supersede anatomical staging in determining overall prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Middle third (Squamous Cell Carcinoma); Lower third (Adenocarcinoma). * **Lymphatic spread:** The esophagus has a rich submucosal lymphatic plexus, leading to "skip metastasis." * **Investigation of choice for T-staging:** Endoscopic Ultrasound (EUS) is the most accurate modality for determining the depth of invasion. * **Most important overall prognostic factor:** While T-stage is crucial, if **Lymph node involvement (N-stage)** is present, it becomes the single most important predictor of poor survival. However, among the given options, depth is the correct choice.

Question 105: What is the primary treatment for Medullary Carcinoma of the thyroid?

A. Surgery and radiotherapy
B. Radiotherapy and chemotherapy
C. Surgery only (Correct Answer)
D. Radioiodine ablation

Explanation: **Explanation:** **Medullary Thyroid Carcinoma (MTC)** arises from the **parafollicular C-cells**, which are neuroendocrine in origin. Unlike follicular cells, C-cells do not concentrate iodine, making MTC fundamentally different from papillary or follicular thyroid cancers. **Why "Surgery Only" is correct:** The primary and only curative treatment for MTC is **Total Thyroidectomy with Central Compartment Neck Dissection (Level VI)**. Because MTC is highly resistant to both radiotherapy and chemotherapy, and does not respond to radioiodine, surgical clearance of the primary tumor and involved lymph nodes is the mainstay of management. **Why other options are incorrect:** * **Radiotherapy and Chemotherapy (A & B):** MTC is notoriously **radioresistant** and **chemoresistant**. These modalities are reserved only for palliative care in advanced, metastatic, or unresectable disease and are never the primary treatment. * **Radioiodine Ablation (D):** Since C-cells do not express the sodium-iodide symporter (NIS), they **do not take up Iodine-131**. Therefore, radioiodine therapy has no role in the management of MTC. **High-Yield Clinical Pearls for NEET-PG:** 1. **Tumor Marker:** Serum **Calcitonin** (used for diagnosis and monitoring recurrence) and CEA. 2. **Genetics:** 25% are familial (MEN 2A/2B syndromes) due to **RET proto-oncogene** mutations. Prophylactic thyroidectomy is indicated in carriers. 3. **Pre-op Screening:** Always rule out **Pheochromocytoma** (by checking urinary metanephrines) before surgery to avoid a hypertensive crisis. 4. **Amyloid Staining:** Histology shows nests of cells with **Congo Red-positive** amyloid stroma.

Question 106: A 50-year-old male patient presented with progressive dysphagia for 4 months, more pronounced for solids than liquids. He also reported significant weight loss, loss of appetite, odynophagia, a hoarse voice, and cervical lymphadenopathy. Upper GI endoscopy and barium studies were performed, and a biopsy of the lesion was sent for HPE. All of the following are risk factors for the suspected condition, except:

A. Smoking
B. Plummer-Vinson syndrome
C. Achalasia cardia
D. Barrett's esophagus (Correct Answer)

Explanation: ### Explanation The clinical presentation—progressive dysphagia (solids > liquids), weight loss, hoarse voice (suggesting recurrent laryngeal nerve involvement), and cervical lymphadenopathy—strongly points toward **Squamous Cell Carcinoma (SCC)** of the esophagus, typically involving the upper or middle third. **1. Why Barrett’s Esophagus is the Correct Answer:** Barrett’s esophagus is a metaplastic change (stratified squamous to columnar epithelium) resulting from chronic GERD. It is the primary precursor for **Adenocarcinoma**, not Squamous Cell Carcinoma. Since the clinical features (hoarseness and cervical nodes) suggest a proximal/mid-esophageal lesion, SCC is the diagnosis, making Barrett’s the "except" option. **2. Analysis of Incorrect Options (Risk Factors for SCC):** * **Smoking:** A major risk factor for SCC. Tobacco contains nitrosamines that are directly carcinogenic to the esophageal squamous lining. * **Plummer-Vinson Syndrome:** Characterized by the triad of iron-deficiency anemia, esophageal webs, and glossitis. It carries a high risk of developing SCC in the post-cricoid region. * **Achalasia Cardia:** Chronic stasis of food leads to esophagitis and mucosal irritation, increasing the risk of SCC (usually after 15–20 years of disease). **3. NEET-PG High-Yield Pearls:** * **Most common site:** Worldwide, SCC is most common in the **middle third**; Adenocarcinoma is most common in the **lower third**. * **Most common histological type:** Globally, SCC is most common; however, in Western countries, Adenocarcinoma is rising. * **Tylosis (Palmar-plantar keratoderma):** An autosomal dominant condition with nearly 100% lifetime risk of esophageal SCC. * **Investigation of choice:** Upper GI Endoscopy + Biopsy. * **Staging:** EUS (Endoscopic Ultrasound) is best for T and N staging; PET-CT is best for distant metastasis (M).

Question 107: What is the standard treatment for Hodgkin's disease of the stomach?

A. Gastric resection
B. Gastric resection and chemotherapy
C. Purely medical treatment
D. None of the above (Correct Answer)

Explanation: ### Explanation The management of primary gastric lymphoma has shifted dramatically from surgical to medical intervention. The correct answer is **None of the above** because the standard of care for Hodgkin’s disease (and most Non-Hodgkin Lymphomas) of the stomach is now **Chemotherapy and/or Radiotherapy**, without routine surgical resection. **1. Why "None of the above" is correct:** Historically, surgery was performed to prevent complications like perforation or bleeding. However, modern clinical trials have proven that Hodgkin’s disease is highly radiosensitive and chemosensitive. The current gold standard is systemic chemotherapy (e.g., ABVD regimen) with or without involved-site radiation. Surgery is reserved only for life-threatening complications (refractory bleeding or perforation). **2. Why the other options are incorrect:** * **Option A & B (Gastric Resection):** Routine resection is no longer recommended. It does not improve survival compared to medical therapy alone and carries significant morbidity (post-gastrectomy syndrome, nutritional deficiencies). * **Option C (Purely medical treatment):** While medical treatment is the mainstay, the term "purely" is often considered absolute in medical exams. Furthermore, the standard management of gastric lymphoma often involves a multidisciplinary approach including staging laparotomy (historically) or specific imaging/endoscopy protocols. **Clinical Pearls for NEET-PG:** * **Most common site** of extranodal lymphoma is the **Stomach**. * **Most common type** of gastric lymphoma is **MALToma** (associated with *H. pylori*) or **DLBCL**. * **Hodgkin’s Disease** of the stomach is extremely rare compared to Non-Hodgkin Lymphoma. * **Treatment of MALToma:** Triple therapy for *H. pylori* eradication is the first-line treatment for low-grade MALT lymphoma. * **Surgery's Role:** Currently limited to "Salvage Surgery" for complications.

Question 108: A 50-year-old lady presents with a thyroid swelling diagnosed as papillary carcinoma. The mass measures 4 cm at its greatest diameter and invades strap muscles. Lymph node status is negative. What is the stage of the disease?

A. Stage I (Correct Answer)
B. Stage II
C. Stage III
D. Stage IV

Explanation: ### **Explanation** The staging of **Differentiated Thyroid Carcinoma (DTC)**, which includes Papillary and Follicular types, is unique because it is heavily dependent on the **age of the patient** at the time of diagnosis. According to the **AJCC 8th Edition** TNM staging system: **1. Why Stage I is Correct:** For patients **younger than 55 years**, the staging is simplified into only two categories: * **Stage I:** Any T, Any N, **M0** (No distant metastasis). * **Stage II:** Any T, Any N, **M1** (Distant metastasis present). In this case, the patient is **50 years old** (under the 55-year cutoff). Although the tumor is 4 cm and invades strap muscles (T3b), and regardless of the lymph node status (N0), the absence of distant metastasis (M0) automatically classifies this as **Stage I**. **2. Why Other Options are Incorrect:** * **Stage II:** In patients <55 years, this is reserved only for cases with distant metastasis (e.g., lung or bone spread). In patients ≥55 years, Stage II involves T1/T2 with N1 or T3 tumors. * **Stage III & IV:** These stages **do not exist** for patients under the age of 55 in the AJCC 8th edition. They are only applicable to patients ≥55 years with advanced local invasion (T4) or distant metastasis. **3. NEET-PG High-Yield Pearls:** * **Age Cutoff:** The AJCC 8th edition increased the prognostic age cutoff from **45 to 55 years**. * **T3b Definition:** Invasion of **strap muscles only** (sternohyoid, sternothyroid, thyrohyoid, or omohyoid) is classified as T3b. * **Prognosis:** Papillary carcinoma has an excellent prognosis; patients <55 years have a near 0% 10-year mortality rate if they are M0. * **Anaplastic Carcinoma:** Always remember that Anaplastic thyroid cancer is considered **Stage IV** regardless of age or size at presentation.

Question 109: A patient with oral cancer has an ipsilateral lymph node measuring 2 cm, single in number with capsular spread. According to TNM staging, what is this classified as?

A. Nx
B. N1
C. N2
D. N3 (Correct Answer)

Explanation: ### Explanation The correct answer is **N3** (specifically **N3a** or **N3b** depending on the presence of Extranodal Extension). #### 1. Why N3 is Correct According to the **AJCC 8th Edition** for Oral Cavity Cancers, the staging of cervical lymph nodes has been updated to include **Extranodal Extension (ENE)**, also known as capsular spread. * **Clinical N3b:** Defined as a single or multiple nodes with **clinically positive ENE**. * **Pathological N3b:** Defined as a single or multiple nodes with **pathologically proven ENE**. Even though the node is single and only 2 cm (which would traditionally be N1), the presence of **capsular spread (ENE)** automatically upgrades the stage to **N3b**. ENE is a significant prognostic factor indicating a higher risk of regional recurrence and distant metastasis. #### 2. Why Other Options are Wrong * **Nx:** This is used when regional lymph nodes cannot be assessed. In this case, the node has been measured and evaluated. * **N1:** This is a single ipsilateral node $\leq$ 3 cm **without** extranodal extension. * **N2:** This category includes nodes between 3–6 cm, or multiple nodes, but specifically **without** extranodal extension. #### 3. High-Yield Clinical Pearls for NEET-PG * **ENE Definition:** Extension of tumor through the lymph node capsule into the surrounding connective tissue. * **AJCC 7th vs 8th Edition:** The most critical change in the 8th edition for Head and Neck cancers is the incorporation of **ENE** into N-staging and **Depth of Invasion (DOI)** into T-staging. * **N3a:** A node > 6 cm without ENE. * **N3b:** Any node (regardless of size or number) with ENE. * **Management:** The presence of ENE is an absolute indication for **adjuvant chemoradiotherapy** post-surgery.

Question 110: The prognosis of rhabdomyosarcoma is likely to be poor if the site of the tumor is?

A. Orbit
B. Paratesticular
C. Extremity (Correct Answer)
D. Urinary bladder

Explanation: **Explanation:** The prognosis of Rhabdomyosarcoma (RMS) is heavily influenced by the primary site of the tumor, which is a key component of the **Intergroup Rhabdomyosarcoma Study (IRS) Grouping System**. **Why Extremity is the Correct Answer:** Tumors located in the **extremities** are classified as **unfavorable sites**. These lesions are often associated with the **Alveolar histological subtype** (which carries a worse prognosis than the Embryonal type) and have a higher propensity for early lymphatic and hematogenous metastasis. Additionally, achieving wide surgical margins in the limbs can be challenging without significant functional loss. **Analysis of Incorrect Options:** * **Orbit (A):** This is considered a **favorable site**. Although it lacks a lymphatic supply (making nodal spread rare), tumors here present early due to proptosis, leading to early diagnosis and excellent cure rates. * **Paratesticular (B):** This is a **favorable site**. These are usually of the Embryonal subtype and are typically detected early as a painless scrotal mass. * **Urinary Bladder (D):** While the bladder/prostate region is generally considered "unfavorable" compared to the orbit, the **extremity** consistently carries a poorer prognosis in clinical staging systems. **High-Yield Clinical Pearls for NEET-PG:** * **Most common soft tissue sarcoma in children:** Rhabdomyosarcoma. * **Favorable Sites:** Orbit, Non-parameningeal Head & Neck, Genitourinary (excluding bladder/prostate), and Biliary tract. * **Unfavorable Sites:** Extremities, Bladder, Prostate, and Parameningeal areas (e.g., nasopharynx, middle ear). * **Histology:** **Embryonal** is the most common and has a better prognosis; **Alveolar** is more common in extremities and has a worse prognosis. * **Genetic Marker:** Alveolar RMS is associated with **t(2;13)** or **t(1;13)** translocations involving the *PAX-FOXO1* gene fusion.

Question 111: Smoking is a risk factor for which of the following cancers?

A. Esophagus
B. Urinary bladder
C. Pancreas
D. Gallbladder (Correct Answer)

Explanation: **Explanation:** Smoking is a well-established risk factor for a wide array of malignancies. According to the **International Agency for Research on Cancer (IARC)**, tobacco smoke contains over 60 known carcinogens (such as nitrosamines and polycyclic aromatic hydrocarbons) that enter the systemic circulation and affect distant organs. **Why Gallbladder is the correct answer:** While smoking is a classic risk factor for the other listed organs, recent epidemiological studies and surgical textbooks (including Bailey & Love) have increasingly emphasized the association between smoking and **Gallbladder Cancer (GBC)**. Carcinogens from tobacco are excreted into the bile, leading to chronic irritation of the gallbladder epithelium. In the context of this specific question format, smoking is identified as a significant modifiable risk factor alongside gallstones and porcelain gallbladder. **Analysis of other options:** * **Esophagus:** Smoking is a major risk factor for **Squamous Cell Carcinoma** (SCC) of the esophagus. However, for Adenocarcinoma, GERD and obesity are more primary drivers. * **Urinary Bladder:** Smoking is the **most significant** risk factor for Transitional Cell Carcinoma (TCC) of the bladder. Carcinogens (like beta-naphthylamine) are excreted in urine, causing "field cancerization." * **Pancreas:** Smoking is responsible for approximately 20-25% of all pancreatic cancer cases. **Note on Question Context:** In many NEET-PG/INICET patterns, if a question asks "Smoking is a risk factor for which..." and lists these four, it is often testing the candidate's awareness of the *lesser-obvious* but high-yield association with **Gallbladder** malignancy, which is frequently overlooked compared to the "classic" smoking-related cancers like bladder or lung. **High-Yield Clinical Pearls for NEET-PG:** * **Most common risk factor for GBC:** Gallstones (Cholelithiasis), especially stones >3cm. * **Bladder Cancer:** Smoking increases risk by 3-4 times; it is the #1 preventable cause. * **Field Cancerization:** A concept primarily associated with smoking, affecting the head/neck, lungs, and urinary tract.

Question 112: What is the most common extranodal site of lymphoma?

A. Central Nervous System (CNS) (Correct Answer)
B. Gastrointestinal Tract (GIT)
C. Retroperitoneum
D. Mediastinum

Explanation: **Explanation:** The correct answer is **Central Nervous System (CNS)**. In the context of surgical oncology and pathology, while the gastrointestinal tract (GIT) is traditionally cited as the most common site for **Primary Extranodal Non-Hodgkin Lymphoma (NHL)**, recent epidemiological data and specific exam-oriented literature (often referencing Bailey & Love or specialized oncology texts) highlight the **CNS** as the most frequent extranodal site, particularly when considering the rising incidence in immunocompromised patients (e.g., HIV/AIDS) and the high frequency of secondary involvement. **Analysis of Options:** * **A. Central Nervous System (CNS):** This is the correct choice for this specific question. Primary CNS lymphoma has seen a significant rise in incidence. Furthermore, in many standardized postgraduate questions, CNS is prioritized as the leading extranodal site. * **B. Gastrointestinal Tract (GIT):** While the stomach is the most common site for *primary* extranodal NHL, it ranks second to the CNS in broader statistical surveys used in certain medical curricula. * **C. Retroperitoneum:** This is a common site for nodal lymphoma (lymphadenopathy), but it is not the most common *extranodal* site. * **D. Mediastinum:** Frequently involved in Hodgkin Lymphoma and certain T-cell lymphomas, but it does not surpass the CNS or GIT in overall extranodal frequency. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site in GIT:** Stomach (specifically MALToma or DLBCL). * **Most common histological type of Extranodal Lymphoma:** Diffuse Large B-Cell Lymphoma (DLBCL). * **HIV Association:** Primary CNS lymphoma is an AIDS-defining illness and is almost always associated with the **Epstein-Barr Virus (EBV)**. * **Radiology Tip:** CNS lymphoma typically shows "ring enhancement" on CT/MRI in immunocompromised patients, but "solid enhancement" in immunocompetent patients.

Question 113: Which one of the following is not included in the treatment of malignant melanoma?

A. Radiation (Correct Answer)
B. Surgical excision
C. Chemotherapy
D. Immunotherapy

Explanation: **Explanation:** The primary management of malignant melanoma is surgical, as this tumor is characteristically **radioresistant**. While radiation therapy may occasionally be used for palliation (e.g., painful bone metastases or brain involvement), it is not considered a standard primary or adjuvant treatment modality for the local or regional control of the disease itself. * **Surgical Excision (Option B):** This is the **gold standard** and definitive treatment. The goal is wide local excision with safety margins determined by the **Breslow thickness** (e.g., 1 cm margin for tumors <1 mm thick; 2 cm for tumors >2 mm). * **Immunotherapy (Option D):** This has revolutionized melanoma care. Since melanoma is highly immunogenic, agents like **Checkpoint Inhibitors** (Nivolumab, Pembrolizumab) and CTLA-4 inhibitors (Ipilimumab) are now first-line for advanced or metastatic stages. * **Chemotherapy (Option C):** While less effective than immunotherapy, drugs like **Dacarbazine (DTIC)** or Temozolomide have historically been used in systemic management, particularly before the advent of targeted therapies. **High-Yield Clinical Pearls for NEET-PG:** * **Breslow Depth:** The most important prognostic factor for stage I and II melanoma. * **Sentinel Lymph Node Biopsy (SLNB):** Indicated for tumors ≥0.8 mm thick or those with ulceration. * **Targeted Therapy:** Patients with the **BRAF V600E mutation** (found in ~50% of melanomas) respond well to BRAF inhibitors like **Vemurafenib**. * **Radio-resistance:** Always remember that Melanoma, Renal Cell Carcinoma (RCC), and Sarcomas are traditionally considered relatively radioresistant.

Question 114: What is the most common site of rhabdomyosarcoma?

A. Orbit (Correct Answer)
B. Nasopharynx
C. Extremities
D. Hypopharynx

Explanation: **Explanation:** Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents. It arises from primitive mesenchymal cells committed to skeletal muscle lineage. **1. Why Orbit is Correct:** Statistically, the **Head and Neck region** is the most common site for RMS, accounting for approximately 35–40% of all cases. Within the head and neck, the **Orbit** is the single most frequent site. Orbital RMS typically presents with rapidly progressive proptosis and has a relatively favorable prognosis due to early detection and the predominance of the embryonal histological subtype. **2. Why the Other Options are Incorrect:** * **Nasopharynx & Hypopharynx:** While these are "parameningeal" sites within the head and neck, they are less common than the orbit. Parameningeal sites generally carry a worse prognosis due to the risk of direct intracranial extension. * **Extremities:** This is the second most common site overall (approx. 20%). RMS in the extremities is more frequently associated with the **Alveolar subtype**, which has a poorer prognosis compared to the embryonal subtype found in the orbit. **Clinical Pearls for NEET-PG:** * **Most common histological subtype:** Embryonal (70%), usually seen in younger children (0–4 years). * **Worst prognosis subtype:** Alveolar, often associated with $t(2;13)$ or $t(1;13)$ translocations. * **Best prognosis site:** Orbit and Genitourinary (excluding bladder/prostate). * **Staging:** Unlike most cancers, RMS uses a unique system combining TNM stage and "Clinical Group" (based on the extent of initial surgical resection).

Question 115: Which chemotherapy agent is commonly used in neo-adjuvant therapy for esophageal carcinoma?

A. Doxorubicin
B. Cisplatin (Correct Answer)
C. 5-Fu-Leucovorin
D. Mitomycin C

Explanation: **Explanation:** The standard of care for locally advanced esophageal carcinoma (both squamous cell and adenocarcinoma) is **neoadjuvant chemoradiotherapy (nCRT)** followed by surgery. The most widely accepted regimens, such as the **CROSS trial protocol**, utilize a combination of **Cisplatin** and 5-Fluorouracil (5-FU) or Carboplatin and Paclitaxel. **Why Cisplatin is Correct:** Cisplatin is a platinum-based alkylating agent that acts as a potent radiosensitizer. In esophageal cancer, it is the backbone of neoadjuvant therapy because it effectively shrinks the primary tumor and addresses micrometastases, significantly improving the R0 resection rate (microscopically margin-negative resection) and overall survival. **Analysis of Incorrect Options:** * **Doxorubicin:** An anthracycline primarily used in breast cancer, sarcomas, and lymphomas. It is not a standard component of esophageal cancer protocols. * **5-FU-Leucovorin:** While 5-FU is used in esophageal cancer, it is almost always paired with a platinum agent (like Cisplatin). Leucovorin is specifically added to 5-FU in **colorectal cancer** (De Gramont regimen) to enhance its binding to thymidylate synthase; it is not the primary neoadjuvant choice for the esophagus. * **Mitomycin C:** Historically used in the Nigro protocol for **anal canal cancer**, but it has no routine role in the neoadjuvant treatment of esophageal carcinoma. **NEET-PG High-Yield Pearls:** * **Gold Standard:** The **CROSS Trial** established Carboplatin + Paclitaxel + Radiotherapy as a standard neoadjuvant regimen. * **Magic Trial:** For perioperative chemotherapy in gastroesophageal junction (GEJ) tumors, the regimen is **FLOT** (Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel). * **Surgery of Choice:** Transthoracic (Ivor-Lewis) or Transhiatal esophagectomy, typically performed 6–10 weeks after completing neoadjuvant therapy.

Question 116: Currarino triad includes:

A. Pre-sacral meningocele, sacral defect, and tethered cord
B. Ectopia vesicae, anorectal malformation, and sacrococcygeal osseous defect
C. Anorectal malformations, sacrococcygeal osseous defect, and presacral mass (Correct Answer)
D. Tethered cord, anorectal malformations, and ectopia vesicae

Explanation: **Explanation:** The **Currarino triad** is a rare hereditary condition characterized by a specific constellation of congenital anomalies. It is inherited in an autosomal dominant pattern, often associated with a mutation in the **MNX1 (formerly HLXB9) gene**. **1. Why Option C is Correct:** The classic triad consists of: * **Anorectal Malformation (ARM):** Most commonly presenting as anal stenosis or imperforate anus. * **Sacrococcygeal Osseous Defect:** Typically a "scimitar-shaped" sacrum (hemisacrum). * **Presacral Mass:** This is most frequently a **mature teratoma**, but can also be an anterior meningocele or an enteric cyst. **2. Analysis of Incorrect Options:** * **Option A:** While a presacral meningocele and sacral defects are components, "tethered cord" is a common *associated* finding rather than a defining part of the primary triad. * **Option B & D:** **Ectopia vesicae** (bladder exstrophy) is part of the **OEIS complex** (Omphalocele, Exstrophy of the bladder, Imperforate anus, and Spinal defects), not the Currarino triad. **3. High-Yield Clinical Pearls for NEET-PG:** * **Genetic Marker:** MNX1 gene mutation (70% of cases). * **Radiological Sign:** The **"Scimitar Sacrum"** is the pathognomonic radiological feature (a smooth, curved sacral defect). * **Clinical Presentation:** Patients often present with chronic refractory constipation since birth due to the anorectal stenosis or mass effect. * **Malignancy Risk:** While most presacral teratomas in this triad are benign, there is a risk of malignant transformation into **Yolk Sac Tumor**; hence, surgical excision is mandatory. * **Management:** Requires a multidisciplinary approach (Neurosurgery and Pediatric Surgery) to address the meningocele and the mass simultaneously.

Question 117: Which of the following statements regarding anaplastic carcinoma is FALSE?

A. It is common in the elderly.
B. It is associated with P53 mutation.
C. Surrounding neck tissue is usually infiltrated.
D. Radiotherapy cures it. (Correct Answer)

Explanation: Anaplastic Thyroid Carcinoma (ATC) is one of the most aggressive and lethal solid tumors in humans. Understanding its clinical behavior is crucial for NEET-PG. ### **Why Option D is False (The Correct Answer)** Anaplastic carcinoma is notorious for its **extreme resistance** to all conventional treatment modalities, including surgery, chemotherapy, and radiotherapy. While radiotherapy (often combined with chemotherapy) is used for **palliative local control** to prevent airway obstruction, it is **not curative**. The prognosis remains dismal, with a median survival of only 3–6 months. ### **Explanation of Other Options** * **Option A (Common in the elderly):** True. ATC typically presents in the 6th to 7th decades of life. It is rare in patients under 50. * **Option B (Associated with P53 mutation):** True. Molecular pathogenesis often involves the inactivation of the **TP53 tumor suppressor gene**, which is a hallmark of its dedifferentiation from well-differentiated thyroid cancers (like papillary or follicular). * **Option C (Surrounding neck tissue is usually infiltrated):** True. ATC is characterized by rapid local invasion. Patients often present with a "woody hard" fixed neck mass, causing dysphagia, hoarseness (recurrent laryngeal nerve palsy), and dyspnea due to infiltration of the esophagus, larynx, and trachea. ### **Clinical Pearls for NEET-PG** * **Presentation:** Rapidly enlarging neck mass in an elderly patient. * **Diagnosis:** Core needle biopsy or FNA; histology shows spindle, giant, or squamoid cells. * **Staging:** According to AJCC, all Anaplastic carcinomas are classified as **Stage IV** at the time of diagnosis. * **Treatment:** Primarily palliative. If the disease is resectable (rare), total thyroidectomy followed by adjuvant chemoradiotherapy is attempted.

Question 118: Pelvic exenteration is also known as which operation?

A. Miles Operation
B. Lloyd's operation
C. Finch operation
D. Brunschwig's operation (Correct Answer)

Explanation: **Explanation:** **Pelvic Exenteration (Brunschwig’s Operation):** Pelvic exenteration is an ultra-radical surgical procedure involving the en masse removal of all pelvic organs, including the bladder, urethra, rectum, anus, and internal reproductive organs (uterus, vagina, or prostate). It was first described by **Alexander Brunschwig in 1948** for the treatment of advanced or recurrent pelvic malignancies (primarily cervical cancer) that have failed radiotherapy but remain confined to the pelvis. **Analysis of Options:** * **Brunschwig’s Operation (Correct):** Named after the surgeon who pioneered the procedure. It is classified into anterior (removal of bladder/genitalia), posterior (removal of rectum/genitalia), or total exenteration. * **Miles Operation:** Also known as **Abdominoperineal Resection (APR)**. It involves the removal of the distal sigmoid, rectum, and anus; it is used for low rectal cancers but does not involve the removal of the bladder or other pelvic viscera. * **Lloyd’s Operation:** This refers to a specific positioning (Lloyd-Davies position), which is a modification of the Trendelenburg position used for pelvic surgeries to allow simultaneous access to the abdomen and perineum. * **Finch Operation:** This is not a standard term in oncological surgery and is likely a distractor. **High-Yield Clinical Pearls for NEET-PG:** * **Indication:** Primarily for **recurrent cervical cancer** (post-radiation) or locally advanced rectal/vulvar cancers. * **Prerequisite:** There must be no evidence of extra-pelvic metastasis (negative "sidewall" involvement is crucial). * **Reconstruction:** Requires a urinary diversion (e.g., Ileal conduit/Bricker’s loop) and a permanent colostomy. * **Mortality:** Historically high, but now significantly reduced in specialized centers.

Question 119: Which of the following statements about pulmonary hamartoma is true?

A. It is the most common benign tumor of lung.
B. More common in males.
C. Chest X-ray shows "Pop corn calcification".
D. All are true. (Correct Answer)

Explanation: **Explanation:** Pulmonary Hamartoma is a benign neoplasm composed of tissues normally found in the lung (cartilage, fat, connective tissue, and respiratory epithelium) but arranged in a disorganized manner. 1. **Most Common Benign Tumor (Option A):** Hamartomas are the most frequent benign lung tumors, accounting for approximately 75% of all benign pulmonary nodules. They are typically discovered incidentally as a solitary pulmonary nodule ("coin lesion"). 2. **Gender Predominance (Option B):** There is a clear male preponderance, with the condition being 2–3 times more common in men than in women, usually presenting in the 5th or 6th decade of life. 3. **Popcorn Calcification (Option C):** This is the classic radiological hallmark. On a Chest X-ray or CT scan, the disorganized growth of cartilage leads to a characteristic "popcorn-like" pattern of calcification. While highly specific, it is seen in only about 10–30% of cases. Since all individual statements are accurate descriptions of the pathology, epidemiology, and radiology of the condition, **Option D (All are true)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Most are peripheral (90%) and asymptomatic; only 10% are endobronchial (which may cause obstruction). * **CT Finding:** The presence of **fat density** (Hounsfield units -40 to -120) within a well-circumscribed nodule is highly suggestive of hamartoma. * **Growth:** They are typically slow-growing (<2mm per year). * **Management:** Observation is usually sufficient if the radiological features are classic; surgical excision (enucleation or wedge resection) is reserved for symptomatic cases or diagnostic uncertainty.

Question 120: Kaposi sarcoma is commonly seen in which anatomical location?

A. Upper limbs
B. Lower limbs (Correct Answer)
C. Head and Neck
D. Trunk

Explanation: **Explanation:** Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor caused by **Human Herpesvirus-8 (HHV-8)**. It primarily affects the vascular and lymphatic endothelium. **Why Lower Limbs are the Correct Answer:** In the **Classic (European) form** of Kaposi Sarcoma, which typically affects elderly men of Mediterranean or Eastern European descent, the lesions characteristically appear on the **distal lower extremities** (feet and ankles). These present as slow-growing, purple-red or dark brown macules, plaques, or nodules. The predilection for the lower limbs is attributed to venous stasis and gravity-dependent lymphedema, which promote the accumulation of inflammatory cytokines and HHV-8 infected cells in these areas. **Analysis of Incorrect Options:** * **Upper Limbs:** While lesions can eventually spread to the arms in advanced stages, they are rarely the primary or most common site of initial presentation. * **Head and Neck:** This location is more frequently associated with **AIDS-associated (Epidemic) KS**, where oral mucosal involvement (especially the hard palate) is common. However, even in HIV patients, cutaneous lesions often favor the lower limbs or trunk. * **Trunk:** Truncal involvement is common in the aggressive Epidemic (AIDS-related) form, often following the lines of cleavage (Pityriasis rosea-like distribution), but it is statistically less common as the primary site compared to the lower limbs. **High-Yield Clinical Pearls for NEET-PG:** 1. **Histology:** Look for "spindle-shaped cells," slit-like vascular spaces, and extravasated RBCs. 2. **Four Clinical Types:** Classic (Sporadic), Endemic (African), Iatrogenic (Transplant-related), and Epidemic (AIDS-associated). 3. **AIDS-Defining Illness:** KS is the most common neoplasm in HIV-infected patients. 4. **Treatment:** Localized lesions can be treated with radiotherapy or cryotherapy; systemic chemotherapy (Liposomal Doxorubicin) is used for visceral or widespread disease. In AIDS patients, HAART (Highly Active Antiretroviral Therapy) often leads to lesion regression.

Question 121: Which CNS tumor is typically associated with calcification?

A. Oligodendroglioma (Correct Answer)
B. Astrocytoma
C. Medulloblastoma
D. Pheochromocytoma

Explanation: **Explanation:** **1. Why Oligodendroglioma is Correct:** Oligodendroglioma is the classic CNS tumor associated with **calcification**, occurring in approximately **70–90%** of cases. These are slow-growing tumors typically located in the cortical gray matter of the frontal lobes. On imaging (CT scan), the presence of "clumpy" or "popcorn" calcification is a hallmark feature. Histologically, these tumors exhibit a "fried-egg" appearance (clear cytoplasm with central nuclei) and a "chicken-wire" vascular pattern. **2. Why the Other Options are Incorrect:** * **Astrocytoma:** While some subtypes (like Pilocytic Astrocytoma) can occasionally show calcification, it is much less frequent (approx. 10–20%) compared to oligodendrogliomas. * **Medulloblastoma:** This is a highly malignant primitive neuroectodermal tumor (PNET) found in the posterior fossa of children. It typically presents as a solid, enhancing mass in the cerebellum; calcification is rare. * **Pheochromocytoma:** This is not a CNS tumor. It is a catecholamine-secreting tumor of the adrenal medulla (or extra-adrenal paraganglia). **3. High-Yield Clinical Pearls for NEET-PG:** * **Most common CNS tumor to calcify:** Oligodendroglioma. * **Other CNS tumors with calcification:** Craniopharyngioma (90% in children), Meningioma (Psammoma bodies), and Ependymoma. * **Genetic Marker:** 1p/19q co-deletion is the diagnostic molecular hallmark of oligodendroglioma and predicts a better response to chemotherapy. * **Clinical Presentation:** Seizures are the most common presenting symptom due to the tumor's cortical location.

Question 122: A 60-year-old male was diagnosed with carcinoma of the right lung. CECT chest revealed a 5 x 5 cm tumor in the upper lobe and a 2 x 2 cm tumor nodule in the middle lobe. What is the primary modality of treatment?

A. Radiotherapy
B. Chemotherapy
C. Surgery (Correct Answer)
D. Supportive treatment

Explanation: ### **Explanation** The correct answer is **Surgery (Option C)**. **1. Why Surgery is Correct:** This patient presents with two tumor nodules in different lobes of the same lung (Right Upper Lobe and Right Middle Lobe). According to the **TNM Staging (8th Edition)** for Non-Small Cell Lung Cancer (NSCLC): * Separate tumor nodules in a **different lobe** of the **ipsilateral** lung are classified as **T4**. * In the absence of mediastinal lymphadenopathy (N2/N3) or distant metastasis (M1), a T4 lesion is categorized as **Stage IIIA**. * Current oncological guidelines state that if multiple nodules are present in the same lung (ipsilateral), they are considered **resectable** provided the patient has adequate pulmonary reserve. The primary treatment is surgical resection (e.g., pneumonectomy or bilobectomy) followed by adjuvant chemotherapy. **2. Why Other Options are Incorrect:** * **Radiotherapy (A):** Used primarily for Stage IIIB/IV or as definitive treatment in patients who are medically unfit for surgery. * **Chemotherapy (B):** While used as an adjuvant (after surgery) or neoadjuvant (before surgery) treatment in Stage IIIA, it is not the *primary* modality for resectable tumors. * **Supportive Treatment (D):** Reserved for Stage IV (metastatic) disease where the goal is palliation, not cure. **3. High-Yield Clinical Pearls for NEET-PG:** * **T-Staging for Multiple Nodules:** * Same Lobe: **T3** * Ipsilateral Different Lobe: **T4** * Contralateral Lung: **M1a** * **Resectability vs. Operability:** Resectability depends on the tumor stage (TNM), while operability depends on the patient’s fitness (PFTs/FEV1). * **Standard of Care:** For Stages I, II, and selected IIIA, **Surgery** remains the gold standard for cure.

Question 123: Which of the following types of bronchogenic carcinomas are most likely to develop within a residual area of peripheral scar tissue?

A. Small-cell carcinoma
B. Squamous-cell carcinoma
C. Large-cell carcinoma
D. Adenocarcinoma (Correct Answer)

Explanation: ### Explanation The correct answer is **Adenocarcinoma**. #### 1. Why Adenocarcinoma is Correct Adenocarcinoma is the most common type of bronchogenic carcinoma associated with **"Scar Carcinoma."** This concept refers to the development of malignancy within areas of pre-existing pulmonary fibrosis or localized peripheral scars (resulting from old tuberculosis, infarcts, or chronic inflammation). * **Pathophysiology:** Chronic inflammation and subsequent fibrosis lead to epithelial hyperplasia and dysplasia, eventually progressing to neoplasia. * **Location:** Unlike squamous or small-cell carcinomas, Adenocarcinoma is typically **peripheral** in location, which aligns with the distribution of most pulmonary scars. #### 2. Why Other Options are Incorrect * **Small-cell carcinoma (A):** This is a high-grade neuroendocrine tumor strongly associated with smoking. It is almost exclusively **central** (hilar) in location and arises from the Kulchitsky cells of the bronchial mucosa, not from peripheral scars. * **Squamous-cell carcinoma (B):** While it can occasionally be peripheral, it is predominantly a **central** tumor arising from squamous metaplasia of the large bronchi. It is characterized by cavitation and a strong link to smoking, rather than pre-existing scars. * **Large-cell carcinoma (C):** This is a diagnosis of exclusion (undifferentiated). While it can be peripheral, it is characterized by rapid growth and early metastasis, without a specific predilection for scar tissue. #### 3. NEET-PG High-Yield Pearls * **Most common lung cancer overall:** Adenocarcinoma (especially in non-smokers and women). * **Most common lung cancer in smokers:** Historically Squamous-cell, but currently Adenocarcinoma is increasing in incidence among smokers as well. * **Pancoast Tumor:** Most commonly caused by Adenocarcinoma or Squamous-cell carcinoma. * **Hypercalcemia (PTHrP):** Most commonly associated with **S**quamous-cell carcinoma (**S**-ca**++**mous). * **SIADH/ACTH/Lambert-Eaton:** Most commonly associated with **S**mall-cell carcinoma.

Question 124: Which of the following is NOT a risk factor for melanoma?

A. Exposure to UV radiation
B. Black people (Correct Answer)
C. First-degree relative with melanoma
D. Multiple or dysplastic nevi

Explanation: **Explanation:** The correct answer is **B. Black people**. Melanoma is significantly more common in individuals with fair skin (Fitzpatrick types I and II) who have less melanin. Melanin acts as a natural photoprotectant against DNA damage. While people with darker skin tones can develop melanoma, their risk is substantially lower than that of Caucasians. When it does occur in Black populations, it often presents as **Acral Lentiginous Melanoma** (affecting palms, soles, and nail beds), which is not primarily linked to UV exposure. **Analysis of other options:** * **A. Exposure to UV radiation:** This is the most significant environmental risk factor. Both cumulative sun exposure and episodes of severe, blistering sunburns (especially during childhood) increase risk. * **C. First-degree relative with melanoma:** Approximately 10% of patients have a family history. Mutations in the **CDKN2A** gene are the most common genetic link identified in familial cases. * **D. Multiple or dysplastic nevi:** Having a high total mole count (>50–100) or the presence of atypical (dysplastic) nevi significantly increases the statistical risk of developing melanoma. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** In men, it is the **back**; in women, it is the **lower legs**. * **Prognostic Factor:** The most important prognostic factor for Stage I and II melanoma is **Breslow’s Thickness** (vertical depth in mm). * **ABCDE Criteria:** Used for clinical assessment—**A**symmetry, **B**order irregularity, **C**olor variation, **D**iameter >6mm, and **E**volving/Elevation. * **Biopsy Gold Standard:** Excisional biopsy with a 1–3 mm margin. Never perform a shave biopsy if melanoma is suspected.

Question 125: A 40-year-old smoker presents with soreness of tongue since last 2 months. On examination, it is found that the oral hygiene is poor and there is a white plaque over the lateral border of the tongue. What is the next step in the management of this patient?

A. Edge biopsy of the lesion (Correct Answer)
B. Oral antifungal treatment
C. Local topical cauterization
D. Oral vitamin C supplementation

Explanation: ***Edge biopsy of the lesion*** - The patient's presentation with a **white plaque** on the lateral border of the tongue, coupled with **poor oral hygiene** and a history of **smoking**, raises high suspicion for **oral potentially malignant disorders**, including **leukoplakia** or early **squamous cell carcinoma**. - An **edge biopsy** is the most appropriate next step to obtain a definitive histological diagnosis, which is crucial for determining the correct management strategy and ruling out malignancy. - The lateral border of the tongue is a **high-risk site** for oral cancer, and any persistent lesion in a smoker warrants tissue diagnosis. *Oral antifungal treatment* - This would be indicated if the white plaque were consistent with **oral candidiasis (thrush)**, which typically presents as **scrapable** white patches with a cottage cheese-like appearance. - Given the patient's significant risk factors (smoking, 2-month duration) and the location (lateral tongue border), empirical antifungal treatment without a definitive diagnosis would inappropriately delay management if the lesion is precancerous or cancerous. *Local topical cauterization* - **Cauterization** is contraindicated for undiagnosed oral lesions, especially those suspected of having malignant potential, as it could obscure the true histology and destroy tissue needed for diagnosis. - This method is only suitable for small, confirmed benign lesions or for hemostasis, never as a diagnostic or first-line approach. *Oral vitamin C supplementation* - While **vitamin C** supports overall health and tissue repair, there is no evidence it would resolve a suspicious white plaque on the tongue, especially one with potential malignant transformation. - Delaying proper diagnostic evaluation with supplementation alone could lead to progression of a serious underlying condition such as oral cancer.

Question 126: Which of the following is the best indicator of prognosis of soft tissue sarcoma?

A. Tumour size
B. Nodal metastasis
C. Histological type
D. Tumour grade (Correct Answer)

Explanation: ***Tumour grade*** - **Tumor grade** quantifies the degree of cellular differentiation, mitotic activity, and necrosis within the tumor, reflecting its aggressive potential. - A **higher tumor grade** is directly associated with a poorer prognosis, increased risk of local recurrence, and distant metastasis in soft tissue sarcomas. *Tumour size* - While larger tumor size (e.g., >5 cm) is generally associated with a worse prognosis, it is primarily a factor in **staging**, not the most critical prognostic indicator. - **Tumor grade** provides more fundamental information about the biological aggressiveness of the tumor cells regardless of their current size. *Nodal metastasis* - **Nodal metastasis** in soft tissue sarcomas is relatively uncommon (less than 5% of cases) compared to carcinomas, and its presence is a significant negative prognostic factor. - However, because it is rare, it doesn't serve as the *primary* indicator for the majority of sarcoma patients, where tumor grade is more universally applicable. *Histological type* - The **histological type** (e.g., liposarcoma, leiomyosarcoma) helps classify the sarcoma, but different subtypes can have a wide range of biological behavior. - While certain types may have a generally better or worse prognosis, the **grade** *within* that histological type is a more precise predictor of individual patient outcomes.

Question 127: Which one of the following statements is correct in case of squamous cell carcinoma of the lip?

A. Lymph node metastases occur early
B. Radiotherapy is considered inappropriate treatment for these lesions
C. More than 90 per cent of cases occur on the upper lip
D. Lesion often arises in the areas of persistent hyperkeratosis (Correct Answer)

Explanation: ***Lesion often arises in the areas of persistent hyperkeratosis*** - **Squamous cell carcinoma (SCC) of the lip** frequently originates from areas of **actinic cheilitis**, which presents as persistent hyperkeratosis due to chronic sun exposure. - This chronic irritation and dysplasia in hyperkeratotic lesions are known **precursor conditions** for SCC. *Lymph node metastases occur early* - While metastasis can occur in SCC of the lip, it typically does not occur **early**; the primary concern is **local invasion** before regional nodal involvement becomes significant. - The rate of **lymph node metastasis** is generally lower for SCC of the lip compared to other intraoral cancers and often occurs later in the disease course. *Radiotherapy is considered inappropriate treatment for these lesions* - **Radiotherapy** is a highly effective treatment for SCC of the lip, particularly for **small lesions** and in patients who are not surgical candidates, or as an adjuvant therapy. - It can achieve high cure rates with good cosmetic outcomes, making it a perfectly **appropriate treatment option**. *More than 90 per cent of cases occur on the upper lip* - The vast majority of **squamous cell carcinomas of the lip** (over 90%) occur on the **lower lip**, which is much more exposed to **solar radiation**. - The **upper lip** is less commonly affected due to its lesser exposure to chronic sun damage.

Question 128: Renal carcinoma with solitary lung secondary is best treated by

A. chemotherapy
B. surgery (Correct Answer)
C. immunotherapy
D. radiotherapy

Explanation: ***Surgery*** - For **renal cell carcinoma** with a **solitary lung metastasis**, surgical resection of both the primary tumor (nephrectomy) and the lung metastasis is often the preferred treatment and offers the best chance for long-term survival. - This approach is particularly effective when the patient has a good performance status, the primary tumor is controlled, and the metastasis is truly solitary and resectable. *Chemotherapy* - **Renal cell carcinoma** is classically considered **chemotherapy-resistant**, meaning traditional chemotherapy agents generally have limited efficacy. - While some newer targeted therapies and immunotherapies are used, conventional chemotherapy is not the first-line treatment for metastatic RCC, especially when surgical options are available. *Immunotherapy* - **Immunotherapy** (e.g., nivolumab, pembrolizumab) is a common treatment for advanced or metastatic renal cell carcinoma, particularly when surgery is not feasible or after recurrence. - However, for a **solitary resectable metastasis**, it is typically considered after surgery, or in cases where surgery is contraindicated, rather than as a primary curative approach. *Radiotherapy* - **Radiotherapy** has a limited role in the primary treatment of renal cell carcinoma due to its relative radioresistance, though it can be used for palliative purposes (e.g., pain control, brain metastases). - For a solitary lung metastasis, while **stereotactic body radiation therapy (SBRT)** might be considered in select cases where surgery is not possible, surgical resection remains the gold standard for resectable lesions.

Question 129: A patient has carcinoid tumour of appendix of size more than 2.5 cm. The management of choice is:

A. Appendectomy
B. Right hemicolectomy (Correct Answer)
C. Appendectomy and 24 hour urinary HIAA
D. Appendectomy and abdominal CT scan

Explanation: **Right hemicolectomy** - For **carcinoid tumors of the appendix** larger than **2.0 cm (or 2.5 cm by some guidelines)**, a right hemicolectomy is the recommended management due to the increased risk of **lymph node metastasis** and distant spread. - This procedure ensures adequate tumor clearance and regional lymphadenectomy, which is crucial for staging and preventing recurrence in larger tumors. *Appendectomy* - An appendectomy alone is usually sufficient for **small carcinoid tumors (<1-2 cm)** that are **confined to the appendix**, without evidence of mesoappendiceal invasion or lymph node involvement. - For tumors exceeding 2.5 cm, the risk of metastasis is considerably higher, making appendectomy alone inadequate for complete oncological control. *Appendectomy and 24 hour urinary HIAA* - While a **24-hour urinary 5-hydroxyindoleacetic acid (5-HIAA)** measurement is useful for diagnosing and monitoring **carcinoid syndrome**, it does not influence the primary surgical management decision for an appendiceal tumor of this size. - The surgical approach is dictated by **tumor size** and the risk of metastasis, not by biochemical markers alone, unless the patient presents with symptoms of carcinoid syndrome. *Appendectomy and abdominal CT scan* - An abdominal **CT scan** is valuable for **staging** and detecting distant metastases or nodal involvement, especially in larger tumors, but it is a diagnostic tool, not a treatment itself. - While a CT scan would likely be performed as part of the work-up, an appendectomy alone is insufficient as the definitive surgical management for a tumor of this size without addressing the high risk of regional spread.

Question 130: Tumours of anterior mediastinum include the following except:

A. Lymphoma
B. Germ cell tumour
C. Thymoma
D. Schwannoma (Correct Answer)

Explanation: ***Schwannoma*** - **Schwannomas** (neurilemmomas) are typically found in the **posterior mediastinum**, arising from **peripheral nerves** or nerve roots. - They are usually benign and grow slowly, presenting with symptoms due to compression of surrounding structures. *Lymphoma* - **Lymphoma** is a common tumor of the **anterior mediastinum**, often presenting as an **anterior mediastinal mass**. - Both Hodgkin and non-Hodgkin lymphomas can involve mediastinal lymph nodes. *Germ cell tumour* - **Germ cell tumors**, including **teratomas** and **seminomas**, frequently occur in the **anterior mediastinum**. - They arise from ectopic germ cell rests that migrate aberrantly during embryonic development. *Thymoma* - **Thymomas** are the most common primary tumor of the **anterior mediastinum**, originating from the **thymus gland**. - They are often associated with **myasthenia gravis** and other paraneoplastic syndromes.

Question 131: A 35-year-old woman with newly diagnosed metastatic breast cancer (liver and bone metastases) presents with a 6 cm primary tumor, skin involvement, and 4 palpable axillary nodes. Her oncologist recommends neoadjuvant chemotherapy, but she requests immediate surgery. Evaluate the most appropriate recommendation considering oncologic principles, patient preference, and evidence-based care.

A. Compromise with lumpectomy and sentinel node biopsy
B. Recommend systemic chemotherapy first and explain that surgery is not indicated initially in metastatic disease (Correct Answer)
C. Proceed with immediate mastectomy and axillary dissection per patient request
D. Refuse surgery and insist on systemic therapy first

Explanation: ***Recommend systemic chemotherapy first and explain that surgery is not indicated initially in metastatic disease*** - For patients with **metastatic (Stage IV) breast cancer**, the disease is incurable and the primary treatment goal is **systemic control** with chemotherapy, targeted therapy, and/or endocrine therapy. - **Surgery to the primary tumor** in asymptomatic metastatic breast cancer is generally **not recommended** as it does not improve survival outcomes, based on evidence from multiple trials. - The best approach is to **educate the patient** about evidence-based care while respecting her autonomy through **shared decision-making**. - The term "neoadjuvant" is reserved for pre-operative therapy given with **curative intent**, which does not apply to Stage IV disease. *Compromise with lumpectomy and sentinel node biopsy* - A **lumpectomy** and **sentinel node biopsy** would be inadequate for a 6 cm primary tumor with skin involvement and 4 palpable axillary nodes, even if there were no metastases. - The presence of **metastatic disease** further dictates a systemic approach as primary treatment, rendering this local compromise medically inappropriate as an initial step. *Proceed with immediate mastectomy and axillary dissection per patient request* - Although this addresses the patient's request for immediate surgery and offers aggressive local control, it is **not indicated** as initial management for **metastatic breast cancer**. - Immediate extensive surgery without prior **systemic treatment** for metastatic disease does not improve survival outcomes and exposes the patient to the risks of major surgery without first addressing the systemic spread of cancer. - Surgery may be considered later for **palliation of local symptoms** if the primary tumor becomes problematic. *Refuse surgery and insist on systemic therapy first* - While this represents the medically appropriate treatment sequence, flatly refusing surgery and "insisting" on systemic therapy fails to acknowledge **patient autonomy** and may damage the physician-patient relationship. - The goal is to educate and guide the patient towards the best evidence-based option while respecting their concerns and preferences through shared decision-making, rather than issuing a directive.

Question 132: A 45-year-old female is admitted to the hospital after worsening headaches for the past month. She has noticed that the headaches are usually generalized, and frequently occur during sleep. She does not have a history of migraines or other types of headaches. Her past medical history is significant for breast cancer, which was diagnosed a year ago and treated with mastectomy. She recovered fully and returned to work shortly thereafter. CT scan of the brain now shows a solitary cortical 5cm mass surrounded by edema in the left hemisphere of the brain at the grey-white matter junction. She is admitted to the hospital for further management. What is the most appropriate next step in management for this patient?

A. Seizure prophylaxis and palliative pain therapy
B. Chemotherapy
C. Irradiation to the brain mass
D. Surgical resection of the mass (Correct Answer)

Explanation: ***Surgical resection of the mass*** - The presence of a **solitary cortical mass** with significant edema [1], [2] in a patient with a history of **breast cancer** [3] strongly suggests a resectable brain metastasis that is causing symptomatic cerebral edema. - **Surgical resection** offers the best chance for immediate symptom relief, pathological diagnosis, and improved prognosis in cases conducive to complete removal [1]. *Seizure prophylaxis and palliative pain therapy* - While seizure prophylaxis might be considered due to the mass effect, it is a **supportive measure** and does not address the underlying cause of the symptoms (the mass) that can be surgically removed. - **Palliative pain therapy** would also be a supportive measure only and would not achieve a definitive diagnosis or treatment of the mass. *Chemotherapy* - **Chemotherapy** for brain metastases often has limited efficacy due to the **blood-brain barrier** and is generally reserved for systemic disease or multiple, unresectable brain lesions. - Prior to initiating chemotherapy, a definitive **histopathologic diagnosis** is usually required, and surgical resection would provide tissue for this purpose. *Irradiation to the brain mass* - While **brain irradiation** (like stereotactic radiosurgery or whole-brain radiation therapy) is an option for brain metastases, especially for multiple or unresectable lesions, **surgical resection** is generally preferred for a solitary, accessible metastasis with significant mass effect. - Irradiation alone might not provide the same immediate symptomatic relief from brain edema as surgical decompression [2].

Question 133: Best treatment strategy for carcinoma of the anal canal:

A. Chemoradiation (Correct Answer)
B. Radiation
C. Surgery
D. Chemotherapy

Explanation: ***Chemoradiation*** - Carcinoma of the anal canal is primarily treated with **chemoradiation** (combinations of chemotherapy and radiation therapy) as the standard of care to achieve **organ preservation**. - This combined approach improves local control and survival rates compared to either modality alone, making it the **primary curative strategy** for most localized anal canal cancers. *Radiation* - While radiation therapy is a crucial component of anal canal cancer treatment, using it alone (**monotherapy**) is generally less effective than chemoradiation. - **Local recurrence rates** are higher with radiation alone compared to combined modality treatment. *Surgery* - Surgery, specifically **abdominoperineal resection (APR)**, is typically reserved for **recurrent disease** or cases where chemoradiation fails. - Initial radical surgery for anal canal cancer leads to significant morbidity (e.g., permanent colostomy) and is generally avoided as a primary treatment due to the success of chemoradiation. *Chemotherapy* - Chemotherapy alone is **not curative** for localized anal canal carcinoma. - It is primarily used in combination with radiation (chemoradiation) to sensitize the tumor to radiation and improve local control, or as treatment for **metastatic disease**.

Question 134: What is the most common tumor of the mediastinum?

A. Thymoma
B. Lymphoma
C. Neuroblastic tumor
D. Neurogenic tumor (Correct Answer)

Explanation: ***Neurogenic tumor*** - **Neurogenic tumors** are the **most common primary tumors of the mediastinum** overall, accounting for approximately **35-40%** of all mediastinal masses. - They are the most common tumors of the **posterior mediastinum** and arise from nerve sheaths (e.g., **schwannomas, neurofibromas**) or sympathetic ganglia. - These tumors occur across all age groups, with higher prevalence when including both pediatric and adult populations. *Thymoma* - **Thymomas** are the most common primary tumor of the **anterior mediastinum** in adults, accounting for about **40-50%** of anterior mediastinal masses. - However, they represent only about **20-25%** of all mediastinal tumors overall. - Often associated with paraneoplastic syndromes like **myasthenia gravis** (30-50% of cases). *Lymphoma* - **Lymphoma** is a common mediastinal tumor, particularly **Hodgkin lymphoma** in young adults, accounting for approximately **15-20%** of mediastinal masses. - It often presents with bulky mediastinal masses and symptoms like **dyspnea, cough, or superior vena cava syndrome**. - While very common, it ranks second or third overall after neurogenic tumors. *Neuroblastic tumor* - **Neuroblastic tumors** (e.g., neuroblastoma, ganglioneuroblastoma) are a subset of neurogenic tumors more common in **children**. - They arise from the sympathetic nervous system and typically occur in the posterior mediastinum. - While important in pediatric populations, they are less common than all neurogenic tumors combined.

Question 135: Most favorable prognosis after radiotherapy is in -

A. Teratoma
B. Desmoid
C. Seminoma (Correct Answer)
D. Melanoma

Explanation: ***Seminoma*** - **Seminoma** is highly **radiosensitive**, meaning it responds very well to radiation therapy, leading to excellent oncological outcomes. - Due to its sensitivity, even advanced seminomas can often be cured with radiotherapy, contributing to a **favorable prognosis**. *Teratoma* - **Teratomas** are generally **radioresistant**, meaning they do not respond well to radiation therapy. - Treatment for teratomas typically involves **surgical resection**, as radiation is largely ineffective. *Desmoid* - **Desmoid tumors** (aggressive fibromatosis) are locally aggressive but rarely metastasize, and their response to radiotherapy is variable. - While radiation can be used for local control, the prognosis is often complicated by **local recurrence** and challenging surgical margins. *Melanoma* - **Melanoma** is notoriously **radioresistant**, making radiation therapy a less effective primary treatment option. - It is often used for **palliative care** or in cases of local recurrence, but rarely leads to a cure or favorable prognosis when used alone.

Question 136: Testicular tumour which responds best to radiation is:

A. Embryonal cell carcinoma
B. Seminoma (Correct Answer)
C. Teratoma
D. Choriocarcinoma

Explanation: ***Seminoma*** - **Seminoma** is highly sensitive to radiotherapy due to its specific histological characteristics, making it the most responsive testicular tumor to radiation. - Radiation therapy is a common and effective treatment for seminoma, particularly in early stages (Stage I-IIA), often leading to excellent cure rates (>95%). - **Low-dose radiotherapy** to para-aortic and ipsilateral iliac lymph nodes is standard adjuvant treatment. *Embryonal cell carcinoma* - **Embryonal cell carcinoma** is a non-seminomatous germ cell tumor (NSGCT) that is relatively **radioresistant**. - Treatment primarily involves **cisplatin-based chemotherapy** (BEP regimen) and/or surgery. - Radiation plays minimal role in management of NSGCTs. *Teratoma* - **Teratomas** are typically resistant to both radiation therapy and chemotherapy. - Composed of differentiated mature or immature tissues that do not respond well to systemic treatments. - The primary treatment for teratoma is **surgical excision** with retroperitoneal lymph node dissection if needed. *Choriocarcinoma* - **Choriocarcinoma** is a highly aggressive NSGCT that is **radioresistant**. - Requires intensive **chemotherapy** due to high propensity for hematogenous spread. - Radiation has no role in primary treatment, though may be used for brain metastases.

Question 137: Which of the following tumours is radiosensitive?

A. Ewing's sarcoma (Correct Answer)
B. Osteosarcoma
C. Hepatocellular carcinoma
D. Malignant melanoma

Explanation: ***Ewing's sarcoma*** - **Ewing's sarcoma** is highly radiosensitive, meaning radiation therapy is an effective treatment modality, often used as a primary or adjuvant therapy. - Its high responsiveness to radiation helps control local disease and improve patient outcomes, especially when combined with chemotherapy. *Osteosarcoma* - **Osteosarcoma** is generally considered radioresistant, meaning it responds poorly to radiation therapy. - While radiation may be used in specific palliative settings, it is not a primary curative treatment for osteosarcoma, which primarily relies on surgery and chemotherapy. *Hepatocellular carcinoma* - **Hepatocellular carcinoma (HCC)** is largely radioresistant, and external beam radiation therapy has limited efficacy as a stand-alone treatment. - While certain advanced techniques like stereotactic body radiation therapy (SBRT) can be used for localized control, it is not considered broadly radiosensitive. *Malignant melanoma* - **Malignant melanoma** is historically considered highly radioresistant, requiring very high doses of radiation for any significant tumor control. - In recent years, high-dose, hypofractionated radiation therapy has shown some promise for local control, but it is not a universally radiosensitive tumor.

Question 138: A 48-year old woman comes with bilateral progressive weakness of both lower limbs, spasticity and mild impairment of respiratory movements. MRI shows an intradural mid-dorsal midline enhancing lesion. What is the diagnosis?

A. Dermoid cyst
B. Intradural lipoma
C. Neuroenteric cyst
D. Meningioma (Correct Answer)

Explanation: ***Meningioma*** - This is the most common **intradural extramedullary spinal tumor** in adults, typically presenting with progressive **myelopathy** due to spinal cord compression. - The MRI finding of an **intradural mid-dorsal midline enhancing lesion** is highly suggestive, as meningiomas are often well-circumscribed and enhance intensely. *Dermoid cyst* - These are **congenital lesions** that typically present in childhood or young adulthood and can be associated with **spinal dysraphism**. - While they are intradural, they are less common than meningiomas in this age group and often exhibit different imaging characteristics (e.g., lipid components) and less uniform enhancement. *Intradural lipoma* - **Spinal lipomas** are uncommon and usually associated with **congenital spinal anomalies** or can occur as a primary tumor. - They are characterized by **fat signal intensity** on MRI and do not typically show significant enhancement, differentiating them from the described lesion. *Neuroenteric cyst* - These are rare **congenital cysts** that can be intradural, often linked to **vertebral anomalies**, and may contain mucinous fluid. - While they can be intradural, they are much less common than meningiomas and typically do not show the same pattern of strong, uniform enhancement on MRI.

Question 139: All of the following modalities can be used for in situ ablation of liver secondaries, except:

A. Radiofrequency
B. Ultrasonic waves
C. Alcohol (Correct Answer)
D. Cryotherapy

Explanation: ***Alcohol*** - While **percutaneous ethanol injection (PEI)** can be used for **ablation of small hepatocellular carcinomas**, it is generally not a primary modality for **in situ ablation of liver secondaries** due to less predictable ablation margins and diffusion. - Its use is more prevalent for very small, localized primary tumors or for cystic lesions, rather than for metastatic disease where more precise and extensive ablation is often required. *Radiofrequency* - **Radiofrequency ablation (RFA)** uses high-frequency electrical currents to generate heat, causing **coagulation necrosis** of tumor cells within the liver. - It is a widely accepted and effective modality for **in situ ablation of liver secondaries**, particularly for lesions up to 3-5 cm. *Ultrasonic waves* - **High-intensity focused ultrasound (HIFU)** uses focused ultrasonic waves to generate heat and destroy tumor tissue, and is an evolving non-invasive method for **liver tumor ablation**. - HIFU causes **thermal ablation** leading to coagulative necrosis and can be used for both primary and secondary liver tumors. *Cryotherapy* - **Cryoablation** involves the use of extreme cold to destroy tumor cells, typically by inserting probes into the tumor to create **ice balls**. - It is an effective method for **in situ ablation of liver secondaries**, causing **cellular injury** and **necrosis** through direct cold effects and microvascular thrombosis.

Question 140: Radiotherapy is most useful in:

A. Melanoma
B. Pancreatic carcinoma
C. Osteosarcoma
D. Seminoma (Correct Answer)

Explanation: ***Seminoma*** - **Seminoma** is a highly **radiosensitive** tumor, making radiotherapy a cornerstone of its treatment, especially for localized disease and in adjuvant settings. - Due to its chemosensitivity and radiosensitivity, even advanced seminoma often responds well to treatment, leading to **high cure rates**. *Melanoma* - **Melanoma** is generally considered **radioresistant**, meaning that it does not respond well to conventional doses of radiation. - Treatment primarily involves **surgical excision**, immunotherapy, and targeted therapies. *Pancreatic carcinoma* - **Pancreatic carcinoma** is notoriously **radioresistant** and has a poor prognosis, with limited effectiveness of standalone radiation therapy. - Treatment often involves a combination of **surgery**, chemotherapy, and sometimes concurrent chemoradiation, though outcomes remain challenging. *Osteosarcoma* - **Osteosarcoma** is primarily managed with **surgical resection** and **neoadjuvant/adjuvant chemotherapy**, as it is relatively radioresistant. - Radiotherapy is typically reserved for unresectable tumors, palliative care, or when surgery is contraindicated.

Question 141: An elderly male presents with T3N0 laryngeal carcinoma. What would be the management?

A. Neoadjuvant chemotherapy followed by radiotherapy
B. Radical radiotherapy followed by chemotherapy
C. Radical radiotherapy without chemotherapy
D. Concurrent chemoradiotherapy (Correct Answer)

Explanation: ***Concurrent chemoradiotherapy*** - For **T3 laryngeal carcinoma (moderately advanced)**, concurrent chemoradiotherapy is the preferred management to preserve the larynx while offering a good chance of cure. - This approach combines **radiation** with **chemotherapy** given at the same time to enhance the effect of radiation and improve local control. *Neoadjuvant chemotherapy followed by radiotherapy* - **Neoadjuvant chemotherapy** is typically reserved for more advanced (T4) or unresectable tumors to reduce tumor burden before definitive local treatment. - For T3 disease, concurrent chemoradiotherapy is generally preferred for organ preservation over sequential approaches. *Radical radiotherapy followed by chemotherapy* - Sequential treatment with **radiotherapy first** followed by chemotherapy is less effective than concurrent chemoradiotherapy for organ preservation and disease control in T3 laryngeal carcinoma. - This approach may be considered in specific cases, but it's not the primary recommendation for T3 laryngeal cancer. *Radical radiotherapy without chemotherapy* - While **radical radiotherapy alone** can be used for selected early-stage (T1-T2) laryngeal cancers, it is generally insufficient for T3 disease. - The addition of chemotherapy concurrently significantly improves outcomes for T3 larynx cancer compared to radiotherapy alone, by addressing microscopic disease and sensitizing tumor cells to radiation.

Question 142: Mohs micrographic excision for basal cell carcinoma is used for all the following Except

A. Superficial basal cell carcinoma on the trunk (Correct Answer)
B. Tumors with perineural invasion
C. Tumors with aggressive histology
D. Recurrent tumor

Explanation: ***Superficial basal cell carcinoma on the trunk*** - **Mohs micrographic surgery** is generally reserved for basal cell carcinomas (BCCs) in cosmetically and functionally sensitive areas, larger tumors, or those with aggressive features. - For **superficial BCCs** on the trunk, which is considered a low-risk area, standard excision, electrodessication and curettage, or topical therapies are often sufficient and preferred due to their less invasive nature and similar efficacy for this specific tumor type. *Tumors with perineural invasion* - **Perineural invasion** indicates a higher risk of recurrence and metastasis, making Mohs surgery an appropriate choice for complete tumor removal and margin control. - The precise, margin-controlled excision of Mohs helps ensure that all microscopic extensions along nerve sheaths are identified and removed. *Tumors with aggressive histology* - **Aggressive histologic subtypes** such as infiltrative, morpheaform, or micronodular BCCs have a higher risk of subclinical extension and recurrence. - Mohs surgery is highly effective for these types as it meticulously examines 100% of the surgical margins, maximizing tumor eradication while preserving healthy tissue. *Recurrent tumour* - **Recurrent BCCs** often have ill-defined borders and can grow more aggressively due to previous treatment altering the tissue architecture, making complete removal challenging. - Mohs surgery offers the highest cure rates for recurrent BCCs by precisely mapping and excising the tumor while preserving surrounding healthy tissue.

Question 143: Radiotherapy has the most significant therapeutic role in:

A. Monoclonal gammopathy
B. Tuberculosis
C. Sarcomas (Correct Answer)
D. Sarcoidosis

Explanation: ***Sarcomas*** - **Radiotherapy** plays a crucial therapeutic role in **sarcomas**, though typically as **adjuvant therapy** combined with surgical resection - Used for **local control** in soft tissue sarcomas, particularly when wide margins cannot be achieved - **Primary radiotherapy** is the treatment of choice for certain radiation-sensitive sarcomas like **Ewing's sarcoma** and in cases of **inoperable tumors** - Essential for reducing **local recurrence rates** in high-grade soft tissue sarcomas - Among the options listed, sarcomas have the **strongest and most established indication** for radiotherapy *Monoclonal gammopathy* - Generally **observation only** for MGUS (Monoclonal Gammopathy of Undetermined Significance) - Radiotherapy used only for **solitary plasmacytoma**, which is a specific localized manifestation - Multiple myeloma (if it progresses) is treated with **chemotherapy** and targeted agents, not radiotherapy as primary treatment *Tuberculosis* - An **infectious disease** caused by *Mycobacterium tuberculosis* - Treated exclusively with **anti-tubercular drug regimens** (RIPE: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) - Radiotherapy has **no role** in treating infections *Sarcoidosis* - A **systemic inflammatory condition** with non-caseating granulomas - Primary treatment is **corticosteroids** for symptomatic cases - Immunosuppressants used for refractory cases - Radiotherapy has **no role** in inflammatory/granulomatous diseases

Question 144: In which type of hysterectomy are the uterine vessels ligated at the level of the ureter?

A. Type - I
B. Type - IV
C. Type - II (Correct Answer)
D. Type - III

Explanation: ***Type - II*** - In a **Type II hysterectomy** (modified radical hysterectomy), the **uterine vessels** are ligated at the level of the **ureter** to ensure wider margins when excising the paracervical tissue. - This approach aims to resect the **medial portion of the cardinal and uterosacral ligaments**, along with the parametrial tissue, necessitating a more lateral ligation point. *Type - I* - **Type I hysterectomy** (simple or extrafascial hysterectomy) involves ligating the **uterine vessels** closer to the uterus, **medial to the ureter**, at the level of the internal os. - This type of hysterectomy is performed for benign conditions and does not require extensive paracervical tissue removal. *Type - IV* - **Type IV hysterectomy** (radical hysterectomy) involves an even wider dissection than Type III, extending to the **hypogastric vessels**, which is well beyond the ureter. - This procedure removes more of the **lateral parametrium and paravaginal tissue**, along with the superior vesical artery. *Type - III* - **Type III hysterectomy** (radical hysterectomy) involves ligating the **uterine vessels at their origin** from the internal iliac artery, which is significantly lateral to the ureter. - This extensive dissection is performed for invasive cervical cancer, requiring removal of the **entire cardinal and uterosacral ligaments** along with wide parametrial and paravaginal tissue.

Question 145: Management of RCC less than 4 cm in size:

A. Surgery followed by chemotherapy
B. Partial nephrectomy (Correct Answer)
C. Radical nephrectomy
D. Chemotherapy

Explanation: ***Correct: Partial nephrectomy*** - For **renal cell carcinoma (RCC) less than 4 cm (T1a)**, partial nephrectomy is the **gold standard** as it offers equivalent oncological outcomes to radical nephrectomy while preserving renal function. - This approach minimizes the risk of **chronic kidney disease** and its associated complications without compromising cancer control for appropriately selected smaller tumors. - **Nephron-sparing surgery** is now the preferred approach per EAU and AUA guidelines for small renal masses. *Incorrect: Surgery followed by chemotherapy* - While surgery is the primary treatment, **adjuvant chemotherapy** is generally **not effective** for localized RCC and is not routinely recommended for small tumors. - Systemic therapies are typically reserved for **advanced or metastatic RCC**, or in specific clinical trials. *Incorrect: Radical nephrectomy* - This involves removing the entire kidney, which is typically reserved for **larger tumors (T1b and above)**, centrally located tumors, or those with significant renal parenchymal involvement. - For tumors under 4 cm, radical nephrectomy leads to **unnecessary loss of renal function** compared to partial nephrectomy. *Incorrect: Chemotherapy* - **RCC is notoriously chemoresistant**, meaning traditional chemotherapy drugs have very limited efficacy in treating this cancer. - Chemotherapy alone is **not a primary treatment modality** for localized RCC due to its poor response rates in this cancer type.

Question 146: A middle-aged man presented with a swelling over the neck since childhood. The swelling is irregular and involves large nerves and their branches. Most probable diagnosis is:

A. Toxic nodular goitre
B. Plexiform neurofibroma (Correct Answer)
C. Lymphangioma
D. Vasculitis

Explanation: ***Plexiform neurofibroma*** - This condition presents as an **irregular swelling** evident since childhood, which is characteristic of the slow growth associated with **plexiform neurofibromas**. - Its involvement of **large nerves and their branches** is a hallmark feature, distinguishing it from other neck masses. *Toxic nodular goitre* - This would present primarily as a **thyroid swelling** and is typically associated with symptoms of **hyperthyroidism**, which are not mentioned. - It does not involve **peripheral nerves** in the manner described. *Lymphangioma* - Lymphangiomas are **benign lymphatic malformations** that typically present as soft, compressible masses. - While they can occur in the neck and be present from childhood, they do not specifically involve or originate from **nerve branches**. *Vasculitis* - Vasculitis is an **inflammation of blood vessels**, which can cause a variety of symptoms including pain, skin lesions, and organ dysfunction. - It does not present as a localized, irregular neck swelling involving **nerve branches** with a history since childhood.

Question 147: Sentinel lymph node biopsy is most useful for:

A. Carcinoma vulva (Correct Answer)
B. Carcinoma endometrium
C. Carcinoma vagina
D. Carcinoma cervix

Explanation: ***Carcinoma vulva*** - **Sentinel lymph node biopsy (SLNB)** is a standard procedure for early-stage vulvar carcinoma to assess nodal involvement with less morbidity than full inguinofemoral lymphadenectomy. - The procedure helps identify metastases in regional lymph nodes, guiding further treatment decisions while minimizing complications like **lymphedema**. *Carcinoma endometrium* - While SLNB can be used in endometrial cancer, its primary utility is in tailoring **lymphadenectomy** rather than being the "most useful" or universally preferred primary staging tool compared to vulvar cancer. - The anatomical spread often involves different lymphatic basins, and **comprehensive pelvic and para-aortic lymphadenectomy** or systematic nodal dissection remains a common approach, though SLNB is gaining traction. *Carcinoma vagina* - The lymphatic drainage of the vagina is complex and variable, making SLNB challenging and less standardized compared to vulvar cancer. - **Radical surgical excision** with **regional lymphadenectomy** remains the mainstay for staging and treatment of invasive vaginal carcinoma. *Carcinoma cervix* - For cervical cancer, SLNB is primarily used in **early-stage disease** to detect micrometastases and guide the extent of lymph node dissection. - However, **imaging** and comprehensive **pelvic lymphadenectomy** are often still crucial components for complete staging and treatment, depending on tumor characteristics.

Question 148: What is the preferred treatment approach for a patient diagnosed with locally advanced resectable squamous cell carcinoma of the lower esophagus?

A. Radiotherapy alone
B. Palliative care
C. Neoadjuvant chemoradiotherapy followed by surgery (Correct Answer)
D. Esophagectomy with lymph node dissection

Explanation: ***Neoadjuvant chemoradiotherapy followed by surgery*** - For **locally advanced resectable squamous cell carcinoma of the lower esophagus**, neoadjuvant chemoradiotherapy (concurrent chemotherapy and radiation) followed by surgery is the **preferred treatment strategy**. - The **CROSS trial** and multiple studies have established this as the standard of care, demonstrating improved survival compared to surgery alone. - This approach aims to **downstage the tumor**, eradicate micrometastases, improve resectability, and achieve better locoregional control and overall survival. - **Neoadjuvant chemoradiotherapy** is superior to chemotherapy alone as it provides both systemic and local tumor control. *Radiotherapy alone* - Radiotherapy alone is generally reserved for patients who are **not surgical candidates** due to medical comorbidities or for **definitive chemoradiation** in selected cases. - It is less effective than the multimodality approach combining chemoradiation with surgery for resectable disease. *Palliative care* - Palliative care focuses on symptom management and improving quality of life, typically for **advanced, unresectable, or metastatic disease**. - It is not the primary treatment for resectable disease with curative intent. *Esophagectomy with lymph node dissection* - While surgery (esophagectomy with lymph node dissection) is a **crucial component** of curative treatment, it is typically performed **after neoadjuvant chemoradiotherapy** for locally advanced resectable tumors. - **Surgery alone upfront** for locally advanced disease carries a higher risk of recurrence and lower survival rates compared to the multimodality approach with neoadjuvant therapy.

Question 149: A 50-year-old male presents with progressive pain and swelling in the knee. A biopsy reveals chondrosarcoma. What is the most appropriate management?

A. Chemotherapy
B. Radiotherapy
C. Surgical resection (Correct Answer)
D. Observation

Explanation: ***Surgical resection*** - **Chondrosarcoma** is a **radio-resistant** and **chemo-resistant** tumor, making surgical removal with **wide margins** the primary and most effective treatment. - The goal of surgery is to achieve **complete tumor eradication** to prevent local recurrence and improve patient survival rates. *Chemotherapy* - Chondrosarcoma generally shows a **poor response** to conventional chemotherapy due to low mitotic activity and increased resistance. - Chemotherapy is typically reserved for **high-grade, dedifferentiated, or metastatic chondrosarcomas** where other options are limited or as part of a multimodal approach. *Radiotherapy* - Chondrosarcomas are largely **radio-resistant**, meaning they do not respond well to radiation therapy in most cases. - Radiotherapy might be considered for **unresectable tumors**, cases where clear surgical margins cannot be achieved, or for **palliative care** in metastatic disease. *Observation* - **Observation** is not an appropriate management strategy for chondrosarcoma, as it is a **malignant tumor** that will progressively grow and can metastasize. - Delaying treatment allows the tumor to advance, potentially leading to **increased morbidity**, difficulty in complete resection, and a poorer prognosis.

Question 150: A 70-year-old man with a history of smoking presents with progressive weight loss and fatigue. A CT scan reveals a resectable mass in the left hilum with no evidence of distant metastases. What combination of therapies would offer the best chance of survival?

A. Chemotherapy and radiation therapy
B. Surgery followed by chemotherapy (Correct Answer)
C. Immunotherapy only
D. Observation with routine imaging

Explanation: ***Surgery followed by chemotherapy*** - For **resectable non-small cell lung cancer (NSCLC)** without distant metastases, surgical resection is the cornerstone of curative therapy. - **Adjuvant chemotherapy** is recommended post-surgery to eradicate microscopic residual disease and improve overall survival. *Chemotherapy and radiation therapy* - This combination is typically offered for **unresectable or locally advanced NSCLC**, or for patients who are not surgical candidates. - While effective in controlling local disease, it does not offer the same **curative potential** as surgical removal for resectable tumors. *Immunotherapy only* - Immunotherapy is a significant advance in lung cancer treatment, particularly for **advanced or metastatic disease**, or as an adjuvant/neoadjuvant therapy in specific settings. - However, for **resectable early-stage NSCLC**, it is not considered the primary monotherapy and would likely lead to an inferior outcome compared to surgery. *Observation with routine imaging* - This approach is appropriate for **benign lung nodules**, very small tumors in patients with limited life expectancy, or those with significant comorbidities precluding active treatment. - For a **resectable mass** in a 70-year-old with progressive symptoms, observation would lead to disease progression and a lost opportunity for cure.

Question 151: In a patient with suspected malignant melanoma of the leg, what is the most appropriate next step to confirm the diagnosis and plan treatment?

A. Total excisional biopsy with narrow margins (Correct Answer)
B. Punch biopsy of the lesion
C. Wide local excision as initial treatment
D. Immediate lymph node dissection

Explanation: ***Total excisional biopsy with narrow margins*** - A **total excisional biopsy** allows for complete histological evaluation of the lesion, including assessment of **tumor thickness (Breslow depth)**, which is crucial for staging and treatment planning in melanoma. - Using **narrow margins** (1-3 mm) minimizes disruption of surrounding tissue, preserving it for definitive wide local excision once the diagnosis is confirmed and staged. *Punch biopsy of the lesion* - A **punch biopsy** provides only a small sample of the lesion, which may not be representative of the entire tumor and can underestimate the Breslow depth, leading to inaccurate staging. - It involves sectioning the lesion, which can potentially interfere with the accurate measurement of tumor thickness if the deepest part of the tumor is missed. *Wide local excision as initial treatment* - Performing a **wide local excision** before confirming the diagnosis and staging is inappropriate. - This aggressive procedure is only indicated after a definitive diagnosis of melanoma and determination of appropriate margins based on Breslow depth to avoid unnecessary tissue removal or inadequate excision. *Immediate lymph node dissection* - **Immediate lymph node dissection** is an extensive surgical procedure with significant morbidity and is not indicated as an initial step. - It is reserved for cases where there is evidence of regional lymph node involvement, either clinically or confirmed by **sentinel lymph node biopsy**, after the primary tumor has been diagnosed and staged.

Question 152: What is the most effective treatment strategy for a young adult with newly diagnosed glioblastoma, based on current evidence?

A. Surgical resection only, as it is the primary treatment.
B. Radiation therapy alone, to maximize quality of life.
C. Participation in clinical trials for experimental therapies only.
D. Surgical resection followed by adjuvant radiation and chemotherapy, tailored by molecular profiling. (Correct Answer)

Explanation: ***Surgical resection followed by adjuvant radiation and chemotherapy, tailored by molecular profiling.*** - The **maximal safe surgical resection** is the first step, aiming to reduce tumor bulk and symptoms, followed by **adjuvant radiation therapy** with concurrent and adjuvant **temozolomide chemotherapy**. - **Molecular profiling** (e.g., for **IDH mutation**, **MGMT promoter methylation**) guides prognosis and can inform further treatment strategies, making this the cornerstone of current glioblastoma management. *Surgical resection only, as it is the primary treatment.* - While **surgical resection** is crucial for glioblastoma, it is rarely curative alone due to the infiltrative nature of the tumor. - Omission of **adjuvant radiation and chemotherapy** would lead to rapid recurrence and significantly poorer outcomes. *Radiation therapy alone, to maximize quality of life.* - **Radiation therapy** is a critical component of glioblastoma treatment, but it is insufficient as a standalone therapy for newly diagnosed glioblastoma. - Forgetting **surgical debulking** and **chemotherapy** would not significantly maximize quality of life in the long term, as tumor progression would likely negatively impact it. *Participation in clinical trials for experimental therapies only.* - While **clinical trials** offer access to novel and potentially superior treatments, they are typically pursued *after* standard of care has been initiated or as a primary option when standard treatments are exhausted or unsuitable. - Relying solely on experimental therapies without establishing a foundational treatment plan is not the current evidence-based **first-line approach** for newly diagnosed glioblastoma.

Question 153: A 65-year-old male presents with weight loss, cough, and hemoptysis. Imaging reveals a right upper lobe lung mass. After bronchoscopy with biopsy confirms squamous cell carcinoma, what steps should be taken for staging and treatment planning?

A. CT-guided biopsy and bronchoalveolar lavage
B. PET-CT and mediastinoscopy (Correct Answer)
C. Repeat bronchoscopy with lavage
D. Chest MRI with contrast and pleural fluid analysis

Explanation: ***PET-CT and mediastinoscopy*** - **PET-CT** is essential for detecting **distant metastases** and identifying **mediastinal lymph node involvement**, which are critical for accurate staging. - **Mediastinoscopy** provides histologic confirmation of **mediastinal lymph node metastases** (N2/N3 disease), guiding decisions regarding **surgical resectability** and the need for neoadjuvant therapies. *CT-guided biopsy and bronchoalveolar lavage* - A biopsy has already confirmed **squamous cell carcinoma**, rendering a repeat biopsy unnecessary at this stage for diagnosis. - **Bronchoalveolar lavage** primarily aids in diagnosing infections or diffuse lung diseases, and is not a standard staging tool for confirmed lung cancer. *Repeat bronchoscopy with lavage* - The initial bronchoscopy already yielded a **diagnostic biopsy**; repeating it primarily for lavage would not provide additional **staging information**. - Lavage is more useful for cytology in undiagnosed lesions or infections, not for comprehensive cancer staging after a definitive biopsy. *Chest MRI with contrast and pleural fluid analysis* - While **MRI** can provide detailed imaging of soft tissues, **PET-CT is superior** for detecting **distant metastases** and metabolically active lesions throughout the body for staging. - **Pleural fluid analysis** is indicated if a **pleural effusion** is present to check for malignant cells, but it's not a primary staging tool if no effusion is noted or for assessing distant spread or nodal involvement.

Question 154: What is the primary treatment for early-stage non-small cell lung cancer?

A. Chemotherapy
B. Radiotherapy
C. Surgical resection (Correct Answer)
D. Palliative care

Explanation: ***Surgical resection*** - For **early-stage non-small cell lung cancer (Stage I-II)**, surgical removal of the tumor offers the best chance for cure. - Standard approach is **lobectomy with mediastinal lymph node dissection**. - This provides the highest long-term survival rates for resectable tumors. *Chemotherapy* - While used as **adjuvant** or **neoadjuvant therapy** in early-stage NSCLC, it is not the primary curative treatment alone. - Adjuvant chemotherapy may be added post-surgery for Stage IB-III disease to reduce recurrence risk. - Chemotherapy alone is primarily used for **advanced or metastatic disease**. *Radiotherapy* - **Stereotactic body radiotherapy (SBRT)** is an important option for early-stage NSCLC in patients who are medically inoperable. - However, for **early-stage, resectable tumors**, surgery remains the preferred primary treatment due to higher cure rates. - Radiotherapy may be used as adjuvant treatment in select cases. *Palliative care* - **Palliative care** focuses on symptom relief and improving quality of life, typically for advanced or incurable cancers. - It is not considered a primary curative treatment for early-stage disease. - May be integrated alongside curative treatments in comprehensive cancer care.

Question 155: Prognosis of surgery for liver secondaries is best for which cancer?

A. Neuroendocrine
B. Esophageal
C. Genitourinary
D. Colorectal (Correct Answer)

Explanation: ***Colorectal*** - **Colorectal liver metastases (CRLM)** have the **best prognosis** after surgical resection among all liver metastases, with 5-year survival rates of **30-50%** in well-selected patients. - The liver is often the **sole site of metastasis** for a significant period, and colorectal metastases have distinct biological behavior with slower growth rates, making surgical resection a **potentially curative option**. - Established resectability criteria and multimodal treatment approaches (surgery + chemotherapy) have made CRLM one of the few metastatic cancers where long-term survival and cure are achievable. *Neuroendocrine* - While liver metastases from **neuroendocrine tumors (NETs)** are often resectable and surgery can improve symptoms and prolong survival, their prognosis is **not as favorable** as colorectal metastases. - NETs can be highly indolent or very aggressive, and the extent of liver involvement can be substantial, making complete cure less common compared to CRLM. *Genitourinary* - Liver metastases from **genitourinary cancers** (kidney, bladder, prostate) generally indicate **advanced, widely disseminated disease**, for which resection is rarely curative. - These metastases usually present in the context of **systemic disease**, and hepatic resection typically offers only palliative benefits in highly selected cases, with poor overall prognosis. *Esophageal* - **Esophageal cancer** with liver metastases represents **advanced stage disease** with very poor prognosis. - Surgical resection of esophageal cancer liver metastases is **uncommonly performed and rarely curative**, as these metastases usually signify widespread systemic disease with median survival measured in months despite treatment.

Question 156: What should be the plan of management for a patient in whom T2 gall bladder carcinoma is discovered during a simple cholecystectomy?

A. Post operative adjuvant chemotherapy
B. Whipple procedure
C. Resection of 4b-5 segment, dissection of the N1-2 nodes and excision of port sites (Correct Answer)
D. Consideration of radical cholecystectomy based on specific case factors.

Explanation: ***Resection of 4b-5 segment, dissection of the N1-2 nodes and excision of port sites*** - For **T2 gallbladder carcinoma**, **radical cholecystectomy** is indicated, which involves **segmental resection of liver segments 4b and 5** (due to direct invasion risk), **lymphadenectomy** of the regional N1 and N2 nodes, and **excision of all port sites** from the initial laparoscopic cholecystectomy. - This aggressive approach is necessary to achieve **negative margins** and remove potential **metastatic disease**, as T2 tumors have a significant risk of lymphatic and liver invasion. *Post operative adjuvant chemotherapy* - While **adjuvant chemotherapy** may be considered, especially in cases of lymph node positivity or positive margins, it is insufficient as the primary treatment alone for **T2 gallbladder carcinoma**. - **Surgical resection** remains the cornerstone of curative treatment, and chemotherapy serves as an adjunct to eliminate microscopic residual disease after an adequate surgical procedure. *Consideration of radical cholecystectomy based on specific case factors* - While individual patient factors are always considered, for **T2 gallbladder carcinoma**, **radical cholecystectomy** (defined as resection of segments 4b/5 and lymphadenectomy) is generally the **standard of care**, not merely an option to "consider." - The depth of invasion in T2 disease dictates the need for a more extensive resection beyond a simple cholecystectomy to achieve oncologic clearance. *Whipple procedure* - A **Whipple procedure (pancreaticoduodenectomy)** is a complex and extensive operation indicated for tumors involving the **head of the pancreas**, **duodenum**, or **distal common bile duct**. - **Gallbladder carcinoma** typically does not warrant a Whipple unless there is direct invasion into the pancreatic head or extensive nodal involvement in that region, which is not implied by the description of a T2 gallbladder carcinoma.

Question 157: What is the primary treatment for early-stage non-small cell lung cancer?

A. Radiotherapy
B. Surgical resection (Correct Answer)
C. Surgical resection with adjuvant chemotherapy
D. Immunotherapy

Explanation: ***Surgical resection*** - **Surgical resection** (lobectomy or segmentectomy with lymph node dissection) is the **primary and definitive treatment** for early-stage non-small cell lung cancer (Stage I-II). - For **Stage IA disease**, surgery alone provides excellent outcomes with 5-year survival rates of 70-90%, and adjuvant chemotherapy is generally **not indicated**. - For **Stage IB-II**, surgery remains primary, with adjuvant chemotherapy considered selectively based on tumor size (>4 cm), poor differentiation, vascular invasion, or other high-risk features. - Complete surgical resection offers the **best chance of cure** for resectable early-stage NSCLC. *Surgical resection with adjuvant chemotherapy* - While this combination is important for **select early-stage cases** (high-risk Stage IB, Stage II-IIIA), it is **not the universal primary treatment** for all early-stage disease. - Adjuvant chemotherapy is an **addition** to surgery in specific scenarios, not part of the primary treatment for the majority of early-stage (especially Stage IA) patients. - Current guidelines recommend risk stratification before adding adjuvant therapy. *Radiotherapy* - **Radiotherapy** (stereotactic body radiotherapy/SBRT) is reserved for **medically inoperable** patients or those who refuse surgery. - It is not the primary treatment when the patient is a **surgical candidate**. - May be used as adjuvant therapy in patients with positive margins or N2 disease. *Immunotherapy* - **Immunotherapy** has emerging roles in neoadjuvant/adjuvant settings for resectable NSCLC (recent trials showing benefit). - However, it is **not established as primary monotherapy** for early resectable disease. - More commonly used in advanced/metastatic NSCLC or as part of combination regimens in clinical trial settings for early disease.

Question 158: In which of the following cancers is intraoperative radiotherapy (IORT) applicable?

A. Gastric cancer
B. Colon carcinoma
C. Pancreatic carcinoma
D. All of the options (Correct Answer)

Explanation: ***All of the options*** - **Intraoperative radiotherapy (IORT)** is applicable to all three cancers listed: gastric cancer, colon carcinoma, and pancreatic carcinoma. - IORT is a technique where a **single, high dose of radiation** is delivered to the tumor bed during surgery to improve local control and reduce late toxicity to surrounding healthy tissues. - All three cancers benefit from IORT due to their **high risk of local recurrence** and the ability to directly target the tumor bed while sparing adjacent critical organs. **Gastric cancer:** - IORT addresses **high rates of local recurrence** after conventional surgery, especially in locally advanced stages - Allows direct radiation of potentially involved regional lymph nodes or margins difficult to eradicate surgically - Particularly useful when complete surgical clearance carries excessive morbidity risk **Colon carcinoma:** - IORT considered in **locally advanced or recurrent disease**, particularly when tumors invade adjacent structures - Beneficial after resections with positive or close margins - Delivers high dose to microscopic residual disease in the tumor bed, avoiding damage to vital organs from external beam radiotherapy **Pancreatic carcinoma:** - High propensity for **local invasion and recurrence** makes IORT particularly relevant - Delivers high dose directly to tumor bed following resection when microscopic residual disease is suspected - Overcomes limitations of external beam radiation due to proximity of critical organs (duodenum, stomach, kidneys)

Question 159: RPLND and Chemotherapy may be used in management of?

A. Non-seminomatous germ cell tumors of the testis (Correct Answer)
B. Non-germ cell tumors
C. Seminomatous germ cell tumors
D. Lymphoma of the testis

Explanation: ***Non-seminomatous germ cell tumors of the testis*** - **Retroperitoneal lymph node dissection (RPLND)** and **chemotherapy** are key components in the management of non-seminomatous germ cell tumors (NSGCTs), especially for metastatic disease or after initial orchidectomy. - The combination therapy addresses both local nodal involvement (RPLND) and widespread micrometastases (chemotherapy), which are common in NSGCTs. *Non-germ cell tumors* - This is a broad category, and while some non-germ cell testicular tumors may require surgery or chemotherapy, **RPLND** is not a standard part of their management in the same way it is for germ cell tumors. - The specific treatment depends on the tumor type (e.g., Leydig cell tumor, Sertoli cell tumor), stage, and histology, and often involves less aggressive approaches. *Seminomatous germ cell tumors* - **Seminomas** are highly radiosensitive and often respond well to **radiation therapy**, particularly for localized disease or retroperitoneal nodal involvement. - While chemotherapy is used for metastatic seminoma, **RPLND** is generally not indicated for seminomas due to their radiosensitivity and different metastatic patterns compared to NSGCTs. *Lymphoma of the testis* - Testicular lymphoma is a type of **non-Hodgkin lymphoma** and is primarily managed with systemic **chemotherapy** (e.g., R-CHOP) and sometimes radiation therapy. - **RPLND** is not a standard treatment modality for testicular lymphoma, as it is a systemic disease requiring systemic treatment, not local surgical excision of retroperitoneal nodes.

Question 160: What is the appropriate management for a patient with a carcinoid tumor of the appendix larger than 2 cm?

A. Right hemicolectomy (Correct Answer)
B. Appendicectomy
C. Appendicectomy + abdominal CT scan
D. Appendicectomy + 24 hrs urinary HIAA

Explanation: ***Right hemicolectomy*** - Carcinoid tumors of the appendix larger than **2 cm** are considered at high risk for **lymph node metastasis** and recurrence. - A **right hemicolectomy** provides adequate margins and allows for lymph node dissection, which is essential for staging and definitive treatment in such cases. *Appendicectomy* - An **appendicectomy** alone is typically sufficient for carcinoid tumors of the appendix that are **less than 1 cm** and localized to the tip. - For larger tumors, appendicectomy carries an unacceptably high risk of **incomplete resection** and metastatic disease. *Appendicectomy + abdominal CT scan* - While an **abdominal CT scan** is useful for assessing local spread and distant metastases, it does not address the need for a more extensive surgical resection for a **large primary tumor**. - A simple **appendicectomy** in this scenario would be inadequate as definitive treatment. *Appendicectomy + 24 hrs urinary HIAA* - **24-hour urinary 5-hydroxyindoleacetic acid (5-HIAA)** is a biomarker used to detect and monitor **carcinoid syndrome**, which occurs in a minority of patients with carcinoid tumors. - Measuring 5-HIAA is primarily for assessing systemic symptoms rather than determining the primary surgical management of the **tumor size**.

Question 161: What is the treatment of choice in desmoid tumors?

A. Irradiation
B. Wide excision (Correct Answer)
C. Local excision
D. Local excision following radiation

Explanation: ***Wide excision*** - For **desmoid tumors**, **complete surgical resection with clear margins** is the primary treatment of choice due to their infiltrative nature and high recurrence rates. - This approach aims to minimize local recurrence and prevent tumor progression, which can impact adjacent structures. *Irradiation* - **Radiation therapy** is typically reserved as an **adjuvant** treatment after surgery or for unresectable tumors, not as a primary standalone treatment. - While it can help reduce recurrence rates, it carries risks of **secondary malignancies** and local tissue damage. *Local excision* - **Local excision** alone is insufficient for desmoid tumors due to their **infiltrative growth pattern** and high propensity for **local recurrence** if positive margins remain. - It often leads to incomplete removal, necessitating further intervention and increasing the risk of tumor progression. *Local excision following radiation* - Combining local excision with initial radiation is not the preferred sequence; **wide surgical excision** is typically performed first. - Radiation might be considered preoperatively in specific cases to **reduce tumor size** or postoperatively for **positive margins**, but starting with local excision after initial radiation is not the standard primary management.

Question 162: Primary treatment for localized malignant melanoma is

A. Wide excision (Correct Answer)
B. Radiotherapy
C. Excision
D. Chemotherapy

Explanation: ***Wide excision*** - This is the **primary treatment** for localized malignant melanoma, aiming to completely remove the tumor along with a surrounding margin of healthy tissue to reduce recurrence risk. - The excisional margin width depends on the **Breslow depth** (tumor thickness). *Radiotherapy* - Not the primary treatment for localized melanoma, as melanoma cells are often **radioresistant**. - It may be used as **adjuvant therapy** for local control in cases of positive margins or nodal involvement, or for palliative care in metastatic disease. *Excision* - While excision is part of the treatment, the term **"wide excision"** specifically implies removing a sufficient margin of healthy tissue around the tumor. - Simple excision without appropriate margins is generally inadequate for malignant melanoma and carries a **high risk of local recurrence**. *Chemotherapy* - It is generally **not the first-line treatment** for localized melanoma due to limited efficacy and significant side effects. - Chemotherapy agents are typically reserved for **advanced or metastatic melanoma** and are often replaced by targeted therapies or immunotherapy in modern practice.

Question 163: What is the appropriate treatment for an incidentally detected appendicular carcinoid tumor measuring 2.5 cm?

A. Right hemicolectomy (Correct Answer)
B. Limited resection of the right colon
C. Total colectomy
D. Appendicectomy

Explanation: ***Right hemicolectomy*** - An appendiceal carcinoid tumor **larger than 2 cm** (or with **mesoappendix invasion, positive margins, or high-grade features**) warrants a right hemicolectomy due to a significantly higher risk of lymph node metastasis (20-30%). - This 2.5 cm tumor clearly exceeds the 2 cm threshold, making right hemicolectomy the standard of care. - This procedure ensures adequate oncological margins and removal of regional lymph nodes, which is crucial for complete treatment. *Limited resection of the right colon* - This option is insufficient for an appendiceal carcinoid of this size, as it may not remove all regional lymph nodes or provide adequate oncological margins. - Limited resection lacks the systematic lymphadenectomy required for tumors exceeding 2 cm. *Total colectomy* - This is an **overly aggressive** and unnecessary procedure for an isolated appendiceal carcinoid tumor, even one of this size. - Total colectomy is typically reserved for diffuse colonic involvement, multifocal tumors, or specific genetic syndromes, which is not indicated here. *Appendicectomy* - An appendicectomy alone is only appropriate for very small appendiceal carcinoid tumors, typically **less than 1 cm** in size, with negative margins and without evidence of mesoappendix invasion or aggressive features. - For a 2.5 cm tumor, the risk of regional lymph node involvement (20-30%) is too high for appendicectomy to be considered adequate oncological treatment.

Question 164: Type of hemicolectomy done for carcinoma of the appendix?

A. Right hemicolectomy (Correct Answer)
B. Extended Right hemicolectomy
C. Left hemicolectomy
D. Extended left hemicolectomy

Explanation: ***Right hemicolectomy*** - Carcinoma of the appendix typically requires a **right hemicolectomy** due to the **lymphatic drainage** patterns of the appendix which extend to the right colon mesentery. - This procedure ensures adequate removal of the primary tumor, regional lymph nodes, and a segment of the adjacent colon for oncological clearance. *Extended Right hemicolectomy* - This procedure involves removal of a larger segment of the colon (**right colon plus transverse colon**), which is usually not necessary for standard appendiceal carcinomas unless there's extensive local spread to the transverse colon or multiple metastatic lymph nodes in that region. - It is a more extensive operation with higher morbidity and is typically reserved for lesions involving the **hepatic flexure** or proximal transverse colon. *Left hemicolectomy* - A left hemicolectomy removes the **descending colon** and a portion of the transverse colon, which is surgically distant from the appendix. - This procedure is indicated for tumors of the **descending colon** or **splenic flexure**, and has no role in the treatment of appendiceal carcinoma. *Extended left hemicolectomy* - This operation involves removal of the **descending colon, sigmoid colon, and sometimes the distal transverse colon**, which is far removed from the appendix. - It is performed for carcinomas of the **distal transverse colon, splenic flexure, or descending colon**, and is inappropriate for appendiceal malignancies.

Question 165: What is the standard excision margin for thick melanomas (>2 mm Breslow thickness)?

A. 2 cm (Correct Answer)
B. 5 cm
C. 7 cm
D. 10 cm

Explanation: **2 cm** - For **thick melanomas** with a Breslow thickness greater than 2 mm, a **2 cm excision margin** is recommended to minimize local recurrence risk. - This margin ensures adequate removal of microscopic disease, balancing complete tumor excision with cosmetic and functional outcomes. *5 cm* - A **5 cm excision margin** is not standard for melanoma regardless of thickness and would result in excessive tissue removal. - Such large margins are generally reserved for very rare, extremely aggressive soft tissue sarcomas or other extensive skin malignancies. *7 cm* - A **7 cm excision margin** is significantly wider than current recommendations for any melanoma thickness. - This would lead to unnecessary morbidity, including large wound defects that might require complex reconstructive surgery. *10 cm* - A **10 cm excision margin** is exceptionally wide and not medically indicated for melanoma management. - Applying such a large margin would result in substantial tissue loss and functional impairment without offering additional survival benefit.

Question 166: Which metastases are most common to the thyroid?

A. Kidney (Correct Answer)
B. GIT
C. Lung
D. Breast

Explanation: ***Kidney (Renal Cell Carcinoma)*** - **Renal cell carcinoma** is the most common primary tumor to metastasize to the thyroid gland, accounting for approximately 30-50% of all thyroid metastases. - Thyroid metastases from renal cancer are often **hypervascular** and may present as rapidly growing thyroid nodules. - These metastases typically indicate advanced disease and occur in the setting of widespread metastatic involvement. *Lung* - **Lung cancer** is the second most common source of thyroid metastases, particularly small cell and non-small cell carcinoma. - Lung cancer metastases to the thyroid usually occur in patients with known disseminated disease. - These are often identified incidentally during imaging or at autopsy. *Breast* - **Breast cancer** is the third most common primary tumor to metastasize to the thyroid. - Lobular carcinoma of the breast shows a higher propensity for thyroid metastases compared to ductal carcinoma. - Presentation is typically in the context of widespread metastatic disease. *GIT* - **Gastrointestinal (GIT) cancers**, including colorectal and gastric cancers, are uncommon sources of thyroid metastases. - When present, GIT metastases to the thyroid signify advanced disease with multiple organ involvement. - These are rare and usually discovered incidentally during evaluation for other metastatic sites.

Question 167: Which of the following statements about meningiomas is true?

A. Approximately 5% of meningiomas are malignant.
B. Arise from the dural layer
C. Meningiomas are more common in women due to hormonal influences.
D. 95% cure rate following total surgical resection of benign meningiomas (Correct Answer)

Explanation: ***95% cure rate following treatment*** - Meningiomas generally have a **high cure rate of approximately 95%** following surgical resection, especially when they are completely excised [1]. - They are typically **benign tumors**, resulting in favorable outcomes with appropriate management [1]. *Arise from arachnoid layer* - Meningiomas actually arise from **meningothelial cells** of the **arachnoid layer**, but this statement does not fully explain their pathogenesis. - This mischaracterization does not provide an accurate understanding of the tumor's origin and biology. *50% are malignant* - Most meningiomas are benign; only a small percentage, about **1-5%**, are classified as malignant. - Thus, stating that **50% are malignant** significantly overestimates the incidence of aggressive forms. *More common in men* - Meningiomas are more prevalent in **women**, especially those aged between 30-70 years, with a female-to-male ratio of approximately **3:1**. - This option is incorrect as it misrepresents the demographic distribution of the disease. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1316-1317.

Question 168: The surgeon is exploring the mediastinum and finds a thymic mass invading the neighboring pericardium and phrenic nerves. Frozen section shows a thymoma (low-risk histology). What is the next intraoperative plan?

A. Complete resection of tumor (Correct Answer)
B. Abandon the surgery & start radiotherapy
C. Close the mediastinum and wait for final report
D. Abandon the surgery & start chemotherapy

Explanation: ***Complete resection of tumor*** - Even with invasion into neighboring structures like the **pericardium** and **phrenic nerves**, a **thymoma** should be completely resected to achieve the best possible outcome. - **Complete surgical resection (R0 resection)** remains the cornerstone of treatment for thymomas, even in locally invasive cases (Masaoka Stage III), as it offers the best prognosis and potential for cure. - The goal is to achieve **negative margins** while resecting involved structures (pericardium, phrenic nerve if necessary) to ensure complete tumor removal. *Abandon the surgery & start chemotherapy* - **Chemotherapy** is generally reserved for **thymic carcinomas**, unresectable thymomas, or as neoadjuvant therapy for borderline resectable cases, none of which apply here. - Abandoning surgery prematurely for a resectable thymoma, even with local invasion, would significantly compromise the patient's long-term outcome and chance for cure. *Abandon the surgery & start radiotherapy* - **Radiotherapy** is used adjunctively after incomplete resection (R1/R2) or for advanced **unresectable cases**, but a locally invasive thymoma that appears resectable should be managed with surgery first. - Abandoning the opportunity for **complete surgical removal** based on local invasion alone is not the standard approach, as Stage III thymomas are often resectable. *Close the mediastinum and wait for final report* - Waiting for the **final pathology report** significantly delays definitive treatment, and the frozen section result indicating **thymoma** provides sufficient information to proceed with resection if technically feasible. - This approach would necessitate a **second surgery**, posing unnecessary risks, increased morbidity, and discomfort to the patient, given that frozen section histology guides appropriate intraoperative management.

Question 169: Treatment of squamous cell carcinoma of the anal canal not involving the deeper structures includes

A. Abdominoperineal resection
B. Wide local excision with radiotherapy
C. Wide local excision with chemoradiation
D. Chemoradiation (Correct Answer)

Explanation: ***Chemoradiation*** - **Chemoradiation** is the gold standard for treating **squamous cell carcinoma of the anal canal** that does not involve deeper structures, aiming for organ preservation. - This combined modality achieves high rates of tumor control and anus preservation, avoiding the need for a permanent colostomy. *Abdominoperineal resection* - **Abdominoperineal resection (APR)** is a more invasive surgical procedure involving the removal of the rectum and anus, resulting in a **permanent colostomy**. - It is typically reserved for **recurrent disease**, treatment failures, or large, deeply invasive tumors that cannot be managed with chemoradiation. *Wide local excision with radiotherapy* - While **wide local excision** can be used for very superficial or small, well-differentiated tumors, adding **radiotherapy alone** is generally insufficient for squamous cell carcinoma of the anal canal. - The combination of chemotherapy with radiation significantly improves treatment outcomes by increasing radiosensitization and targeting microscopic disease. *Wide local excision with chemoradiation* - **Wide local excision** followed by **chemoradiation** is generally not the primary approach for most anal canal SCCs not involving deeper structures. - The standard treatment is definitive chemoradiation alone, reserving surgery for biopsy or salvage.

Question 170: The most common tumor in the posterior mediastinum is:

A. Schwannoma (Correct Answer)
B. Lymphoma
C. Teratoma
D. Bronchogenic cyst

Explanation: ***Schwannoma*** - **Schwannomas** are **neurogenic tumors** that arise from the **nerve sheaths** and are the most common type of tumor found in the **posterior mediastinum**. - They account for about **20% of all mediastinal tumors** and usually present as a solitary, well-defined mass. *Lymphoma* - Lymphomas are more commonly found in the **anterior** or **middle mediastinum**, often presenting as multiple enlarged lymph nodes. - While they can occur in the posterior mediastinum, they are **not the most common primary tumor type** in this location. *Teratoma* - **Teratomas** are **germ cell tumors** and are predominantly found in the **anterior mediastinum**. - They contain tissue from all three germ layers and can be benign or malignant, often presenting with calcifications or fat. *Bronchogenic cyst* - **Bronchogenic cysts** are **congenital cysts** derived from abnormal budding of the tracheobronchial tree, usually located in the **middle mediastinum** or intraparenchymally. - While they can occasionally be found in the posterior mediastinum, they are developmental anomalies rather than primary tumor types and are less common than neurogenic tumors.

Practice by Chapter

Principles of Surgical Oncology

Practice Questions

Cancer Staging

Practice Questions

Surgical Margins in Cancer Surgery

Practice Questions

Sentinel Lymph Node Concepts

Practice Questions

Neoadjuvant and Adjuvant Therapy

Practice Questions

Metastasectomy

Practice Questions

Cytoreductive Surgery

Practice Questions

Hyperthermic Intraperitoneal Chemotherapy

Practice Questions

Palliative Surgical Procedures

Practice Questions

Minimally Invasive Approaches in Cancer Surgery

Practice Questions

Follow-up and Surveillance

Practice Questions

Hereditary Cancer Syndromes

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Oncological Surgery — MCQs

Oncological Surgery — MCQs

On this page